UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2021~~2022

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number	Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number	State of Incorporation or Organization	I.R.S. Employer Identification No.
001-32427	Huntsman Corporation 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	42-1648585
333-85141	Huntsman International LLC 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	87-0630358

Securities registered pursuant to Section 12(b) of the Act:

Registrant	Title of each class	Trading Symbol	Name of each exchange on which registered
Huntsman Corporation	Common Stock, par value $0.01 per share	HUN	New York Stock Exchange
Huntsman International LLC	NONE	NONE	NONE

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Huntsman Corporation	Large accelerated filer ☒	Accelerated filer ☐	Non-accelerated filer ☐	Smaller reporting company ☐	Emerging growth company ☐
Huntsman International LLC	Large accelerated filer ☐	Accelerated filer ☐	Non-accelerated filer ☒	Smaller reporting company ☐	Emerging Growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Huntsman Corporation		☐
Huntsman International LLC		☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Huntsman Corporation	Yes ☐	No ☒
Huntsman International LLC	Yes ☐	No ☒

On October ~~20, 2021, 218,030,754~~25, 2022, 192,099,455 shares of common stock of Huntsman Corporation were outstanding and 2,728 units of membership interests of Huntsman International LLC were outstanding. There is no trading market for Huntsman International LLC’s units of membership interests. All of Huntsman International LLC’s units of membership interests are held by Huntsman Corporation.

This Quarterly Report on Form 10-Q presents information for two registrants: Huntsman Corporation and Huntsman International LLC. Huntsman International LLC is a wholly-owned subsidiary of Huntsman Corporation and is the principal operating company of Huntsman Corporation. The information reflected in this Quarterly Report on Form 10-Q is equally applicable to both Huntsman Corporation and Huntsman International LLC, except where otherwise indicated. Huntsman International LLC meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q and, to the extent applicable, is therefore filing this form with a reduced disclosure format.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD

ENDED September 30, ~~2021~~2022

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION	4
ITEM 1.	Condensed Consolidated Financial Statements (Unaudited)	4
	Huntsman Corporation and Subsidiaries:
	Unaudited Condensed Consolidated Balance Sheets	4
	Unaudited Condensed Consolidated Statements of Operations	5
	Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income	6
	Unaudited Condensed Consolidated Statements of Equity	7
	Unaudited Condensed Consolidated Statements of Cash Flows	9
	Huntsman International LLC and Subsidiaries:
	Unaudited Condensed Consolidated Balance Sheets	10
	Unaudited Condensed Consolidated Statements of Operations	11
	Unaudited Condensed Consolidated Statements of ~~Operations~~Comprehensive (Loss) Income	12
	Unaudited Condensed Consolidated Statements of ~~Comprehensive Income~~Equity	13
	~~Condensed Consolidated Statements of Equity~~	14
	Unaudited Condensed Consolidated Statements of Cash Flows	1514
	Huntsman Corporation and Subsidiaries and Huntsman International LLC and Subsidiaries:
	Notes to Unaudited Condensed Consolidated Financial Statements	1715
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3936
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	5654
ITEM 4.	Controls and Procedures	5654
PART II	OTHER INFORMATION	5755
ITEM 1.	Legal Proceedings	5755
ITEM 1A.	Risk Factors	5755
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	5755
ITEM 6.	Exhibits	5856

Table of Contents

FORWARD-LOOKING STATEMENTS

Certain information set forth in this report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; projected impact of COVID-19 on our operations and future financial results; projected impact of the potential expansion of the Russia-Ukraine conflict on our operations and future financial results; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, business separations, spin-offs, or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. In some cases, forward-looking statements can be identified by terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates” or “intends” or the negative of such terms or other comparable terminology, or by discussions of strategy. We may also make additional forward-looking statements from time to time. All such subsequent forward-looking statements, whether written or oral, by us or on our behalf, are also expressly qualified by these cautionary statements.

All forward-looking statements, including without limitation any projections derived from management’s examination of historical operating trends, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them, but there can be no assurance that management’s expectations, beliefs and projections will be achieved. All forward-looking statements apply only as of the date made. We undertake no obligation to publicly update or revise forward-looking statements whether because of new information, future events or otherwise, except as required by securities and other applicable law.

There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in or contemplated by this report. Any forward-looking statements should be considered in light of the risks set forth in “Part II. Item 1A. Risk Factors” below and “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021.

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Share and Per Share Amounts)

	*September 30,*			*December 31,*			*September 30,*			*December 31,*
	*2021*			*2020*			*2022*			*2021*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	505		$	1,593		$	515		$	1,041
Accounts and notes receivable (net of allowance for doubtful accounts of $25 and $26, respectively), ($336 and $198 pledged as collateral, respectively)(a)		1,216			902
Accounts and notes receivable (net of allowance for doubtful accounts of $11 and $12, respectively), ($348 and $324 pledged as collateral, respectively)(a)								981			988
Accounts receivable from affiliates		23			8			23			27
Inventories(a)		1,174			848			1,079			1,038
Receivable associated with the Albemarle Settlement								—			333
Other current assets		196			217			115			155
Current assets held for sale								483			346
Total current assets		3,114			3,568			3,196			3,928
Property, plant and equipment, net(a)		2,540			2,505			2,288			2,443
Investment in unconsolidated affiliates		466			373			430			470
Intangible assets, net		404			453			433			469
Goodwill		741			533			636			650
Deferred income taxes		281			288			167			180
Operating lease right-of-use assets		418			445			359			381
Other noncurrent assets(a)		605			548			623			689
Noncurrent assets held for sale								—			182
Total assets	$	8,569		$	8,713		$	8,132		$	9,392

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	955		$	842		$	865		$	1,054
Accounts payable to affiliates		30			34			33			60
Accrued liabilities(a)		569			458			393			713
Current portion of debt(a)		16			593			12			12
Current operating lease liabilities(a)		54			52			50			49
Current liabilities held for sale								242			163
Total current liabilities		1,624			1,979			1,595			2,051
Long-term debt(a)		1,567			1,528			1,476			1,538
Deferred income taxes		201			212			249			161
Noncurrent operating lease liabilities(a)		383			411			326			346
Other noncurrent liabilities(a)		840			910			502			586
Noncurrent liabilities held for sale								—			151
Total liabilities		4,615			5,040			4,148			4,833
Commitments and contingencies (Notes 15 and 16)
Equity
Huntsman Corporation stockholders’ equity:
Common stock $0.01 par value, 1,200,000,000 shares authorized, 259,468,984 and 258,520,411 shares issued and 217,028,320 and 220,046,262 shares outstanding, respectively		3			3
Common stock $0.01 par value, 1,200,000,000 shares authorized, 261,142,535 and 259,701,770 shares issued and 192,757,360 and 214,170,287 shares outstanding, respectively								3			3
Additional paid-in capital		4,096			4,048			4,155			4,102
Treasury stock, 42,448,875 and 38,477,091 shares, respectively		(833	)		(731	)
Treasury stock, 68,385,175 and 45,531,489 shares, respectively								(1,686	)		(934	)
Unearned stock-based compensation		(30	)		(19	)		(37	)		(25	)
Retained earnings		1,881			1,564			2,836			2,435
Accumulated other comprehensive loss		(1,338	)		(1,346	)		(1,497	)		(1,203	)
Total Huntsman Corporation stockholders’ equity		3,779			3,519			3,774			4,378
Noncontrolling interests in subsidiaries		175			154			210			181
Total equity		3,954			3,673			3,984			4,559
Total liabilities and equity	$	8,569		$	8,713		$	8,132		$	9,392

(a)

At September 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively, ~~$31~~$22 and $2$1 of cash and cash equivalents, ~~$10~~$4 and $6$12 of accounts and notes receivable (net), ~~$52~~$60 and ~~$38~~$64 of inventories, $161 ~~and $167~~each of property, plant and equipment (net), $29 and $23 ~~each~~ of other noncurrent assets, ~~$144~~$126 and ~~$119~~$146 of accounts payable, $11 and $13 ~~each~~ of accrued liabilities, ~~$13 and $47~~$10 each of current portion of debt, $6$10 and $5$6 of current operating lease liabilities, ~~$53~~$28 and $3$35 of long-term debt, ~~$22~~$21 and ~~$17~~$20 of noncurrent operating lease liabilities and ~~$76~~$45 and ~~$82~~$46 of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In Millions, Except Per Share Amounts)

	*Three months*						*Nine months*						*Three months*						*Nine months*
	*ended*						*ended*						*ended*						*ended*
	*September 30,*						*September 30,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2022*			*2021*			*2022*			*2021*
Revenues:
Trade sales, services and fees, net	$	2,230		$	1,487		$	6,006		$	4,262		$	1,946		$	2,042		$	6,189		$	5,418
Related party sales		55			23			140			88			65			55			184			140
Total revenues		2,285			1,510			6,146			4,350			2,011			2,097			6,373			5,558
Cost of goods sold		1,802			1,231			4,840			3,612			1,662			1,660			5,017			4,397
Gross profit		483			279			1,306			738			349			437			1,356			1,161
Operating expenses:
Selling, general and administrative		204			178			620			563			165			176			532			536
Research and development		38			33			113			101			31			35			97			102
Restructuring, impairment and plant closing (credits) costs		(1	)		12			34			34
Restructuring, impairment and plant closing costs (credits)														12			(1	)		36			34
Gain on sale of India-based DIY business		0			0			(28	)		0			—			—			—			(28	)
Other operating income, net		(3	)		(3	)		(13	)		(4	)
Other operating expense (income), net														3			(3	)		(8	)		(13	)
Total operating expenses		238			220			726			694			211			207			657			631
Operating income		245			59			580			44			138			230			699			530
Interest expense, net		(15	)		(24	)		(52	)		(63	)		(16	)		(15	)		(46	)		(52	)
Equity in income of investment in unconsolidated affiliates		34			21			118			25			21			34			55			118
Fair value adjustments to Venator investment		(3	)		6			(28	)		(100	)
Fair value adjustments to Venator investment, net														(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt		0			0			(27	)		0			—			—			—			(27	)
Other income, net		7			10			23			27			10			7			23			21
Income (loss) from continuing operations before income taxes		268			72			614			(67	)
Income from continuing operations before income taxes														146			253			722			562
Income tax expense		(38	)		(15	)		(114	)		(9	)		(30	)		(34	)		(155	)		(101	)
Income (loss) from continuing operations		230			57			500			(76	)
Income from continuing operations														116			219			567			461
(Loss) income from discontinued operations, net of tax		(5	)		0			(3	)		782			(1	)		6			30			36
Net income		225			57			497			706			115			225			597			497
Net income attributable to noncontrolling interests		(16	)		(9	)		(49	)		(15	)		(15	)		(16	)		(46	)		(49	)
Net income attributable to Huntsman Corporation	$	209		$	48		$	448		$	691		$	100		$	209		$	551		$	448

Basic income (loss) per share:
Income (loss) from continuing operations attributable to Huntsman Corporation common stockholders	$	0.97		$	0.22		$	2.04		$	(0.41	)
Basic income per share:
Income from continuing operations attributable to Huntsman Corporation common stockholders													$	0.52		$	0.93		$	2.54		$	1.87
(Loss) income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		(0.02	)		0			(0.01	)		3.54			(0.01	)		0.02			0.15			0.16
Net income attributable to Huntsman Corporation common stockholders	$	0.95		$	0.22		$	2.03		$	3.13		$	0.51		$	0.95		$	2.69		$	2.03
Weighted average shares		219.4			219.8			220.2			220.8			197.7			219.4			205.2			220.2

Diluted income (loss) per share:
Income (loss) from continuing operations attributable to Huntsman Corporation common stockholders	$	0.96		$	0.22		$	2.03		$	(0.41	)
Diluted income per share:
Income from continuing operations attributable to Huntsman Corporation common stockholders													$	0.51		$	0.92		$	2.52		$	1.86
(Loss) income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		(0.02	)		0			(0.01	)		3.54			(0.01	)		0.02			0.14			0.16
Net income attributable to Huntsman Corporation common stockholders	$	0.94		$	0.22		$	2.02		$	3.13		$	0.50		$	0.94		$	2.66		$	2.02
Weighted average shares		221.3			221.3			222.2			220.8			199.2			221.3			207.2			222.2

Amounts attributable to Huntsman Corporation common stockholders:
Income (loss) from continuing operations	$	214		$	48		$	451		$	(91	)
Amounts attributable to Huntsman Corporation:
Income from continuing operations													$	101		$	203		$	521		$	412
(Loss) income from discontinued operations, net of tax		(5	)		0			(3	)		782			(1	)		6			30			36
Net income	$	209		$	48		$	448		$	691		$	100		$	209		$	551		$	448

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(In Millions)

	*Three months*						*Nine months*						*Three months*						*Nine months*
	*ended*						*ended*						*ended*						*ended*
	*September 30,*						*September 30,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2022*			*2021*			*2022*			*2021*
Net income	$	225		$	57		$	497		$	706		$	115		$	225		$	597		$	497
Other comprehensive (loss) income, net of tax:
Foreign currency translations adjustments		(36	)		14			(42	)		(42	)		(204	)		(36	)		(338	)		(42	)
Pension and other postretirement benefits adjustments		17			14			52			78			10			17			28			52
Other, net														—			—			(1	)		—
Other comprehensive (loss) income, net of tax		(19	)		28			10			36			(194	)		(19	)		(311	)		10
Comprehensive income		206			85			507			742
Comprehensive income attributable to noncontrolling interests		(17	)		(12	)		(51	)		(18	)
Comprehensive income attributable to Huntsman Corporation	$	189		$	73		$	456		$	724
Comprehensive (loss) income														(79	)		206			286			507
Comprehensive loss (income) attributable to noncontrolling interests														(6	)		(17	)		(29	)		(51	)
Comprehensive (loss) income attributable to Huntsman Corporation													$	(85	)	$	189		$	257		$	456

~~See accompanying notes to condensed consolidated financial statements.~~

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Share Amounts)

	*Huntsman Corporation Stockholders' Equity*																									*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*																									*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*						*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*			*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*			*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2021		220,046,262		$	3	$	4,048	$	(731	)	$	(19	)	$	1,564		$	(1,346	)	$	154		$	3,673
Balance, January 1, 2022																											214,170,287		$	3	$	4,102	$	(934	)	$	(25	)	$	2,435		$	(1,203	)	$	181		$	4,559
Net income		—			0		0		0			0			83			0			17			100			—			—		—		—			—			223			—			17			240
Other comprehensive loss		—			0		0		0			0			0			(13	)		0			(13	)		—			—		—		—			—			—			(11	)		(1	)		(12	)
Issuance of nonvested stock awards		—			0		25		0			(25	)		0			0			0			0			—			—		32		—			(32	)		—			—			—			—
Vesting of stock awards		664,818			0		5		0			0			0			0			0			5			1,327,568			—		7		—			—			—			—			—			7
Recognition of stock-based compensation		—			0		2		0			6			0			0			0			8			—			—		1		—			8			—			—			—			9
Repurchase and cancellation of stock awards		(202,961	)		0		0		0			0			(6	)		0			0			(6	)		(361,250	)		—		—		—			—			(13	)		—			—			(13	)
Stock options exercised		204,005			0		5		0			0			(2	)		0			0			3			387,899			—		10		—			—			(5	)		—			—			5
Dividends declared on common stock ($0.1625 per share)		—			0		0		0			0			(36	)		0			0			(36	)
Balance, March 31, 2021		220,712,124		$	3	$	4,085	$	(731	)	$	(38	)	$	1,603		$	(1,359	)	$	171		$	3,734
Treasury stock repurchased																											(5,549,348	)		—		—		(210	)		—			—			—			—			(210	)
Dividends declared on common stock ($0.2125 per share)																											—			—		—		—			—			(45	)		—			—			(45	)
Balance, March 31, 2022																											209,975,156			3		4,152		(1,144	)		(49	)		2,595			(1,214	)		197			4,540
Net income		—			0		0		0			0			156			0			16			172			—			—		—		—			—			228			—			14			242
Other comprehensive income		—			0		0		0			0			0			41			1			42
Vesting of stock awards		3,732			0		0		0			0			0			0			0			0
Recognition of stock-based compensation		—			0		2		0			4			0			0			0			6
Repurchase and cancellation of stock awards		(19,912	)		0		0		0			0			(1	)		0			0			(1	)
Stock options exercised		263,962			0		6		0			0			(3	)		0			0			3
Dividends declared to noncontrolling interests		—			0		0		0			0			0			0			(30	)		(30	)
Dividends declared on common stock ($0.1875 per share)		—			0		0		0			0			(41	)		0			0			(41	)
Balance, June 30, 2021		220,959,906		$	3	$	4,093	$	(731	)	$	(34	)	$	1,714		$	(1,318	)	$	158		$	3,885
Net income		—			0		0		0			0			209			0			16			225
Other comprehensive (loss) income		—			0		0		0			0			0			(20	)		1			(19	)
Issuance of nonvested stock awards		—			0		1		0			(1	)		0			0			0			0
Other comprehensive loss																											—			—		—		—			—			—			(98	)		(7	)		(105	)
Vesting of stock awards		7,695			0		0		0			0			0			0			0			0			4,045			—		—		—			—			—			—			—			—
Recognition of stock-based compensation		—			0		1		0			5			0			0			0			6			—			—		1		—			8			—			—			—			9
Repurchase and cancellation of stock awards		(1,869	)		0		0		0			0			0			0			0			0			(2,416	)		—		—		—			—			(1	)		—			—			(1	)
Stock options exercised		34,372			0		1		0			0			0			0			0			1			66,840			—		1		—			—			—			—			—			1
Treasury stock repurchased		(3,971,784	)		0		0		(102	)		0			0			0			0			(102	)		(8,371,423	)		—		—		(291	)		—			—			—			—			(291	)
Dividends declared on common stock ($0.1875 per share)		—			0		0		0			0			(42	)		0			0			(42	)
Balance, September 30, 2021		217,028,320		$	3	$	4,096	$	(833	)	$	(30	)	$	1,881		$	(1,338	)	$	175		$	3,954
Dividends declared on common stock ($0.2125 per share)																											—			—		—		—			—			(44	)		—			—			(44	)
Balance, June 30, 2022																											201,672,202			3		4,154		(1,435	)		(41	)		2,778			(1,312	)		204			4,351
Net income																											—			—		—		—			—			100			—			15			115
Other comprehensive loss																											—			—		—		—			—			—			(185	)		(9	)		(194	)
Vesting of stock awards																											10,174			—		—		—			—			—			—			—			—
Recognition of stock-based compensation																											—			—		1		—			4			—			—			—			5
Repurchase and cancellation of stock awards																											(2,533	)		—		—		—			—			—			—			—			—
Stock options exercised																											10,432			—		—		—			—			—			—			—			—
Treasury stock repurchased																											(8,932,915	)		—		—		(251	)		—			—			—			—			(251	)
Dividends declared on common stock ($0.2125 per share)																											—			—		—		—			—			(42	)		—			—			(42	)
Balance, September 30, 2022																											192,757,360		$	3	$	4,155	$	(1,686	)	$	(37	)	$	2,836		$	(1,497	)	$	210		$	3,984

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Share Amounts)

	*Huntsman Corporation Stockholders' Equity*																								*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*																								*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*					*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*Common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*		*Total*			*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*		*equity*			*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2020		224,295,868		$	3	$	4,008	$	(635	)	$	(17	)	$	690		$	(1,362	)	$	137	$	2,824
Balance, January 1, 2021																										220,046,262		$	3	$	4,048	$	(731	)	$	(19	)	$	1,564		$	(1,346	)	$	154		$	3,673
Net income		—			0		0		0			0			705			0			3		708			—			—		—		—			—			83			—			17			100
Other comprehensive loss		—			0		0		0			0			0			(21	)		0		(21	)		—			—		—		—			—			—			(13	)		—			(13	)
Issuance of nonvested stock awards		—			0		18		0			(18	)		0			0			0		0			—			—		25		—			(25	)		—			—			—			—
Vesting of stock awards		943,026			0		4		0			0			0			0			0		4			664,818			—		5		—			—			—			—			—			5
Recognition of stock-based compensation		—			0		2		0			5			0			0			0		7			—			—		2		—			6			—			—			—			8
Repurchase and cancellation of stock awards		(283,975	)		0		0		0			0			(6	)		0			0		(6	)		(202,961	)		—		—		—			—			(6	)		—			—			(6	)
Stock options exercised		57,209			0		2		0			0			(2	)		0			0		0			204,005			—		5		—			—			(2	)		—			—			3
Treasury stock repurchased		(5,364,519	)		0		0		(96	)		0			0			0			0		(96	)
Dividends declared on common stock ($0.1625 per share)		—			0		0		0			0			(37	)		0			0		(37	)
Balance, March 31, 2020		219,647,609		$	3	$	4,034	$	(731	)	$	(30	)	$	1,350		$	(1,383	)	$	140	$	3,383
Net (loss) income		—			0		0		0			0			(62	)		0			3		(59	)
Other comprehensive income		—			0		0		0			0			0			29			0		29
Vesting of stock awards		8,448			0		0		0			0			0			0			0		0
Recognition of stock-based compensation		—			0		2		0			4			0			0			0		6
Repurchase and cancellation of stock awards		(1,093	)		0		0		0			0			0			0			0		0
Stock options exercised		92,057			0		1		0			0			0			0			0		1
Dividends declared on common stock ($0.1625 per share)		—			0		0		0			0			(36	)		0			0		(36	)
Balance, June 30, 2020		219,747,021		$	3	$	4,037	$	(731	)	$	(26	)	$	1,252		$	(1,354	)	$	143	$	3,324
Dividends declared on common stock ($0.1625 per share)																										—			—		—		—			—			(36	)		—			—			(36	)
Balance, March 31, 2021																										220,712,124			3		4,085		(731	)		(38	)		1,603			(1,359	)		171			3,734
Net income		—			0		0		0			0			48			0			9		57			—			—		—		—			—			156			—			16			172
Other comprehensive income		—			0		0		0			0			0			25			3		28			—			—		—		—			—			—			41			1			42
Vesting of stock awards		2,890			0		0		0			0			0			0			0		0			3,732			—		—		—			—			—			—			—			—
Recognition of stock-based compensation		—			0		2		0			3			0			0			0		5			—			—		2		—			4			—			—			—			6
Repurchase and cancellation of stock awards		(710	)		0		0		0			0			(1	)		0			0		(1	)		(19,912	)		—		—		—			—			(1	)		—			—			(1	)
Stock options exercised		78,192			0		3		0			0			(3	)		0			0		0			263,962			—		6		—			—			(3	)		—			—			3
Dividends declared on common stock ($0.1625 per share)		—			0		0		0			0			(36	)		0			0		(36	)
Balance, September 30, 2020		219,827,393		$	3	$	4,042	$	(731	)	$	(23	)	$	1,260		$	(1,329	)	$	155	$	3,377
Dividends declared to noncontrolling interests																										—			—		—		—			—			—			—			(30	)		(30	)
Dividends declared on common stock ($0.1875 per share)																										—			—		—		—			—			(41	)		—			—			(41	)
Balance, June 30, 2021																										220,959,906			3		4,093		(731	)		(34	)		1,714			(1,318	)		158			3,885
Net income																										—			—		—		—			—			209			—			16			225
Other comprehensive (loss) income																										—			—		—		—			—			—			(20	)		1			(19	)
Issuance of nonvested stock awards																										—			—		1		—			(1	)		—			—			—			—
Vesting of stock awards																										7,695			—		—		—			—			—			—			—			—
Recognition of stock-based compensation																										—			—		1		—			5			—			—			—			6
Repurchase and cancellation of stock awards																										(1,869	)		—		—		—			—			—			—			—			—
Stock options exercised																										34,372			—		1		—			—			—			—			—			1
Treasury stock repurchased																										(3,971,784	)		—		—		(102	)		—			—			—			—			(102	)
Dividends declared on common stock ($0.1875 per share)																										—			—		—		—			—			(42	)		—			—			(42	)
Balance, September 30, 2021																										217,028,320		$	3	$	4,096	$	(833	)	$	(30	)	$	1,881		$	(1,338	)	$	175		$	3,954

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

	*Nine months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2021*			*2020*			*2022*			*2021*
Operating Activities:
Net income	$	497		$	706		$	597		$	497
Less: Loss (income) from discontinued operations, net of tax		3			(782	)
Income (loss) from continuing operations		500			(76	)
Adjustments to reconcile income (loss) from continuing operations to net cash provided by operating activities from continuing operations:
Less: Income from discontinued operations, net of tax								(30	)		(36	)
Income from continuing operations								567			461
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:
Equity in income of investment in unconsolidated affiliates		(118	)		(25	)		(55	)		(118	)
Unrealized losses on fair value adjustments to Venator investment		28			100
Unrealized net losses on fair value adjustments to Venator investment								9			28
Cash received from return on investment in unconsolidated subsidiary		31			18			61			31
Depreciation and amortization		219			206			207			205
Noncash lease expense		46			46			47			42
Gain on disposal of businesses/assets		(28	)		0			—			(28	)
Loss on early extinguishment of debt		27			0			—			27
Noncash restructuring and impairment charges		14			5			(1	)		14
Deferred income taxes		(22	)		(16	)		81			(22	)
Stock-based compensation		24			20			26			23
Other, net		(4	)		4			(15	)		(6	)
Changes in operating assets and liabilities:
Accounts and notes receivable		(342	)		103			(60	)		(335	)
Inventories		(329	)		154			(128	)		(270	)
Prepaid expenses		31			23
Other current assets		(11	)		4			357			20
Other noncurrent assets		(84	)		(47	)		(14	)		(84	)
Accounts payable		125			(85	)		(113	)		134
Accrued liabilities		88			(22	)		(292	)		88
Taxes paid on sale of Chemical Intermediates Businesses		0			(188	)
Other noncurrent liabilities		(32	)		(114	)		(82	)		(28	)
Net cash provided by operating activities from continuing operations		163			110			595			182
Net cash used in operating activities from discontinued operations		(1	)		(22	)
Net cash provided by (used in) operating activities from discontinued operations								9			(20	)
Net cash provided by operating activities		162			88			604			162

Investing Activities:
Capital expenditures		(250	)		(170	)		(186	)		(241	)
Cash received from sale of businesses		43			1,923
Acquisition of businesses, net of cash acquired		(245	)		(653	)
Cash received from sale of business								—			43
Acquisition of business, net of cash acquired								—			(245	)
Insurance proceeds for recovery of property damage		3			0			5			3
Other, net		10			5			5			10
Net cash (used in) provided by investing activities		(439	)		1,105
Net cash used in investing activities from continuing operations								(176	)		(430	)
Net cash used in investing activities from discontinued operations								(12	)		(9	)
Net cash used in investing activities								(188	)		(439	)

Financing Activities:
Net borrowings on revolving loan facilities								—			8
Proceeds from issuance of long-term debt								—			427
Repayments of long-term debt								(8	)		(965	)
Debt issuance costs paid								—			(4	)
Dividends paid to noncontrolling interests								—			(30	)
Dividends paid to common stockholders								(132	)		(119	)
Repurchase and cancellation of awards								(14	)		(7	)
Repurchase of common stock								(755	)		(102	)
Proceeds from issuance of common stock								6			7
Costs of early extinguishment of debt								—			(26	)
Other, net								(2	)		2
Net cash used in financing activities								(905	)		(809	)
Effect of exchange rate changes on cash								(37	)		(2	)
Decrease in cash and cash equivalents								(526	)		(1,088	)
Cash and cash equivalents at beginning of period								1,041			1,593
Cash and cash equivalents at end of period							$	515		$	505

Supplemental cash flow information:
Cash paid for interest							$	41		$	57
Cash paid for income taxes								171			83

~~(Continued)~~

~~Table~~As of ~~Contents~~

~~HUNTSMAN CORPORATION AND SUBSIDIARIES~~

~~CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)~~

~~(In Millions)~~

Nine months

ended

September 30,

2021

2020

Financing Activities:

Net borrowings (repayments) on revolving loan facilities
$ 8 $ (153 )
Proceeds from issuance of long-term debt
427 0
Repayments of long-term debt
(965 ) (17 )
Repayments of short-term debt
0 (109 )
Repayments of notes payable
0 (32 )
Debt issuance costs paid
(4 ) 0
Dividends paid to noncontrolling interests
(30 ) (24 )
Dividends paid to common stockholders
(119 ) (109 )
Repurchase and cancellation of awards
(7 ) (7 )
Proceeds from issuance of common stock
7 2
Repurchase of common stock
(102 ) (96 )
Costs of early extinguishment of debt
(26 ) 0
Other, net
2 (1 )
Net cash used in financing activities
(809 ) (546 )
Effect of exchange rate changes on cash
(2 ) (4 )
(Decrease) increase in cash, cash equivalents and restricted cash
(1,088 ) 643
Cash, cash equivalents and restricted cash at beginning of period
1,593 525
Cash, cash equivalents and restricted cash at end of period
$ 505 $ 1,168

Supplemental cash flow information:

Cash paid for interest
$ 57 $ 49
Cash paid for income taxes
83 242

~~For both~~ September 30, ~~2021~~2022 and ~~2020,~~2021, the amount of capital expenditures in accounts payable was ~~$54 million.~~$27 million and $52 million, respectively. For the nine months ended September 30, 2021, the amount of cash paid for taxes in connection with the earnout provision achieved under the terms of the sales agreement of the India-based do-it-yourself (“DIY”) business was $3 million. See “Note 4. Discontinued Operations and Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Unit Amounts)

	*September 30,*			*December 31,*
	*2022*			*2021*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	515		$	1,039
Accounts and notes receivable (net of allowance for doubtful accounts of $11 and $12, respectively), ($348 and $324 pledged as collateral, respectively)(a)		981			988
Accounts receivable from affiliates		1,035			269
Inventories(a)		1,079			1,038
Receivable associated with the Albemarle Settlement		—			333
Other current assets		115			153
Current assets held for sale		483			346
Total current assets		4,208			4,166
Property, plant and equipment, net(a)		2,288			2,443
Investment in unconsolidated affiliates		430			470
Intangible assets, net		433			469
Goodwill		636			650
Deferred income taxes		167			180
Operating lease right-of-use assets		359			381
Other noncurrent assets(a)		623			690
Noncurrent assets held for sale		—			182
Total assets	$	9,144		$	9,631

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	865		$	1,051
Accounts payable to affiliates		40			62
Accrued liabilities(a)		386			704
Current portion of debt(a)		12			12
Current operating lease liabilities(a)		50			49
Current liabilities held for sale		242			163
Total current liabilities		1,595			2,041
Long-term debt(a)		1,476			1,538
Deferred income taxes		251			163
Noncurrent operating lease liabilities(a)		326			346
Other noncurrent liabilities(a)		494			573
Noncurrent liabilities held for sale		—			151
Total liabilities		4,142			4,812
Commitments and contingencies (Notes 15 and 16)
Equity
Huntsman International LLC members’ equity:
Members’ equity, 2,728 units issued and outstanding		3,756			3,732
Retained earnings		2,518			2,093
Accumulated other comprehensive loss		(1,482	)		(1,187	)
Total Huntsman International LLC members’ equity		4,792			4,638
Noncontrolling interests in subsidiaries		210			181
Total equity		5,002			4,819
Total liabilities and equity	$	9,144		$	9,631

(a)

At September 30, 2022 and December 31, 2021, respectively, $22 and $1 of cash and cash equivalents, $4 and $12 of accounts and notes receivable (net), $60 and $64 of inventories, $161 each of property, plant and equipment (net), $29 and $23 of other noncurrent assets, $126 and $146 of accounts payable, $11 and $13 of accrued liabilities, $10 each of current portion of debt, $10 and $6 of current operating lease liabilities, $28 and $35 of long-term debt, $21 and $20 of noncurrent operating lease liabilities and $45 and $46 of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED ~~BALANCE SHEETS~~STATEMENTS OF OPERATIONS

(In ~~Millions, Except Unit Amounts)~~Millions)

September 30,

December 31,

2021

2020

ASSETS

Current assets:

Cash and cash equivalents(a)
$ 505 $ 1,591
Accounts and notes receivable (net of allowance for doubtful accounts of $25 and $26, respectively), ($336 and $198 pledged as collateral, respectively)(a)
1,216 902
Accounts receivable from affiliates
167 47
Inventories(a)
1,174 848
Other current assets
194 223
Total current assets
3,256 3,611
Property, plant and equipment, net(a)
2,540 2,505
Investment in unconsolidated affiliates
466 373
Intangible assets, net
404 453
Goodwill
741 533
Deferred income taxes
281 288
Operating lease right-of-use assets
418 445
Other noncurrent assets(a)
604 548
Total assets
$ 8,710 $ 8,756

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable(a)
$ 954 $ 842
Accounts payable to affiliates
32 36
Accrued liabilities(a)
559 455
Current portion of debt(a)
16 593
Current operating lease liabilities(a)
54 52
Total current liabilities
1,615 1,978
Long-term debt(a)
1,567 1,528
Deferred income taxes
203 214
Noncurrent operating lease liabilities(a)
383 411
Other noncurrent liabilities(a)
831 900
Total liabilities
4,599 5,031
Commitments and contingencies (Notes 15 and 16)

Equity

Huntsman International LLC members’ equity:

Members’ equity, 2,728 units issued and outstanding
3,724 3,701
Retained earnings
1,536 1,203
Accumulated other comprehensive loss
(1,324 ) (1,333 )
Total Huntsman International LLC members’ equity
3,936 3,571
Noncontrolling interests in subsidiaries
175 154
Total equity
4,111 3,725
Total liabilities and equity
$ 8,710 $ 8,756

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Revenues:
Trade sales, services and fees, net	$	1,946		$	2,042		$	6,189		$	5,418
Related party sales		65			55			184			140
Total revenues		2,011			2,097			6,373			5,558
Cost of goods sold		1,662			1,660			5,017			4,397
Gross profit		349			437			1,356			1,161
Operating expenses:
Selling, general and administrative		166			175			528			530
Research and development		31			35			97			102
Restructuring, impairment and plant closing costs (credits)		12			(1	)		36			34
Gain on sale of India-based DIY business		—			—			—			(28	)
Other operating expense (income), net		3			(3	)		(8	)		(13	)
Total operating expenses		212			206			653			625
Operating income		137			231			703			536
Interest expense, net		(16	)		(15	)		(46	)		(52	)
Equity in income of investment in unconsolidated affiliates		21			34			55			118
Fair value adjustments to Venator investment, net		(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt		—			—			—			(27	)
Other income, net		10			7			23			19
Income from continuing operations before income taxes		145			254			726			566
Income tax expense		(30	)		(35	)		(156	)		(102	)
Income from continuing operations		115			219			570			464
(Loss) income from discontinued operations, net of tax		(1	)		6			30			36
Net income		114			225			600			500
Net income attributable to noncontrolling interests		(15	)		(16	)		(46	)		(49	)
Net income attributable to Huntsman International LLC	$	99		$	209		$	554		$	451

~~(a)~~

At September 30, 2021 and December 31, 2020, respectively, $31 and $2 of cash and cash equivalents, $10 and $6 of accounts and notes receivable (net), $52 and $38 of inventories, $161 and $167 of property, plant and equipment (net), $23 each of other noncurrent assets, $144 and $119 of accounts payable, $13 each of accrued liabilities, $13 and $47 of current portion of debt, $6 and $5 of current operating lease liabilities, $53 and $3 of long-term debt, $22 and $17 of noncurrent operating lease liabilities and $76 and $82 of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF ~~OPERATIONS~~COMPREHENSIVE (LOSS) INCOME

(In Millions)

Three months

Nine months

ended

ended

September 30,

September 30,

2021

2020

2021

2020

Revenues:

Trade sales, services and fees, net
$ 2,230 $ 1,487 $ 6,006 $ 4,262
Related party sales
55 23 140 88
Total revenues
2,285 1,510 6,146 4,350
Cost of goods sold
1,802 1,231 4,840 3,612
Gross profit
483 279 1,306 738
Operating expenses:

Selling, general and administrative
203 177 614 559
Research and development
38 33 113 101
Restructuring, impairment and plant closing (credits) costs
(1 ) 12 34 34
Gain on sale of India-based DIY business
0 0 (28 ) 0
Other operating income, net
(3 ) (3 ) (13 ) (4 )
Total operating expenses
237 219 720 690
Operating income
246 60 586 48
Interest expense, net
(15 ) (24 ) (52 ) (65 )
Equity in income of investment in unconsolidated affiliates
34 21 118 25
Fair value adjustments to Venator investment
(3 ) 6 (28 ) (100 )
Loss on early extinguishment of debt
0 0 (27 ) 0
Other income, net
7 10 21 25
Income (loss) from continuing operations before income taxes
269 73 618 (67 )
Income tax expense
(39 ) (15 ) (115 ) (9 )
Income (loss) from continuing operations
230 58 503 (76 )
(Loss) income from discontinued operations, net of tax
(5 ) 0 (3 ) 782
Net income
225 58 500 706
Net income attributable to noncontrolling interests
(16 ) (9 ) (49 ) (15 )
Net income attributable to Huntsman International LLC
$ 209 $ 49 $ 451 $ 691

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Net income	$	114		$	225		$	600		$	500
Other comprehensive (loss) income, net of tax:
Foreign currency translations adjustment		(204	)		(36	)		(339	)		(42	)
Pension and other postretirement benefits adjustments		10			17			28			53
Other, net		—			—			(1	)		—
Other comprehensive (loss) income, net of tax		(194	)		(19	)		(312	)		11
Comprehensive (loss) income		(80	)		206			288			511
Comprehensive loss (income) attributable to noncontrolling interests		(6	)		(17	)		(29	)		(51	)
Comprehensive (loss) income attributable to Huntsman International LLC	$	(86	)	$	189		$	259		$	460

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF ~~COMPREHENSIVE INCOME~~ EQUITY

(In ~~Millions)~~Millions, Except Unit Amounts)

Three months

Nine months

ended

ended

September 30,

September 30,

2021

2020

2021

2020

Net income
$ 225 $ 58 $ 500 $ 706
Other comprehensive (loss) income, net of tax:

Foreign currency translations adjustment
(36 ) 15 (42 ) (42 )
Pension and other postretirement benefits adjustments
17 14 53 80
Other comprehensive (loss) income, net of tax
(19 ) 29 11 38
Comprehensive income
206 87 511 744
Comprehensive income attributable to noncontrolling interests
(17 ) (12 ) (51 ) (18 )
Comprehensive income attributable to Huntsman International LLC
$ 189 $ 75 $ 460 $ 726

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*			*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2022		2,728	$	3,732	$	2,093		$	(1,187	)	$	181		$	4,819
Net income		—		—		226			—			17			243
Dividends paid to parent		—		—		(45	)		—			—			(45	)
Other comprehensive loss		—		—		—			(11	)		(1	)		(12	)
Contribution from parent		—		9		—			—			—			9
Balance, March 31, 2022		2,728		3,741		2,274			(1,198	)		197			5,014
Net income		—		—		229			—			14			243
Dividends paid to parent		—		—		(42	)		—			—			(42	)
Other comprehensive loss		—		—		—			(99	)		(7	)		(106	)
Contribution from parent		—		10		—			—			—			10
Balance, June 30, 2022		2,728		3,751		2,461			(1,297	)		204			5,119
Net income		—		—		99			—			15			114
Dividends paid to parent		—		—		(42	)		—			—			(42	)
Other comprehensive loss		—		—		—			(185	)		(9	)		(194	)
Contribution from parent		—		5		—			—			—			5
Balance, September 30, 2022		2,728	$	3,756	$	2,518		$	(1,482	)	$	210		$	5,002

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*			*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2021		2,728	$	3,701	$	1,203		$	(1,333	)	$	154		$	3,725
Net income		—		—		85			—			17			102
Dividends paid to parent		—		—		(36	)		—			—			(36	)
Other comprehensive loss		—		—		—			(12	)		—			(12	)
Contribution from parent		—		8		—			—			—			8
Balance, March 31, 2021		2,728		3,709		1,252			(1,345	)		171			3,787
Net income		—		—		157			—			16			173
Dividends paid to parent		—		—		(41	)		—			—			(41	)
Other comprehensive income		—		—		—			41			1			42
Contribution from parent		—		7		—			—			—			7
Dividends declared to noncontrolling interests		—		—		—			—			(30	)		(30	)
Balance, June 30, 2021		2,728		3,716		1,368			(1,304	)		158			3,938
Net income		—		—		209			—			16			225
Dividends paid to parent		—		—		(41	)		—			—			(41	)
Other comprehensive loss		—		—		—			(20	)		1			(19	)
Contribution from parent		—		8		—			—			—			8
Balance, September 30, 2021		2,728	$	3,724	$	1,536		$	(1,324	)	$	175		$	4,111

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

~~CONDENSED CONSOLIDATED STATEMENTS OF EQUITY~~

~~(In Millions, Except Unit Amounts)~~

Huntsman International LLC Members

Members'

Accumulated other

Noncontrolling

equity

comprehensive

interests in

Total

Units

Amount

Retained earnings

loss

subsidiaries

equity

Balance, January 1, 2021
2,728 $ 3,701 $ 1,203 $ (1,333 ) $ 154 $ 3,725
Net income
— 0 85 0 17 102
Dividends paid to parent
— 0 (36 ) 0 0 (36 )
Other comprehensive loss
— 0 0 (12 ) 0 (12 )
Contribution from parent
— 8 0 0 0 8
Balance, March 31, 2021
2,728 $ 3,709 $ 1,252 $ (1,345 ) $ 171 $ 3,787
Net income
— 0 157 0 16 173
Dividends paid to parent
— 0 (41 ) 0 0 (41 )
Other comprehensive income
— 0 0 41 1 42
Contribution from parent
— 7 0 0 0 7
Dividends declared to noncontrolling interests
— 0 0 0 (30 ) (30 )
Balance, June 30, 2021
2,728 $ 3,716 $ 1,368 $ (1,304 ) $ 158 $ 3,938
Net income
— 0 209 0 16 225
Dividends paid to parent
— 0 (41 ) 0 0 (41 )
Other comprehensive (loss) income
— 0 0 (20 ) 1 (19 )
Contribution from parent
— 8 0 0 0 8
Balance, September 30, 2021
2,728 $ 3,724 $ 1,536 $ (1,324 ) $ 175 $ 4,111

Huntsman International LLC Members

Members'

Accumulated other

Noncontrolling

equity

comprehensive

interests in

Total

Units

Amount

Retained earnings

loss

subsidiaries

equity

Balance, January 1, 2020
2,728 $ 3,675 $ 312 $ (1,352 ) $ 137 $ 2,772
Net income
— 0 704 0 3 707
Dividends paid to parent
— 0 (37 ) 0 0 (37 )
Other comprehensive loss
— 0 0 (20 ) 0 (20 )
Contribution from parent
— 6 0 0 0 6
Balance, March 31, 2020
2,728 $ 3,681 $ 979 $ (1,372 ) $ 140 $ 3,428
Net (loss) income
— 0 (62 ) 0 3 (59 )
Dividends paid to parent
— 0 (36 ) 0 0 (36 )
Other comprehensive income
— 0 0 29 0 29
Contribution from parent
— 7 0 0 0 7
Balance, June 30, 2020
2,728 $ 3,688 $ 881 $ (1,343 ) $ 143 $ 3,369
Net income
— 0 49 0 9 58
Dividends paid to parent
— 0 (36 ) 0 0 (36 )
Other comprehensive income
— 0 0 26 3 29
Contribution from parent
— 6 0 0 0 6
Balance, September 30, 2020
2,728 $ 3,694 $ 894 $ (1,317 ) $ 155 $ 3,426

~~See accompanying notes to condensed consolidated financial statements.~~

~~Table of Contents~~

~~HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES~~

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

Nine months

ended

September 30,

2021

2020

Operating Activities:

Net income
$ 500 $ 706
Less: Loss (income) from discontinued operations, net of tax
3 (782 )
Income (loss) from continuing operations
503 (76 )
Adjustments to reconcile income (loss) from continuing operations to net cash provided by operating activities from continuing operations:

Equity in income of investment in unconsolidated affiliates
(118 ) (25 )
Unrealized losses on fair value adjustments to Venator investment
28 100
Cash received from return on investment in unconsolidated subsidiary
31 18
Depreciation and amortization
219 206
Noncash lease expense
46 46
Gain on disposal of businesses/assets
(28 ) 0
Loss on early extinguishment of debt
27 0
Noncash restructuring and impairment charges
14 5
Deferred income taxes
(22 ) (17 )
Noncash compensation
23 19
Other, net
(6 ) 8
Changes in operating assets and liabilities:

Accounts and notes receivable
(342 ) 103
Inventories
(329 ) 154
Prepaid expenses
32 24
Other current assets
(4 ) 11
Other noncurrent assets
(84 ) (47 )
Accounts payable
124 (87 )
Accrued liabilities
82 (29 )
Taxes paid on sale of Chemical Intermediates Businesses
0 (188 )
Other noncurrent liabilities
(29 ) (112 )
Net cash provided by operating activities from continuing operations
167 113
Net cash used in operating activities from discontinued operations
(1 ) (22 )
Net cash provided by operating activities
166 91

Investing Activities:

Capital expenditures
(250 ) (170 )
Cash received from sale of businesses
43 1,923
Acquisition of businesses, net of cash acquired
(245 ) (653 )
(Increase) decrease in receivable from affiliate
(105 ) 275
Insurance proceeds for recovery of property damage
3 0
Other, net
10 4
Net cash (used in) provided by investing activities
(544 ) 1,379

~~(Continued)~~

~~Table of Contents~~

~~HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES~~

~~CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)~~

~~(In Millions)~~

	*Nine months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2021*			*2020*			*2022*			*2021*
Operating Activities:
Net income							$	600		$	500
Less: Income from discontinued operations, net of tax								(30	)		(36	)
Income from continuing operations								570			464
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:
Equity in income of investment in unconsolidated affiliates								(55	)		(118	)
Unrealized net losses on fair value adjustments to Venator investment								9			28
Cash received from return on investment in unconsolidated subsidiary								61			31
Depreciation and amortization								207			205
Noncash lease expense								47			42
Gain on disposal of businesses/assets								—			(28	)
Loss on early extinguishment of debt								—			27
Noncash restructuring and impairment charges								(1	)		14
Deferred income taxes								81			(22	)
Noncash compensation								24			22
Other, net								(15	)		(8	)
Changes in operating assets and liabilities:
Accounts and notes receivable								(60	)		(335	)
Inventories								(128	)		(270	)
Other current assets								356			28
Other noncurrent assets								(14	)		(84	)
Accounts payable								(113	)		133
Accrued liabilities								(290	)		82
Other noncurrent liabilities								(82	)		(25	)
Net cash provided by operating activities from continuing operations								597			186
Net cash provided by (used in) operating activities from discontinued operations								9			(20	)
Net cash provided by operating activities								606			166

Investing Activities:
Capital expenditures								(186	)		(241	)
Cash received from sale of business								—			43
Acquisition of business, net of cash acquired								—			(245	)
Increase in receivable from affiliate								(766	)		(105	)
Insurance proceeds for recovery of property damage								5			3
Other, net								5			10
Net cash used in investing activities from continuing operations								(942	)		(535	)
Net cash used in investing activities from discontinued operations								(12	)		(9	)
Net cash used in investing activities								(954	)		(544	)

Financing Activities:
Net borrowings (repayments) on revolving loan facilities	$	8		$	(153	)
Net borrowings on revolving loan facilities								—			8
Proceeds from issuance of long-term debt		427			0			—			427
Repayments of long-term debt		(965	)		(17	)		(8	)		(965	)
Repayments of short-term debt		0			(109	)
Repayments of notes payable to affiliate		0			(380	)
Repayments of notes payable		0			(32	)
Debt issuance costs paid		(4	)		0			—			(4	)
Dividends paid to noncontrolling interests		(30	)		(23	)		—			(30	)
Dividends paid to parent		(118	)		(109	)		(129	)		(118	)
Costs of early extinguishment of debt		(26	)		0			—			(26	)
Other, net		2			(1	)		(2	)		2
Net cash used in financing activities		(706	)		(824	)		(139	)		(706	)
Effect of exchange rate changes on cash		(2	)		(4	)		(37	)		(2	)
(Decrease) increase in cash, cash equivalents and restricted cash		(1,086	)		642
Cash, cash equivalents and restricted cash at beginning of period		1,591			525
Cash, cash equivalents and restricted cash at end of period	$	505		$	1,167
Decrease in cash and cash equivalents								(524	)		(1,086	)
Cash and cash equivalents at beginning of period								1,039			1,591
Cash and cash equivalents at end of period							$	515		$	505

Supplemental cash flow information:
Cash paid for interest	$	57		$	49		$	41		$	57
Cash paid for income taxes		83			242			171			83

For ~~both~~ September 30, ~~2021~~2022 and ~~2020,~~2021, the amount of capital expenditures in accounts payable was ~~$54 million.~~$27 million and $52 million, respectively. For the nine months ended September 30, 2021, the amount of cash paid for taxes in connection with the earnout provision achieved under the terms of the sales agreement of the India-based DIY business was $3 million. See “Note 4. Discontinued Operations and Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business.”

See accompanying notes to condensed consolidated financial statements.

1614

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. GENERAL

Certain Definitions

For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” may be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary).

In this report, we may use, without definition, the common names of competitors or other industry participants. We may also use the common names or abbreviations for certain chemicals or products.

Interim Financial Statements

Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income, ~~(loss),~~ financial position and cash flows for the periods presented. Results for interim periods are not necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 for our Company and Huntsman International.

Description of Businesses

We are a global manufacturer of differentiated organic chemical products. We operate in 4three segments: Polyurethanes, Performance Products and Advanced ~~Materials and Textile Effects.~~Materials. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining and synthetic fiber ~~textile chemicals and dyes~~ industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride and epoxy-based polymer ~~formulations,~~formulations.

On August 9, 2022, we entered into a definitive agreement to sell our textile chemicals and ~~dyes.~~dyes business (“Textile Effects Business”) to Archroma, a portfolio company of SK Capital Partners (“Archroma”). Beginning in the third quarter of 2022, the results of our Textile Effects Business are reported as discontinued operations for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business.” An insignificant impact on earnings from businesses previously divested is also reported in discontinued operations.

We operate our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in 1999.

Huntsman Corporation and Huntsman International Financial Statements

Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our financial statements and Huntsman International’s financial statements relate primarily to different capital structures and purchase accounting recorded at our Company for the ~~following:~~2003 step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in 2005.

●

~~purchase accounting recorded at our Company for the~~ ~~2003~~ ~~step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in~~ ~~2005;~~ ~~and~~

●

~~the different capital structures.~~

Principles of Consolidation

Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.

~~Table of Contents~~

R~~ecent~~ eclD~~evelopments~~assfications

~~Amendments~~Certain amounts in the condensed consolidated financial statements for prior periods have been recast for all periods presented to ~~Accounts Receivable Securitization Programs~~

On ~~July 1, 2021,~~ we entered into amendments to our U.S. accounts receivable securitization program (“U.S. A/R Program”) and our European accounts receivable securitization program (“EU A/R Program” and collectivelyconform with the ~~U.S. A/R Program, “A/R Programs”) that, among other things, extended~~current presentation. These reclassifications were to present the ~~scheduled termination dates~~assets and liabilities of our ~~A/R Programs from~~ ~~April 2022~~ to ~~July 2024.~~ ~~For additional information, see~~Textile Effects Business as held for sale and its results of operations as discontinued operations. See “— Recent Developments” below as well as “Note 8.4. ~~Debt—Direct~~Discontinued Operations and ~~Subsidiary Debt—A/R Programs.~~Business Dispositions—Sale of Textile Effects Business.”

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Table of Contents

Recent Developments

European Restructuring Program

In early November 2022, we announced our commitment and specific plans to further realign our cost structure beyond the current in-progress cost optimization programs with additional restructuring in Europe. The new program will include exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we expect to record restructuring expenses of approximately $50 million through 2023.

Sale of Textile Effects Business

On August 9, 2022, we entered into a definitive agreement to sell our Textile Effects Business to Archroma for a total enterprise value of $718 million, which includes the assumption of approximately $125 million in net underfunded pension liabilities as of December 31, 2021. We anticipate the transaction will close no later than the first half of 2023. Beginning in the third quarter of 2022, the results of our Textile Effects Business are reported as discontinued operations for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business.”

2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

A~~ccounting~~ P~~ronouncements~~ A~~Dopted~~ D~~uring~~ There have been ~~2021~~no

~~We adopted~~ recently issued accounting pronouncements during the ~~following accounting pronouncement during~~ ~~2021,~~nine ~~which did~~months ended ~~not~~September 30, 2022 ~~have a significant impact on our condensed consolidated financial statements:~~ that are applicable to us.

●

~~Financial Accounting Standards Board Accounting Standards Update~~ ~~No.~~~~2021~~-~~01,~~~~Reference Rate Reform (Topic~~ ~~848~~~~): Scope.~~

3. BUSINESS COMBINATIONS ~~AND ACQUISITIONS~~

Acquisition of gaBRIEL Performance Products

On January 15, 2021, we completed the acquisition of Gabriel Performance Products, a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets ~~(“Gabriel~~(the “Gabriel Acquisition”), from funds affiliated with Audax Private Equity in an all-cash transaction of approximately $251 ~~million, subject to customary closing adjustments.~~million. The purchase price was funded from available liquidity, and the acquired business ~~is being~~has been integrated into our Advanced Materials segment. Transaction costs related to this acquisition were approximately ~~nil~~ ~~and~~ $2 million ~~respectively,~~ for the~~three~~ ~~and~~ nine months ended September 30, 2021 and were recorded in other operating income, net in our condensed consolidated statements of operations.

We accounted for the Gabriel Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The ~~preliminary~~ allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

Fair value of assets acquired and liabilities assumed:

Cash paid for the Gabriel Acquisition
$ 251

Cash
$ 9
Accounts receivable
13
Inventories
26
Property, plant and equipment
23
Intangible assets
16
Goodwill
174
Accounts payable
(7 )
Accrued liabilities
(2 )
Deferred income taxes
(1 )
Total fair value of net assets acquired
$ 251

~~Table of Contents~~

Fair value of assets acquired and liabilities assumed:
Cash paid for the Gabriel Acquisition	$	251

Cash	$	9
Accounts receivable		13
Inventories		23
Property, plant and equipment		50
Intangible assets		96
Goodwill		87
Accounts payable		(7	)
Accrued liabilities		(3	)
Deferred income taxes		(17	)
Total fair value of net assets acquired	$	251

The ~~acquisition cost allocation is preliminary pending final determination~~valuation was finalized during the first quarter of ~~the fair value of assets acquired and liabilities assumed, including final valuation of certain liabilities, property, plant and equipment, intangible assets, leases and deferred taxes.~~2022. Intangible assets acquired included in this ~~preliminary~~ allocation consist ~~primarily~~ of trademarks, technology and trade secrets. The applicable amortization periods are still being assessed. For purposes of this preliminary allocation of fair value, we have assigned any excess of the acquisition cost over the estimated preliminary fair value to goodwill. The estimated goodwill recognized is attributable primarily to projected future profitable growth in our Advanced Materials specialty portfolio and synergies. We expect that a portion of the estimated goodwill arising from the acquisition will be deductible for income tax purposes, but the amount is still being assessed. It is possible that material changes to this preliminary allocation of acquisition cost could occur.

~~The acquired business had revenues and net income of $81 million and $14 million, respectively, for the period from the date of acquisition to~~ ~~September 30, 2021~~.

A~~cquisition of~~ ~~CVC Thermoset~~ S~~pecialties~~

On ~~May 18, 2020,~~ we completed our acquisition of CVC Thermoset Specialties, a North American specialty chemical manufacturer serving the industrial composites, adhesives and coatings markets (“CVC Thermoset Specialties Acquisition”). We acquired the business for $304 million from Emerald Performance Materials LLC, which is majority owned by affiliates of American Securities LLC, in an all-cash transaction funded from available liquidity. The acquired business was integrated into our Advanced Materials segment.

We accounted for the CVC Thermoset Specialties Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

Fair value of assets acquired and liabilities assumed:

Cash paid for the CVC Thermoset Specialties Acquisition
$ 304

Accounts receivable
$ 12
Inventories
37
Property, plant and equipment
67
Intangible assets
117
Goodwill
120
Accounts payable
(7 )
Accrued liabilities
(1 )
Deferred income taxes
(41 )
Total fair value of net assets acquired
$ 304

~~Intangible assets acquired consist primarily of trademarks, trade~~ secrets, ~~and customer relationships,~~ which are ~~predominantly~~ being amortized over a period of 2015 years. The goodwill recognized is attributable primarily to projected future profitable growth in our Advanced Materials specialty portfolio and synergies. ~~None~~We acquired approximately $94 million of ~~the~~ goodwill ~~arising from the acquisition is~~that will be deductible for income tax purposes.

1916

Table of Contents

A~~cquisition of~~ I~~cynene~~-L~~apolla~~

On ~~February 20, 2020,~~ we completed our acquisition of Icynene-Lapolla, a leading North American manufacturer and distributor of spray polyurethane foam insulation systems for residential and commercial applications (“Icynene-Lapolla Acquisition”). We acquired the business from an affiliate of FFL Partners, LLC for $353 million in an all-cash transaction funded from available liquidity. The acquired business was integrated into our Polyurethanes segment.

We accounted for the Icynene-Lapolla Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

Fair value of assets acquired and liabilities assumed:

Cash paid for the Icynene-Lapolla Acquisition
$ 353

Cash
$ 7
Accounts receivable
36
Inventories
32
Prepaid expenses and other current assets
2
Property, plant and equipment
9
Intangible assets
130
Goodwill
167
Other noncurrent assets
4
Accounts payable
(14 )
Accrued liabilities
(11 )
Deferred income taxes
(9 )
Total fair value of net assets acquired
$ 353

~~As a result of the final valuation of the assets and liabilities, reallocations were made during the~~ ~~first~~ ~~quarter of~~ ~~2021~~ in certain current asset and liability, property, plant and equipment, intangible asset, goodwill, other noncurrent assets and deferred tax balances. Intangible assets acquired consist primarily of trademarks, trade secrets and customer relationships, which are predominantly being amortized over a period of 10 years. The goodwill recognized is attributable primarily to projected future profitable growth, penetration into downstream markets and synergies. ~~None~~ ~~of the goodwill arising from the acquisition is deductible for income tax purposes.~~

PRO FORMA INFORMATION FOR A~~CQUISITIONS~~CQUISITION

If the Gabriel ~~Acquisition, the CVC Thermoset Specialties Acquisition and the Icynene-Lapolla~~ Acquisition were to have occurred on January 1, ~~2020~~2021, the following estimated pro forma revenues from continuing operations, net ~~(loss)~~ income and net ~~(loss)~~ income attributable to Huntsman Corporation and Huntsman International would have been reported (dollars in millions):

Three months

Nine months

ended

ended

September 30,

September 30,

2020(1)

2021(1)

2020

Revenues
$ 1,536 $ 6,150 $ 4,487
Net income
55 485 696
Net income attributable to Huntsman Corporation
46 436 681

	*Nine months*
	*ended*
	*September 30, 2021*
Revenues	$	5,562
Net income		485
Net income attributable to Huntsman Corporation		436

Three months

Nine months

ended

ended

September 30,

September 30,

2020(1)

2021(1)
2020
Revenues
$ 1,536 $ 6,150 $ 4,487
Net income
56 488 696
Net income attributable to Huntsman International
47 439 681

(1)	~~Includes pro forma information for the Gabriel Acquisition only.~~

~~Table of Contents~~

	*Nine months*
	*ended*
	*September 30, 2021*
Revenues	$	5,562
Net income		488
Net income attributable to Huntsman International		439

4. DISCONTINUED OPERATIONS AND BUSINESS DISPOSITIONS 

SaLE~~aLE~~of tEXTILE eFFECTS bUSINESS

The following table reconciles the carrying amounts of major classes of assets and liabilities of discontinued operations to total assets and liabilities of discontinued operations that are classified as held for sale in our condensed consolidated balance sheets (dollars in millions):

	*September 30,*		*December 31,*
	*2022*		*2021*
Carrying amounts of major classes of assets held for sale:
Accounts receivable	$	138	$	171
Inventories		173		163
Other current assets		12		12
Total current assets				346
Property, plant and equipment, net		120		133
Deferred income taxes		20		26
Operating lease right-of-use assets		16		22
Other noncurrent assets		4		1
Total noncurrent assets				182
Total assets held for sale(1)	$	483	$	528
Carrying amounts of major classes of liabilities held for sale:
Accounts payable	$	75	$	94
Accrued liabilities		43		67
Current operating lease liabilities		2		2
Total current liabilities				163
Noncurrent operating lease liabilities		17		24
Other noncurrent liabilities		105		127
Total noncurrent liabilities				151
Total liabilities held for sale(1)	$	242	$	314

(1)	Total assets and liabilities held for sale as of September 30, 2022 are classified as current because it is probable that the sale of our Textile Effects Business will close within a year.

Table of Contents

The following table reconciles major line items constituting pretax income of discontinued operations to after-tax income of discontinued operations, primarily related to our Textile Effects Business, as presented in our condensed consolidated statements of operations (dollars in millions):

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Major line items constituting pretax income of discontinued operations:
Trade sales, services and fees, net	$	158		$	188		$	547		$	588
Cost of goods sold		127			142			420			443
Other expense items, net		25			31			83			91
Income from discontinued operations before income taxes		6			15			44			54
Income tax expense		(7	)		(9	)		(14	)		(18	)
Net (loss) income attributable to discontinued operations	$	(1	)	$	6		$	30		$	36

SALE OFINDIA~~ndia-~~-BASED DO-I~~based~~ T-YdOURSELF Co-ONSUMER AiDHESIVES Bt-Y~~ourself~~ c~~onsumer~~ a~~dhesives~~ b~~usiness~~USINESS

On November 3, 2020, we completed the sale of the India-based DIY business to Pidilite Industries Ltd. and received cash of approximately $257 million. ~~Under~~In the ~~terms~~second quarter of 2021, we received the ~~agreement,~~full payment of $28 million pursuant to an earnout provision ~~of up to approximately $28 million of additional cash was attainable if~~based on the ~~business achieved, within 18 months,~~DIY business’s achievement of certain sales revenue targets in line with ~~the DIY business'~~its 2019 performance. ~~The performance criteria of the earnout provision were satisfied in the~~ ~~second~~ ~~quarter of~~ ~~2021,~~ ~~and we received the full payment of $28 million.~~ As a result, we recognized an additional pretax gain of $28 million in the second quarter of 2021, which was recorded in gain on sale of India-based DIY business in our condensed consolidated statements of operations.

SaLE ofof VenatorInterEST

On December 23, 2020, we completed the sale of approximately 42.4 million ordinary shares of Venator Materials PLC (“Venator”) ~~and received approximately $99 million in cash. Subsequent to this sale of ordinary shares, we~~ no longer account for our current remaining ownership interest in Venator as an equity method investment, but rather as an investment in equity securities that are marked to fair value with changes in fair value reported in earnings. Concurrently. Concurrent with the sale of ordinary shares, we entered into an option agreement, pursuant to which we granted an option to funds advised by SK Capital Partners, LP to purchase the remaining approximate 9.7 million ordinary shares we hold in Venator at $2.15 per share. The option will expire on June 23, 2023 and will not be exercisable so long as such exercise would result in a default or an ~~"Event~~“Event of ~~Default"~~Default” under Venator’s Term Loan Credit Agreement and Revolving Credit Agreement. We record this option at fair value with changes in fair value reported in earnings.

We account for our remaining ownership interest in Venator as an investment in equity securities that are marked to fair value with changes in fair value reported in earnings. For the three months ended September 30, ~~2021~~2022 and ~~2020~~2021, we recorded net ~~(losses) gains~~losses of ~~$( 3)~~$7 million and $6$3 million, respectively, and for the nine months ended September 30, ~~2021~~ 2022and ~~2020~~2021,, we recorded net losses of ~~$28~~$9 million and ~~$100~~$28 million, respectively, to record our investment in Venator and related option ~~to sell our remaining Venator shares~~ at fair value. These net ~~(losses) gains~~losses were recorded in “Fair value adjustments to Venator ~~investment”~~investment, net” in our condensed consolidated statements of operations.

~~Summarized financial information of Venator for the~~ ~~three~~ ~~and~~ ~~nine~~ ~~months ended~~ ~~September 30, 2020~~ ~~is as follows (in millions):~~

Three months

Nine months

ended

ended

September 30,

September 30,

2020

2020

Revenues
$ 474 $ 1,462
Gross profit
20 126
Loss from continuing operations
(39 ) (48 )
Net loss
(39 ) (48 )
Net loss attributable to Venator
(42 ) (54 )

S~~ale of~~ C~~hemical~~ I~~ntermediates~~ B~~usinesses~~

On ~~January 3, 2020,~~ we completed the sale of our chemical intermediates businesses, which included PO/MTBE, and our surfactants business (“Chemical Intermediates Businesses”) to Indorama Ventures Holdings L.P. (“Indorama”) in a transaction valued at approximately $2 billion, comprised of a cash purchase price of approximately $1.92 billion and the transfer of approximately $72 million in net underfunded pension and other post-employment benefit liabilities. In connection with this sale, we recognized a net after-tax gain of $748 million in the ~~first~~~~nine~~ ~~months of~~ ~~2020.~~ ~~Also, in connection with this sale, we entered into long-term supply agreements with Indorama to supply us with certain raw materials at market prices.~~

The following table reconciles major line items constituting pretax income of discontinued operations to after-tax income of discontinued operations as presented in our condensed consolidated statements of operations (dollars in millions):

Three months

Nine months

ended

ended

September 30,

September 30,

2021

2020

2021

2020

Major line items constituting pretax income of discontinued operations(1):

Trade sales, services and fees, net⁽²⁾
$ 0 $ 0 $ 0 $ 7
Cost of goods sold⁽²⁾
0 0 0 11
Gain on sale of the Chemical Intermediates Businesses
0 0 0 978
Insurance proceeds
0 0 0 48
Other (income) expense items, net
0 0 (2 ) 1
Income from discontinued operations before income taxes
0 0 2 1,021
Income tax expense
(5 ) 0 (5 ) (239 )
Net (loss) income attributable to discontinued operations
$ (5 ) $ 0 $ (3 ) $ 782

(1)	~~Discontinued operations include our Chemical Intermediates Businesses, our Australian styrenics operations and our North American polymers and base chemicals operations for all periods presented.~~

(2)	~~Includes eliminations of trade sales, services and fees, net and cost of sales between continuing operations and discontinued operations.~~

~~Table of Contents~~

5. INVENTORIES

We state our inventories at the lower of cost or market, with cost determined using average cost, last-in first-out (“LIFO”), and first-in first-out ~~and average cost~~ methods for different components of inventory. Inventories consisted of the following (dollars in millions):

	*September 30,*			*December 31,*			*September 30,*			*December 31,*
	*2021*			*2020*			*2022*			*2021*
Raw materials and supplies	$	284		$	180		$	263		$	248
Work in progress		54			44			44			33
Finished goods		876			651			822			799
Total		1,214			875			1,129			1,080
LIFO reserves		(40	)		(27	)		(50	)		(42	)
Net inventories	$	1,174		$	848		$	1,079		$	1,038

For both September 30, ~~2021~~2022 and December 31, ~~2020~~2021, approximately 7%8% of inventories were recorded using the LIFO cost method.

Table of Contents

6. VARIABLE INTEREST ENTITIES

We evaluate our investments and transactions to identify variable interest entities for which we are the primary beneficiary. We hold a variable interest in the following joint ventures for which we are the primary beneficiary:

●

Rubicon LLC is our 50%-owned joint venture with Lanxess that manufactures products for our Polyurethanes and Performance Products segments.

●

Arabian Amines Company (“AAC”) is our 50%-owned joint venture with Zamil group that manufactures products for our Performance Products segment.

During the nine months ended September 30, ~~2021~~2022, there were no changes in our variable interest entities.

Creditors of these entities have no recourse to our general credit. See “Note 8. Debt—Direct and Subsidiary Debt.” As the primary beneficiary of these variable interest entities at September 30, ~~2021~~2022, the joint ventures’ assets, liabilities and results of operations are included in our condensed consolidated financial statements.

The following table summarizes the carrying ~~amount~~amounts of our variable interest entities’ assets and liabilities included in our condensed consolidated balance sheet as of September 30, ~~2021~~2022 and our consolidated balance sheet as of December 31, ~~2020~~2021 (dollars in millions):

	*September 30,*		*December 31,*		*September 30,*		*December 31,*
	*2021*		*2020*		*2022*		*2021*
Current assets	$	97	$	49	$	92	$	81
Property, plant and equipment, net		161		167		161		161
Operating lease right-of-use assets		28		22		30		26
Other noncurrent assets		147		138		138		148
Deferred income taxes		30		30		21		21
Total assets	$	463	$	406	$	442	$	437
Current liabilities	$	175	$	183	$	157	$	176
Long-term debt		53		3		28		35
Noncurrent operating lease liabilities		22		17		21		20
Other noncurrent liabilities		76		82		45		46
Deferred income taxes		1		1
Total liabilities	$	327	$	286	$	251	$	277

The revenues, income from continuing operations before income taxes and net cash provided by operating activities for our variable interest entities for the three and nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 are as follows (dollars in millions):

	*Three months*				*Nine months*				*Three months*				*Nine months*
	*ended*				*ended*				*ended*				*ended*
	*September 30,*				*September 30,*				*September 30,*				*September 30,*
	*2021*		*2020*		*2021*		*2020*		*2022*		*2021*		*2022*		*2021*
Revenues	$	0	$	0	$	0	$	0	$	—	$	—	$	—	$	—
Income from continuing operations before income taxes		4		0		11		1		11		4		24		11
Net cash provided by operating activities		6		3		14		17		21		6		56		14

2219

Table of Contents

7. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTS

As of September 30, ~~2021~~2022 and December 31, ~~2020~~2021, accrued restructuring costs by type of cost and initiative consisted of the following (dollars in millions):

Workforce reductions
Non-cancelable lease and contract termination costs
Other restructuring costs

Total

Accrued liabilities as of January 1, 2021
$ 29 $ 2 $ — $ 31
2021 charges for 2020 and prior initiatives
13 — 5 18
2021 charges for 2021 initiatives
2 — — 2
2021 payments for 2020 and prior initiatives
(12 ) — (4 ) (16 )
2021 payments for 2021 initiatives
(1 ) — — (1 )
Accrued liabilities as of September 30, 2021
$ 31 $ 2 $ 1 $ 34

	*Workforce reductions*			*Other restructuring costs*			*Total*
Accrued liabilities as of January 1, 2022	$	25		$	1		$	26
2022 charges for 2021 and prior initiatives		17			6			23
2022 charges for 2022 initiatives		14			—			14
2022 payments for 2021 and prior initiatives		(11	)		(6	)		(17	)
2022 payments for 2022 initiatives		(3	)		(1	)		(4	)
Accrued liabilities as of September 30, 2022	$	42		$	—		$	42

Details with respect to our reserves for restructuring, impairment and plant closing costs by segment and initiative are provided below (dollars in millions):

Performance

Advanced

Textile

Corporate

Polyurethanes Products Materials Effects and Other Total
Accrued liabilities as of January 1, 2021
$ 12 $ 2 $ 9 $ 8 $ — $ 31
2021 charges (credits) for 2020 and prior initiatives
5 1 (3 ) — 15 18
2021 charges for 2021 initiatives
— — 2 — — 2
2021 payments for 2020 and prior initiatives
(6 ) (2 ) (2 ) (3 ) (3 ) (16 )
2021 payments for 2021 initiatives
— — (1 ) — — (1 )
Accrued liabilities as of September 30, 2021
$ 11 $ 1 $ 5 $ 5 $ 12 $ 34

Current portion of restructuring reserves
$ 11 $ 1 $ 4 $ 2 $ 5 $ 23
Long-term portion of restructuring reserves
— — 1 3 7 11

				*Performance*			*Advanced*			*Corporate*
	*Polyurethanes*			*Products*			*Materials*			*and other*			*Total*
Accrued liabilities as of January 1, 2022	$	9		$	1		$	5		$	11		$	26
2022 charges for 2021 and prior initiatives		7			—			1			15			23
2022 charges for 2022 initiatives		—			1			1			12			14
2022 payments for 2021 and prior initiatives		(7	)		(1	)		(1	)		(8	)		(17	)
2022 payments for 2022 initiatives		—			—			—			(4	)		(4	)
Accrued liabilities as of September 30, 2022	$	9		$	1		$	6		$	26		$	42

Current portion of restructuring reserves	$	9		$	1		$	6		$	23		$	39
Long-term portion of restructuring reserves		—			—			—			3			3

Details with respect to cash and noncash restructuring charges from continuing operations for the three and nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 are provided below (dollars in millions):

	*Three months*					*Nine months*					*Three months*						*Nine Months*
	*ended*					*ended*					*ended*						*ended*
	*September 30,*					*September 30,*					*September 30,*						*September 30,*
	*2021*			*2020*		*2021*			*2020*		*2022*			*2021*			*2022*			*2021*
Cash charges:
2022 (credits) charges for 2021 and prior initiatives											$	(1	)	$	—		$	23		$	—
2022 charges for 2022 initiatives												14			—			14			—
2021 charges for 2020 and prior initiatives	$	—		$	—	$	18		$	—		—			—			—			18
2021 charges for 2021 initiatives		—			—		2			—		—			—			—			2
2020 charges for 2019 and prior initiatives		—			—		—			3
2020 charges for 2020 initiatives		—			8		—			26
Noncash charges:
Gain on sale of assets												(2	)		(3	)		(2	)		(3	)
Accelerated depreciation		4			3		11			3		—			4			—			11
Gain on sale of assets		(3	)		—		(3	)		—
Other noncash (credits) charges		(2	)		1		6			2
Total restructuring, impairment and plant closing costs	$	(1	)	$	12	$	34		$	34
Other noncash charges (credits)												1			(2	)		1			6
Total restructuring, impairment and plant closing costs (credits)											$	12		$	(1	)	$	36		$	34

Table of Contents

~~2021~~Restructuring Activities

Beginning in the third quarter of 2022, our Corporate function implemented restructuring programs to optimize our global approaches to leveraging managed services in various information technology functions and to align and optimize our environmental, health and safety processes and systems. In connection with these restructuring programs, we recorded net restructuring expense of approximately $12 million in the three months ended September 30, 2022, primarily related to workforce reductions. We expect to record further restructuring expenses of approximately $8 million through 2023.

Beginning in the first quarter of 2021, our Corporate ~~and other segment incurred restructuring costs related to~~function implemented a restructuring program to optimize our global approach to leveraging shared services capabilities. During the second quarter of 2022, this program was further expanded to include additional geographies. In connection with this restructuring program, we recorded net restructuring expense of approximately $15 million and $16 million in the nine months ended September 30, 2022~~30,~~ and 2021, respectively, primarily related to workforce ~~reductions, and we~~reductions. We expect to record further restructuring expenses of approximately $3$5 million through 2023.

Beginning in the third quarter of 2020, our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. During the second quarter of 2022, this optimization program was further expanded to include the entire Polyurethanes business. In connection with this restructuring program, we recorded net restructuring expense of approximately $7 million and $4 million in the nine months ended September 30, 2022~~30,~~ and 2021, respectively, primarily related to workforce ~~reductions and accelerated depreciation, partially offset by a gain on sale of assets of approximately $3 million.~~reductions. We expect to record further restructuring expenses of ~~between~~ approximately ~~$4 million and $5~~$9 million through the ~~first~~ ~~half~~end of ~~2022.~~2023.

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs in connection with the CVC Thermoset Specialties Acquisition, the alignment of the segment’s commercial organization and optimization of the segment’s manufacturing processes. In connection with these restructuring programs, we recorded net restructuring expense of approximately $1 million and $8 million in the nine months ended September 30, 2022 and 2021, respectively, primarily related to accelerated depreciation.

~~Table of Contents~~

~~2020~~R~~estructuring~~ A~~ctivities~~

~~Beginning in the~~ ~~second~~ ~~quarter of~~ ~~2020,~~ ~~our Polyurethanes segment implemented a~~ We expect to record further restructuring program to reorganize its spray polyurethane foam business to better position this business for efficiencies and growth in coming years. In connection with this restructuring program, we recorded restructuring expenseexpenses of approximately $6$9 million inthrough the ~~nine~~ ~~months ended~~ ~~September 30, 2020~~ ~~primarily related to workforce reductions and accelerated depreciation.~~

~~Beginning in the~~ ~~third~~ ~~quarter~~end of ~~2020,~~2023. our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. In connection with this restructuring program, we recorded restructuring expense of approximately $1 million in the ~~third~~ ~~quarter of~~ ~~2020.~~

~~Beginning in the~~ ~~second~~ ~~quarter of~~ ~~2020,~~ our Performance Products segment implemented a restructuring program, primarily related to workforce reductions, in response to the sale of our Chemical Intermediates Businesses to Indorama. In connection with this restructuring program, we recorded restructuring expense of approximately $4 million in the ~~nine~~ ~~months ended~~ ~~September 30, 2020.~~

~~Beginning in the~~ ~~second~~ ~~quarter of~~ ~~2020,~~ our Advanced Materials segment implemented restructuring programs, primarily related to workforce reductions, in connection with the CVC Thermoset Specialties Acquisition and the alignment of the segment's commercial organization and optimization of the segment's manufacturing processes. In connection with these restructuring programs, we recorded restructuring expense of approximately $10 million in the ~~nine~~ ~~months ended~~ ~~September 30, 2020.~~

~~During~~ ~~2020,~~ our Textile Effects segment implemented restructuring programs to rationalize and realign structurally across various functions and certain locations within the segment. In connection with these restructuring programs, we recorded restructuring expense of approximately $10 million in the ~~nine~~ ~~months ended~~ ~~September 30, 2020,~~ ~~related primarily to workforce reductions.~~

8. DEBT

Our outstanding debt, net of debt issuance costs, consisted of the following (dollars in millions):

	*September 30,*		*December 31,*		*September 30,*		*December 31,*
	*2021*		*2020*		*2022*		*2021*
Senior Credit Facilities:
Revolving facility	$	0	$	0	$	—	$	—
Amounts outstanding under A/R programs		0		0		—		—
Senior notes		1,484		2,047		1,423		1,473
Variable interest entities		66		50		38		45
Other		33		24		27		32
Total debt	$	1,583	$	2,121	$	1,488	$	1,550
Current portion of debt	$	16	$	593	$	12	$	12
Long-term portion of debt		1,567		1,528		1,476		1,538
Total debt	$	1,583	$	2,121	$	1,488	$	1,550

Direct and Subsidiary Debt

~~Huntsman Corporation’s direct debt and guarantee obligations consist of a guarantee of certain indebtedness incurred from time to time to finance certain insurance premiums.~~ Substantially all of our ~~other~~ debt, including the facilities described below, has been incurred by our subsidiaries (primarily Huntsman International). Huntsman Corporation is not a guarantor of such subsidiary debt.

Certain of our subsidiaries have third-party debt agreements that contain certain restrictions with regard to dividends, distributions, loans or advances. In certain circumstances, the consent of a third party would be required prior to the transfer of any cash or assets from these subsidiaries to us.

Debt Issuance Costs

We record debt issuance costs related to a debt liability on the balance ~~sheet~~sheets as a reduction to the face amount of that debt liability. ~~For~~As of September 30, ~~2021~~2022 and December 31, ~~2020~~2021, the amount of debt issuance costs directly reducing the debt liability was ~~$10~~$8 million and $9$10 million, respectively. We ~~record the amortization of~~amortize debt issuance costs using either a straight line or effective interest method, depending on the debt agreement, and record them as interest expense.

Table of Contents

Revolving Credit Facility

~~As of~~On ~~September 30, 2021~~May 20, 2022, ~~, our~~Huntsman International entered into a new $1.2 billion senior unsecured revolving credit facility (“(the “2022Revolving Credit Facility”) ~~was~~. Borrowings will bear interest at the rates specified in the credit agreement governing the 2022 Revolving Credit Facility, which will vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the credit agreement will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional $500 million, subject to the satisfaction of certain conditions. In connection with entering into the 2022 Revolving Credit Facility, Huntsman International terminated all commitments and repaid all obligations under its 2018 $1.2 billion senior unsecured credit facility.

The following table presents certain amounts under our 2022 Revolving Credit Facility as ~~follows~~of September 30, 2022 (monetary amounts in millions):

Unamortized

Discounts and

discounts and

Committed

Principal

Debt Issuance

Carrying

Committed

Principal

debt issuance

Carrying

Facility

Amount

Outstanding

Costs

Value

Interest Rate(2)

Maturity

amount

outstanding

costs

value

Interest rate(2)

Maturity

Revolving Credit Facility

1,200

(1)

USD LIBOR plus 1.50%

2023

2022 Revolving Credit Facility

1,200

—

(1)

—

(1)

—

(1)

Term Secured Overnight Financing Rate (“SOFR”) plus 1.475%

May 2027

(1)	On September 30, ~~2021~~2022, we had an additional ~~$10~~$11 million (U.S. dollar equivalents) of letters of credit and bank guarantees issued and outstanding under our2022 Revolving Credit Facility.

(2)	Interest rates on borrowings under the 2022Revolving Credit Facility vary based on the type of loan and Huntsman International’s debt ratings. The representative interest rate for U.S. dollar borrowings as of September 30, ~~2021~~2022 was ~~1.50%~~1.475% above ~~LIBOR.~~term SOFR.

~~Table of Contents~~

~~Term Loan Credit Facility~~

On ~~September 24, 2019,~~ ~~Huntsman International entered into a~~ ~~364~~~~-day term loan facility (the~~ ~~“2019~~ ~~Term Loan”), pursuant to which Huntsman International borrowed an aggregate principal amount of~~ ~~€92~~ ~~million (or $101 million equivalent). We used the net proceeds from the~~ ~~2019~~ ~~Term Loan to finance our acquisition of the 50% noncontrolling interest that we did~~ ~~not~~ ~~own in the Sasol-Huntsman maleic anhydride joint venture. On~~ ~~September 22, 2020,~~ ~~we repaid the~~ ~~2019~~ ~~Term Loan in full at maturity.~~

A/R Programs

Our U.S. accounts receivable securitization program (“U.S. A/R ~~Programs~~Programs”) and our European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”) are structured so that we transfer certain of our trade receivables to the U.S. special purpose entity (“U.S. SPE”) and the European special purpose entity (“EU SPE”) in transactions intended to be true sales or true contributions. The receivables collateralize debt incurred by the U.S. SPE and the EU SPE.

On July 1, 2021, we entered into amendments to our A/R Programs that, among other things, extended the respective scheduled termination dates of our A/R Programs from April 2022 to July 2024.

Information regarding our A/R Programs as of September 30, ~~2021~~2022 was as follows (monetary amounts in millions):

Maximum Funding

Amount

Maximum funding

Amount

Facility

Maturity

Availability(1)

Outstanding

Interest Rate⁽²⁾

Maturity

availability(1)

outstanding

Interest rate(2)

U.S. A/R Program

July 2024

150

(3)

Applicable rate plus 0.90%

July 2024

150

—

(3)

Applicable rate plus 0.90%

EU A/R Program

July 2024

€

100

€

Applicable rate plus 1.30%

July 2024

€

100

€

—

Applicable rate plus 1.30%

(or approximately $117)

(or approximately $96)

(1)

The amount of actual availability under our A/R Programs may be lower based on the level of eligible receivables sold, changes in the credit ratings of our customers, customer concentration levels and certain characteristics of the accounts receivable being transferred, as defined in the applicable agreements.

(2)

The applicable rate for our U.S. A/R Program is defined by the lender as USD LIBOR. The applicable rate for our EU A/R Program is either USD LIBOR, EURIBOR or ~~EURIBOR.~~SONIA (Sterling Overnight Interbank Average Rate). In anticipation of the transition away from USD LIBOR, the amendments we made in July 2021 to our A/R Programs incorporated replacement rates for the USD LIBOR.

(3)	As of September 30, ~~2021~~2022, we had approximately $7$8 million (U.S. dollar equivalents) of letters of credit issued and outstanding under our U.S. A/R Program.

As of September 30, ~~2021~~2022 and December 31, ~~2020~~2021, ~~$336~~$348 million and ~~$198~~$324 million, respectively, of accounts receivable were pledged as collateral under our A/R Programs.

Senior Notes

On January 15, 2021, Huntsman International redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 5.125% senior notes due 2021 (“2021 Senior Notes”) at the redemption price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest to, but not including, the redemption date. In connection with this redemption, we incurred an incremental cash tax liability of approximately $15 million in the first quarter of 2021 related to foreign currency exchange gains.

On May 26, 2021, Huntsman International completed a $400 million offering of its 2.95% senior notes due 2031 (“2031 Senior ~~Notes.~~Notes”). On June 23, 2021, Huntsman International applied the net proceeds from the offering, along with cash on hand, to redeem in full $400 million in aggregate principal amount of its 5.125% senior notes due 2022 (“2022 Senior ~~Notes~~Notes”) and to pay accrued but unpaid interest of approximately $2 million. In addition, we paid redemption premiums and related fees and expenses of approximately $25 million and recognized a corresponding loss on early extinguishment of debt of $26 million in the second quarter of 2021.

~~The~~

~~2031~~22 ~~Senior Notes bear interest at 2.95% per year, payable semi‑annually on~~ ~~June 15~~ ~~and~~ ~~December 15~~

Table of ~~each year, and will mature on~~ ~~June 15, 2031.~~ ~~Huntsman International~~ ~~may~~ ~~redeem the~~ ~~2031~~ ~~Senior Notes in whole or in part at any time prior to~~ ~~March 15, 2031~~ ~~at a price equal to 100% of the principal amount thereof plus a “make‑whole” premium as of, and accrued and unpaid interest, if any, to, but~~ ~~not~~ ~~including, the date of redemption. Huntsman International~~ ~~may~~ ~~redeem the~~ ~~2031~~ ~~Senior Notes at any time in whole or from time to time in part, on or after~~ ~~March 15, 2031~~ ~~at a price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to, but~~ ~~not~~ ~~including, the date of redemption. ~~

Contents

Variable Interest Entity Debt

On September 30, 2021, AAC, our consolidated 50%-owned joint venture, entered into a new term loan facility of 177 million ~~SAR~~Saudi riyal (“SAR”) (approximately $47 million) with Saudi British Bank, of which approximately 104 million SAR (approximately ~~$27~~$27 million) was funded with the remainder being funded subsequent to September 30, 2021. A portion of these funds were used to repay existing debt subsequent to September 30, 2021.

~~Note Payable from Huntsman International to Huntsman Corporation~~

~~During the~~ ~~first~~ ~~quarter~~As of ~~2020,~~September 30, 2022, AAC, our consolidated 50%-owned joint venture, had $38 million outstanding under its loan commitments and debt financing arrangements. As of September 30, 2022, we have $10 million classified as current debt and $28 million as long-term debt on our condensed consolidated balance sheets. We do not guarantee these loan commitments, and AAC is not a guarantor of any of our ~~intercompany loan of $380 million to our subsidiary Huntsman International was repaid to us in full.~~other debt obligations.

Compliance with Covenants

We believe that we are in compliance with the covenants contained in the agreements governing our material debt instruments, including our Revolving Credit Facility, our A/R Programs and our senior notes.

~~Table of Contents~~

9. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We are exposed to market risks, such as changes in interest rates, foreign exchange rates and commodity prices. From time to time, we enter into transactions, including transactions involving derivative instruments, to manage certain of these exposures. We also hedge our net investment in certain European operations.

Our revenues and expenses are denominated in various foreign currencies, and our cash flows and earnings are thus subject to fluctuations due to exchange rate variations. From time to time, we may enter into foreign currency derivative instruments to minimize the short-term impact of movements in foreign currency rates. Where practicable, we generally net multicurrency cash balances among our subsidiaries to help reduce exposure to foreign currency exchange rates. Certain other exposures may be managed from time to time through financial market transactions, principally through the purchase of spot or forward foreign exchange contracts (generally with maturities of one year or less). We do not hedge our foreign currency exposures in a manner that would eliminate the effect of changes in exchange rates on our cash flows and earnings. As of September 30, ~~2021~~2022, we had approximately ~~$178~~$225 million in notional amount (in U.S. dollar equivalents) outstanding in forward foreign currency ~~contracts.~~contracts related to continuing operations.

From time to time, we may purchase interest rate swaps and/or other derivative instruments to reduce the impact of changes in interest rates on our floating-rate exposures. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount.

We review our non-U.S. dollar denominated debt and derivative instruments to determine the appropriate amounts designated as hedges. As of September 30, ~~2021~~2022, we have designated approximately €~~120~~175 million (approximately ~~$140~~$168 million) of euro-denominated debt as a hedge of our net investment. For the nine months ended September 30, ~~2021~~2022 and ~~September 30, 2020~~2021,, the ~~amount~~amounts recognized on the hedge of our net investment ~~was~~were a loss of $29 million and a gain of $7 ~~million and a loss of $31~~ million, respectively, and were recorded in other comprehensive (loss) income in our condensed consolidated statements of comprehensive income.

10. FAIR VALUE

The fair values of financial instruments were as follows (dollars in millions):

	*September 30, 2021*						*December 31, 2020*						*September 30, 2022*						*December 31, 2021*
	*Carrying*			*Estimated*			*Carrying*			*Estimated*			*Carrying*			*Estimated*			*Carrying*			*Estimated*
	*Value*			*Fair Value*			*Value*			*Fair Value*			*value*			*fair value*			*value*			*fair value*
Non-qualified employee benefit plan investments	$	22		$	22		$	26		$	26		$	15		$	15		$	25		$	25
Investment in Venator		28			28			32			32			9			9			25			25
Option agreement for remaining Venator shares		(10	)		(10	)		11			11			—			—			(7	)		(7	)
Long-term debt (including current portion)		(1,583	)		(1,755	)		(2,121	)		(2,334	)		(1,488	)		(1,304	)		(1,550	)		(1,698	)

The carrying amounts reported in the balance sheets of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. Our investment in Venator is marked to fair value, which is obtained through market observable pricing using prevailing market prices (Level 1). Additionally, the estimated fair value of the option agreement related to the remaining ordinary shares we hold in Venator, which rounds to nil as of September 30, 2022, is based on a valuation technique using market observable inputs (Level 2). See “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest.” The fair values of non-qualified employee benefit plan investments are obtained through market observable pricing using prevailing market prices (Level 1). The estimated fair values of our long-term debt are based on quoted market prices for the identical liability when traded in an active market (Level 1). The fair value estimates presented herein are based on pertinent information available to management as of September 30, ~~2021~~2022 and December 31, ~~2020.~~ 2021. Although we are not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since September 30, ~~2021~~2022, and current estimates of fair value may differ significantly from the amounts presented herein.

During the nine months ended September 30, ~~2021~~2022, ~~there were 0~~we held no instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3), and there were 0no gains or losses (realized and unrealized) included in our earnings for instruments categorized as Level 3 within the fair value hierarchy.

2623

Table of Contents

11. REVENUE RECOGNITION

The following tables disaggregate our revenue from continuing operations by major source for the three months ended September 30, ~~2021~~2022 and ~~2020~~ ~~(dollars in millions):~~

Performance

Advanced

Textile

Corporate and

2021

Polyurethanes

Products

Materials

Effects

Eliminations

Total

Primary Geographic Markets(1)

U.S. and Canada
$ 537 $ 183 $ 90 $ 14 $ (6 ) $ 818
Europe
377 106 108 29 (3 ) 617
Asia Pacific
379 88 78 113 (1 ) 657
Rest of world
110 22 28 32 1 193
$ 1,403 $ 399 $ 304 $ 188 $ (9 ) $ 2,285

Major Product Groupings

MDI urethanes
$ 1,403 $ 1,403
Differentiated
$ 399 399
Specialty
$ 276 276
Non-specialty
28 28
Textile chemicals and dyes
$ 188 188
Eliminations
$ (9 ) (9 )
$ 1,403 $ 399 $ 304 $ 188 $ (9 ) $ 2,285

Performance

Advanced

Textile

Corporate and

2020

Polyurethanes

Products

Materials

Effects

Eliminations

Total

Primary Geographic Markets(1)

U.S. and Canada
$ 350 $ 104 $ 52 $ 12 $ (5 ) $ 513
Europe
253 57 70 20 0 400
Asia Pacific
264 63 57 86 0 470
Rest of world
69 14 20 24 0 127
$ 936 $ 238 $ 199 $ 142 $ (5 ) $ 1,510

Major Product Groupings

MDI urethanes
$ 936 $ 936
Differentiated
$ 238 238
Specialty
$ 178 178
Non-specialty
21 21
Textile chemicals and dyes
$ 142 142
Eliminations
$ (5 ) (5 )
$ 936 $ 238 $ 199 $ 142 $ (5 ) $ 1,510

~~Table of Contents~~

~~The following tables disaggregate our revenue from continuing operations by major source for the~~ ~~nine~~ ~~months ended~~ ~~September 30,~~ 2021~~and~~ ~~2020~~ (dollars in millions):

			*Performance*		*Advanced*		*Textile*		*Corporate and*								*Performance*		*Advanced*		*Corporate and*
2021	*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*
Primary Geographic Markets(1)
2022															*Polyurethanes*		*Products*		*Materials*		*eliminations*			*Total*
Primary geographic markets(1)
U.S. and Canada	$	1,338	$	460	$	262	$	39	$	(15	)	$	2,084		$	547	$	216	$	104	$	(3	)	$	864
Europe		949		283		317		95		(8	)		1,636			280		90		114		(3	)		481
Asia Pacific		1,055		276		223		362		(1	)		1,915			335		97		82		(1	)		513
Rest of world		284		56		79		92		0			511			95		31		28		(1	)		153
	$	3,626	$	1,075	$	881	$	588	$	(24	)	$	6,146		$	1,257	$	434	$	328	$	(8	)	$	2,011

Major Product Groupings
Major product groupings
MDI urethanes	$	3,626										$	3,626		$	1,257								$	1,257
Differentiated			$	1,075									1,075				$	434							434
Specialty					$	795							795						$	306					306
Non-specialty						86							86							22					22
Textile chemicals and dyes							$	588					588
Eliminations									$	(24	)		(24	)							$	(8	)		(8	)
	$	3,626	$	1,075	$	881	$	588	$	(24	)	$	6,146		$	1,257	$	434	$	328	$	(8	)	$	2,011

Performance

Advanced

Textile

Corporate and

2020

Polyurethanes

Products

Materials

Effects

Eliminations

Total

Primary Geographic Markets(1)

U.S. and Canada
$ 1,015 $ 333 $ 167 $ 36 $ (16 ) $ 1,535
Europe
681 184 243 71 (1 ) 1,178
Asia Pacific
673 194 164 251 0 1,282
Rest of world
185 47 58 66 (1 ) 355
$ 2,554 $ 758 $ 632 $ 424 $ (18 ) $ 4,350

Major Product Groupings

MDI urethanes
$ 2,554 $ 2,554
Differentiated
$ 758 758
Specialty
$ 561 561
Non-specialty
71 71
Textile chemicals and dyes
$ 424 424
Eliminations
$ (18 ) (18 )
$ 2,554 $ 758 $ 632 $ 424 $ (18 ) $ 4,350

			Performance		Advanced		Corporate and
2021	Polyurethanes		Products		Materials		eliminations			Total
Primary geographic markets(1)
U.S. and Canada	$	537	$	183	$	90	$	(6	)	$	804
Europe		377		106		108		(3	)		588
Asia Pacific		379		88		78		(1	)		544
Rest of world		110		22		28		1			161
	$	1,403	$	399	$	304	$	(9	)	$	2,097

Major product groupings
MDI urethanes	$	1,403								$	1,403
Differentiated			$	399							399
Specialty					$	276					276
Non-specialty						28					28
Eliminations							$	(9	)		(9	)
	$	1,403	$	399	$	304	$	(9	)	$	2,097

(1)	Geographic information for revenues is based upon countries into which product is sold.

2824

Table of Contents

The following tables disaggregate our revenue from continuing operations by major source for the nine months ended September 30, 2022 and 2021 (dollars in millions):

			*Performance*		*Advanced*		*Corporate and*
2022	*Polyurethanes*		*Products*		*Materials*		*eliminations*			*Total*
Primary geographic markets(1)
U.S. and Canada	$	1,678	$	644	$	320	$	(10	)	$	2,632
Europe		983		327		365		(11	)		1,664
Asia Pacific		1,027		341		227		(4	)		1,591
Rest of world		308		94		87		(3	)		486
	$	3,996	$	1,406	$	999	$	(28	)	$	6,373

Major product groupings
MDI urethanes	$	3,996								$	3,996
Differentiated			$	1,406							1,406
Specialty					$	921					921
Non-specialty						78					78
Eliminations							$	(28	)		(28	)
	$	3,996	$	1,406	$	999	$	(28	)	$	6,373

			Performance		Advanced		Corporate and
2021	Polyurethanes		Products		Materials		eliminations			Total
Primary geographic markets(1)
U.S. and Canada	$	1,338	$	460	$	262	$	(15	)	$	2,045
Europe		949		283		317		(8	)		1,541
Asia Pacific		1,055		276		223		(1	)		1,553
Rest of world		284		56		79		—			419
	$	3,626	$	1,075	$	881	$	(24	)	$	5,558

Major product groupings
MDI urethanes	$	3,626								$	3,626
Differentiated			$	1,075							1,075
Specialty					$	795					795
Non-specialty						86					86
Eliminations							$	(24	)		(24	)
	$	3,626	$	1,075	$	881	$	(24	)	$	5,558

(1)	Geographic information for revenues is based upon countries into which product is sold.

Table of Contents

12. EMPLOYEE BENEFIT PLANS

Components of the net periodic benefit ~~costs~~(credit) cost from continuing operations for the three and nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 were as follows (dollars in millions):

Huntsman Corporation

							*Other Postretirement*												*Other postretirement*
	*Defined Benefit Plans*						*Benefit Plans*						*Defined benefit plans*						*benefit plans*
	*Three months*						*Three months*						*Three months*						*Three months*
	*ended*						*ended*						*ended*						*ended*
	*September 30,*						*September 30,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2022*			*2021*			*2022*			*2021*
Service cost	$	13		$	13		$	1		$	0		$	11		$	12		$	1		$	1
Interest cost		13			15			0			1			13			13			—			—
Expected return on assets		(42	)		(44	)		0			0			(37	)		(39	)		—			—
Amortization of prior service benefit		(2	)		(2	)		(1	)		(2	)		(2	)		(2	)		(1	)		(1	)
Amortization of actuarial loss		23			21			0			1			12			20			—			—
Net periodic benefit cost	$	5		$	3		$	0		$	0
Net periodic benefit (credit) cost													$	(3	)	$	4		$	—		$	—

							*Other Postretirement*												*Other postretirement*
	*Defined Benefit Plans*						*Benefit Plans*						*Defined benefit plans*						*benefit plans*
	*Nine months*						*Nine months*						*Nine months*						*Nine months*
	*ended*						*ended*						*ended*						*ended*
	*September 30,*						*September 30,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2022*			*2021*			*2022*			*2021*
Service cost	$	41		$	39		$	1		$	1		$	34		$	38		$	1		$	1
Interest cost		37			46			1			2			41			36			1			1
Expected return on assets		(126	)		(129	)		0			0			(113	)		(115	)		—			—
Amortization of prior service benefit		(5	)		(5	)		(3	)		(4	)		(4	)		(4	)		(3	)		(3	)
Amortization of actuarial loss		69			60			1			1			36			60			1			1
Settlement loss		3			0			0			0			—			3			—			—
Net periodic benefit cost	$	19		$	11		$	0		$	0
Net periodic benefit (credit) cost													$	(6	)	$	18		$	—		$	—

Huntsman International

							*Other Postretirement*												*Other postretirement*
	*Defined Benefit Plans*						*Benefit Plans*						*Defined benefit plans*						*benefit plans*
	*Three months*						*Three months*						*Three months*						*Three months*
	*ended*						*ended*						*ended*						*ended*
	*September 30,*						*September 30,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2022*			*2021*			*2022*			*2021*
Service cost	$	13		$	13		$	1		$	0		$	11		$	12		$	1		$	1
Interest cost		13			15			0			1			13			13			—			—
Expected return on assets		(42	)		(44	)		0			0			(37	)		(39	)		—			—
Amortization of prior service benefit		(2	)		(2	)		(1	)		(2	)		(2	)		(2	)		(1	)		(1	)
Amortization of actuarial loss		24			21			0			1			12			21			—			—
Net periodic benefit cost	$	6		$	3		$	0		$	0
Net periodic benefit (credit) cost													$	(3	)	$	5		$	—		$	—

							*Other Postretirement*												*Other postretirement*
	*Defined Benefit Plans*						*Benefit Plans*						*Defined benefit plans*						*benefit plans*
	*Nine months*						*Nine months*						*Nine months*						*Nine months*
	*ended*						*ended*						*ended*						*ended*
	*September 30,*						*September 30,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2022*			*2021*			*2022*			*2021*
Service cost	$	41		$	39		$	1		$	1		$	34		$	38		$	1		$	1
Interest cost		37			46			1			2			41			36			1			1
Expected return on assets		(126	)		(129	)		0			0			(113	)		(115	)		—			—
Amortization of prior service benefit		(5	)		(5	)		(3	)		(4	)		(4	)		(4	)		(3	)		(3	)
Amortization of actuarial loss		71			62			1			1			36			62			1			1
Settlement loss		3			0			0			0			—			3			—			—
Net periodic benefit cost	$	21		$	13		$	0		$	0
Net periodic benefit (credit) cost													$	(6	)	$	20		$	—		$	—

During the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, we made contributions to our pension and other postretirement benefit plans related to continuing operations of ~~$45~~$35 million and ~~$73~~$41 million, respectively. During the remainder of ~~2021~~2022, we expect to contribute an additional amount of approximately $9$10 million to these plans.

2926

Table of Contents

13. HUNTSMAN CORPORATION STOCKHOLDERS’ EQUITY

Share Repurchase Program

On ~~February 7, 2018~~ ~~and on~~ ~~May 3, 2018,~~October 26, 2021, our Board of Directors ~~collectively authorized us to repurchase up to an aggregate of $1 billion in shares of our common stock. The~~approved a new share repurchase program ~~is supported by~~of $1 billion. In conjunction with the inception of this plan, we retired our ~~free cash flow generation. Repurchases~~ ~~may~~ ~~be made through the open market, including through accelerated~~prior share repurchase ~~programs, or in privately negotiated transactions, and repurchases~~program. On ~~may~~March 25, 2022, ~~be commenced or suspended from time to time without prior notice. Shares~~our Board of ~~common stock acquired through~~Directors increased the ~~repurchase program are held in treasury at cost. Subsequent to the end~~authorization of ~~the~~ ~~first~~ ~~quarter of~~ ~~2020,~~ ~~we suspended share repurchases under~~ our existing share repurchase program ~~in order~~from $1 billion to ~~enhance our liquidity position in response to COVID-~~~~19.~~$2 billion. During the ~~third~~nine ~~quarter of~~months ended ~~2021,~~September 30, 2022, we ~~resumed the share repurchase program and~~ repurchased ~~3,971,784~~22,853,686 shares of our common stock for approximately ~~$102~~$752 million, excluding commissions, under this share repurchase program. From October 1, 2022 through October 25, 2022, we repurchased an additional 1,539,537 shares of our common stock for approximately $40 million, excluding commissions.

Dividends on Common Stock

On ~~April 28, 2021,~~ ~~our Board of Directors declared a $0.1875 per share cash dividend on our common stock. This represents a 15% increase from the previous dividend.~~ During the quarters ended September 30, ~~2021~~2022 and September 30, ~~2020~~2021, we ~~paid $42~~declared dividends of $41 million and ~~$36~~$42 million, respectively, or ~~$0.1875~~$0.2125 and ~~$0.1625~~$0.1875 per share, respectively, to common stockholders. During the quarters ended June 30, ~~2021~~2022 and ~~June 30, 2020,~~ 2021,we ~~paid $41~~declared dividends of $44 million and ~~$36~~$41 million, respectively, or ~~$0.1875~~$0.2125 and ~~$0.1625~~$0.1875 per share, respectively, to common stockholders. During the quarters ended and March 31, ~~2021~~2022 and March 31, ~~2020,~~2021, we ~~paid $36~~declared dividends of $45 million and ~~$37~~$36 million, respectively, or $0.2125 and $0.1625 per share, ~~each~~respectively, to common stockholders.

14. ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of other comprehensive (loss) income and changes in accumulated other comprehensive loss by component were as follows (dollars in millions):

Huntsman Corporation

				*Pension*			*Other*																*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*			*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*			*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*			*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*
	*adjustment(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*Corporation*			*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*Corporation*
Beginning balance, January 1, 2021	$	(328	)	$	(1,050	)	$	8	$	4	$	(1,366	)	$	20		$	(1,346	)
Beginning balance, January 1, 2022																				$	(420	)	$	(810	)	$	8	$	6		$	(1,216	)	$	13	$	(1,203	)
Other comprehensive loss before reclassifications, gross		(42	)		0			0		0		(42	)		(2	)		(44	)		(338	)		—			—		(1	)		(339	)		17		(322	)
Tax expense		0			0			0		0		0			0			0			—			—			—		—			—			—		—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		0			65			0		0		65			0			65			—			36			—		—			36			—		36
Tax expense		0			(13	)		0		0		(13	)		0			(13	)		—			(8	)		—		—			(8	)		—		(8	)
Net current-period other comprehensive (loss) income		(42	)		52			0		0		10			(2	)		8			(338	)		28			—		(1	)		(311	)		17		(294	)
Ending balance, September 30, 2021	$	(370	)	$	(998	)	$	8	$	4	$	(1,356	)	$	18		$	(1,338	)
Ending balance, September 30, 2022																				$	(758	)	$	(782	)	$	8	$	5		$	(1,527	)	$	30	$	(1,497	)

(a)	Amounts are net of tax of $56 million as of both September 30, ~~2021~~2022 and January 1, 2022, respectively.

(b)	Amounts are net of tax of $73 million and $81 million as of September 30, 2022 and January 1,2022, respectively.

(c)	See table below for details about these reclassifications.

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*Corporation*
Beginning balance, January 1, 2021	$	(328	)	$	(1,050	)	$	8	$	4	$	(1,366	)	$	20		$	(1,346	)
Other comprehensive loss before reclassifications, gross		(42	)		—			—		—		(42	)		(2	)		(44	)
Tax expense		—			—			—		—		—			—			—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		—			65			—		—		65			—			65
Tax expense		—			(13	)		—		—		(13	)		—			(13	)
Net current-period other comprehensive (loss) income		(42	)		52			—		—		10			(2	)		8
Ending balance, September 30, 2021	$	(370	)	$	(998	)	$	8	$	4	$	(1,356	)	$	18		$	(1,338	)

(a)	Amounts are net of tax of $56 million for both September 30, 2021 and January 1, 2021.

(b)	Amounts are net of tax of $139 million and $153 million as of September 30, 2021 and January 1, 2021, respectively.

(c)	See table below for details about these reclassifications.

Pension

Other

Foreign

and other

comprehensive

Amounts

Amounts

currency

postretirement

income of

attributable to

attributable to

translation

benefits

unconsolidated

noncontrolling

Huntsman

adjustment(a)

adjustments(b)

affiliates

Other, net

Total

interests

Corporation

Beginning balance, January 1, 2020
$ (369 ) $ (1,031 ) $ 8 $ 4 $ (1,388 ) $ 26 $ (1,362 )
Other comprehensive (loss) income before reclassifications, gross
(42 ) 8 0 0 (34 ) (3 ) (37 )
Tax expense
0 (2 ) 0 0 (2 ) 0 (2 )
Amounts reclassified from accumulated other comprehensive loss, gross(c)
0 93 0 0 93 0 93
Tax expense
0 (21 ) 0 0 (21 ) 0 (21 )
Net current-period other comprehensive (loss) income
(42 ) 78 0 0 36 (3 ) 33
Ending balance, September 30, 2020
$ (411 ) $ (953 ) $ 8 $ 4 $ (1,352 ) $ 23 $ (1,329 )

~~(a)~~

~~Amounts are net of tax of $68 million as of both~~ ~~September 30, 2020~~ ~~and~~ ~~January 1,~~ ~~2020~~.

~~(b)~~

~~Amounts are net of tax of $125 million and $148 million as of~~ ~~September 30, 2020~~ ~~and~~ ~~January~~ 1,~~2020~~~~, respectively.~~

~~(c)~~

~~See table below for details about these reclassifications.~~

3027

Table of Contents

Three Months Ended September 30,

2021

2020

Amounts reclassified

Amounts reclassified

Affected line item in

from accumulated

from accumulated

the statement
Details about Accumulated Other

other

other

where net income
Comprehensive Loss Components(a):
comprehensive loss comprehensive loss
is presented
Amortization of pension and other postretirement benefits:
��
Prior service credit
$ (3 ) $ (3 )
(b)
Actuarial loss
23 21
(b)(d)
20 18
Total before tax
(3 ) (4 )
Income tax expense
Total reclassifications for the period
$ 17 $ 14
Net of tax

	*Three Months Ended September 30,*
	*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(3	)	$	(3	)	(b)(c)	Other income, net
Actuarial loss		15			23		(b)(c)	Other income, net
		12			20			Total before tax
		(2	)		(3	)		Income tax expense
Total reclassifications for the period	$	10		$	17			Net of tax

Nine Months Ended September 30,

2021

2020

Amounts reclassified

Amounts reclassified

Affected line item in

from accumulated

from accumulated

the statement
Details about Accumulated Other

other

other

where net income
Comprehensive Loss Components(a):

comprehensive loss

comprehensive loss

is presented
Amortization of pension and other postretirement benefits:

Prior service credit
$ (8 ) $ (9 )
(b)
Settlement loss
3 41
(c)
Actuarial loss
70 61
(b)(d)
65 93
Total before tax
(13 ) (21 )
Income tax expense
Total reclassifications for the period
$ 52 $ 72
Net of tax

~~(a)~~

~~Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.~~

~~(b)~~

~~These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note~~ ~~12.~~ ~~Employee Benefit Plans.”~~

~~(c)~~

~~In connection with the sale of our Chemical Intermediates Businesses, we recognized $41 million of pension and other post-employment benefit settlement losses during the~~ ~~nine~~ ~~months ended~~ ~~September 30, 2020.~~

~~(d)~~

~~Amounts include approximately $1 million of actuarial losses related to discontinued operations for both the~~ ~~three~~ ~~months ended~~ ~~September 30, 2021~~ ~~and~~ ~~2020~~~~. Amounts include approximately $4 million of actuarial losses related to discontinued operations for both the~~ ~~nine~~ ~~months ended~~ ~~September 30, 2021~~ ~~and~~ ~~2020~~.

~~Huntsman International~~

Pension

Other

Foreign

and other

comprehensive

Amounts

Amounts

currency

postretirement

income of

attributable to

attributable to

translation

benefits

unconsolidated

noncontrolling

Huntsman

adjustment(a)

adjustments(b)

affiliates

Other, net

Total

interests

International

Beginning balance, January 1, 2021
$ (333 ) $ (1,028 ) $ 8 $ 0 $ (1,353 ) $ 20 $ (1,333 )
Other comprehensive loss before reclassifications, gross
(42 ) 0 0 0 (42 ) (2 ) (44 )
Tax expense
0 0 0 0 0 0 0
Amounts reclassified from accumulated other comprehensive loss, gross(c)
0 67 0 0 67 0 67
Tax expense
0 (14 ) 0 0 (14 ) 0 (14 )
Net current-period other comprehensive (loss) income
(42 ) 53 0 0 11 (2 ) 9
Ending balance, September 30, 2021
$ (375 ) $ (975 ) $ 8 $ 0 $ (1,342 ) $ 18 $ (1,324 )

~~(a)~~

~~Amounts are net of tax of $43 million for both~~ ~~September 30, 2021~~ ~~and~~ ~~January~~ 1,~~2021~~.

~~(b)~~

~~Amounts are net of tax of $164 million and $178 million as of~~ ~~September 30, 2021~~ ~~and~~ ~~January~~ 1,~~2021~~~~, respectively.~~

~~(c)~~

~~See table below for details about these reclassifications.~~

~~Table of Contents~~

Pension

Other

Foreign

and other

comprehensive

Amounts

Amounts

currency

postretirement

income of

attributable to

attributable to

translation

benefits

unconsolidated

noncontrolling

Huntsman

adjustment(a)

adjustments(b)

affiliates

Other, net

Total

interests

International

Beginning balance, January 1, 2020
$ (374 ) $ (1,012 ) $ 8 $ 0 $ (1,378 ) $ 26 $ (1,352 )
Other comprehensive (loss) income before reclassifications, gross
(42 ) 8 0 0 (34 ) (3 ) (37 )
Tax expense
0 (2 ) 0 0 (2 ) 0 (2 )
Amounts reclassified from accumulated other comprehensive loss, gross(c)
0 95 0 0 95 0 95
Tax expense
0 (21 ) 0 0 (21 ) 0 (21 )
Net current-period other comprehensive (loss) income
(42 ) 80 0 0 38 (3 ) 35
Ending balance, September 30, 2020
$ (416 ) $ (932 ) $ 8 $ 0 $ (1,340 ) $ 23 $ (1,317 )

~~(a)~~

~~Amounts are net of tax of $55 million as of both~~ ~~September 30, 2020~~ ~~and~~ ~~January~~ 1,~~2020~~.

~~(b)~~

~~Amounts are net of tax of $150 million and $174 million as of~~ ~~September 30, 2020~~ ~~and~~ ~~January~~ 1,~~2020~~~~, respectively.~~

~~(c)~~

~~See table below for details about these reclassifications.~~

Three Months Ended September 30,

2021

2020

Amounts reclassified

Amounts reclassified

Affected line item in

from accumulated

from accumulated

the statement
Details about Accumulated Other

other

other

where net income
Comprehensive Loss Components(a):
comprehensive loss comprehensive loss
is presented
Amortization of pension and other postretirement benefits:

Prior service credit
$ (3 ) $ (3 )
(b)
Actuarial loss
24 22
(b)(d)
21 19
Total before tax
(4 ) (4 )
Income tax expense
Total reclassifications for the period
$ 17 $ 15
Net of tax

	*Nine Months Ended September 30,*							*Nine Months Ended September 30,*
	*2021*			*2020*				*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*			*Affected line item in*	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*			*the statement*	*from accumulated*			*from accumulated*				*the statement*
Details about Accumulated Other	*other*			*other*			*where net income*
Comprehensive Loss Components(a):	*comprehensive loss*			*comprehensive loss*			*is presented*
Details about accumulated other								*other*			*other*				*where net income*
comprehensive loss components(a):								*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(8	)	$	(9	)	(b)	$	(8	)	$	(8	)	(b)(c)	Other income, net
Settlement loss		3			41		(c)		—			3		(b)	Other income, net
Actuarial loss		72			63		(b)(d)		44			70		(b)(c)	Other income, net
		67			95		Total before tax		36			65			Total before tax
		(14	)		(21	)	Income tax expense		(8	)		(13	)		Income tax expense
Total reclassifications for the period	$	53		$	74		Net of tax	$	28		$	52			Net of tax

(a)	Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(b)	These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 12. Employee Benefit Plans.”

(c)

~~In connection with the sale of our Chemical Intermediates Businesses, we recognized $41~~Amounts include approximately $3 million and $4 million of ~~pension~~actuarial losses and ~~other post-employment benefit settlement~~prior service credits related to discontinued operations for the three months ended September 30, 2022 and 2021, respectively. Amounts contain approximately $8 million and $12 million of actuarial losses ~~during~~and prior service credits related to discontinued operations for the nine months ended September 30, ~~2020.~~2022 and 2021, respectively.

Huntsman International

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*
	*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*
	*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*International*
Beginning balance, January 1, 2022	$	(424	)	$	(786	)	$	8	$	2		$	(1,200	)	$	13	$	(1,187	)
Other comprehensive loss before reclassifications, gross		(339	)		—			—		(1	)		(340	)		17		(323	)
Tax expense		—			—			—		—			—			—		—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		—			36			—		—			36			—		36
Tax expense		—			(8	)		—		—			(8	)		—		(8	)
Net current-period other comprehensive (loss) income		(339	)		28			—		(1	)		(312	)		17		(295	)
Ending balance, September 30, 2022	$	(763	)	$	(758	)	$	8	$	1		$	(1,512	)	$	30	$	(1,482	)

(a)	Amounts are net of tax of $43 million as of September 30, 2022 and January 1,2022, respectively.

(b)	Amounts are net of tax of $97 million and $105 million as of September 30, 2022 and January 1,2022, respectively.

~~(d)~~(c)

See table below for details about these reclassifications.

Table of Contents

				*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*International*
Beginning balance, January 1, 2021	$	(333	)	$	(1,028	)	$	8	$	—	$	(1,353	)	$	20		$	(1,333	)
Other comprehensive loss before reclassifications, gross		(42	)		—			—		—		(42	)		(2	)		(44	)
Tax expense		—			—			—		—		—			—			—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		—			67			—		—		67			—			67
Tax expense		—			(14	)		—		—		(14	)		—			(14	)
Net current-period other comprehensive (loss) income		(42	)		53			—		—		11			(2	)		9
Ending balance, September 30, 2021	$	(375	)	$	(975	)	$	8	$	—	$	(1,342	)	$	18		$	(1,324	)

(a)	Amounts are net of tax of $43 million as of both September 30, 2021 and January 1,2021.

(b)	Amounts are net of tax of $164 million and $178 million as of September 30, 2021 and January 1,2021, respectively.

(c)	See table below for details about these reclassifications.

	*Three Months Ended September 30,*
	*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(3	)	$	(3	)	(b)(c)	Other income, net
Actuarial loss		15			24		(b)(c)	Other income, net
		12			21			Total before tax
		(2	)		(4	)		Income tax expense
Total reclassifications for the period	$	10		$	17			Net of tax

	*Nine Months Ended September 30,*
	*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(8	)	$	(8	)	(b)(c)	Other income, net
Settlement loss		—			3		(b)	Other income, net
Actuarial loss		44			72		(b)(c)	Other income, net
		36			67			Total before tax
		(8	)		(14	)		Income tax expense
Total reclassifications for the period	$	28		$	53			Net of tax

(a)	Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(b)	These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 12. Employee Benefit Plans.”

(c)

Amounts include approximately $1$3 million and $4 million of actuarial losses and prior service credits related to discontinued operations for the three months ended September 30, 2022 and 2021, respectively. Amounts contain approximately $8 million and $12 million of actuarial losses related to discontinued operations for ~~both the~~ ~~three~~ ~~months ended~~ ~~September 30, 2021~~ ~~and~~ ~~2020~~~~. Amounts include approximately $4 million of actuarial losses related to discontinued operations for both~~ the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021.

, respectively.

3229

Table of Contents

15. COMMITMENTS AND CONTINGENCIES

Legal Matters

On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site. The case was filed after Praxair refused to properly maintain its own Geismar facility and then repeatedly failed to supply our requirements for industrial gas needed to manufacture MDI under long-term supply contracts that expired in 2013. After the court applies the appropriate amount of interest, we expect that total damages awarded to us will exceed $125 million. The award is subject to appeal, and as such, we have not yet recognized the award in our condensed consolidated statements of operations and the timing of the resolution of this matter is unknown.

We are a party to various other proceedings instituted by private plaintiffs, governmental authorities and others arising under provisions of applicable laws, including various environmental, products liability and other laws. Except as otherwise disclosed in this report, we do not believe that the outcome of any of these matters will have a material effect on our financial condition, results of operations or liquidity.

16. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS

~~EHS~~EHS Capital Expenditures

We may incur future costs for capital improvements and general compliance under environmental, health and safety (“EHS”) laws, including costs to acquire, maintain and repair pollution control equipment. For the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, our capital expenditures from continuing operations for EHS matters totaled ~~$25~~$27 million and ~~$17~~$21 million, respectively. Because capital expenditures for these matters are subject to evolving regulatory requirements and depend, in part, on the timing, promulgation and enforcement of specific requirements, our capital expenditures for EHS matters have varied significantly from year to year and we cannot provide assurance that our recent expenditures are indicative of future amounts we may spend related to EHS and other applicable laws.

Environmental Reserves

We have accrued liabilities relating to anticipated environmental cleanup obligations, site reclamation and closure costs and known penalties. Liabilities are recorded when potential liabilities are either known or considered probable and can be reasonably estimated. Our liability estimates are calculated using present value techniques as appropriate and are based upon requirements placed upon us by regulators, available facts, existing technology and past experience. The environmental liabilities do not include amounts recorded as asset retirement obligations. We had accrued $5$4 million and $4$5 million for environmental liabilities ~~as of~~for September 30, ~~2021~~2022 and December 31, ~~2020~~2021, respectively. Of these amounts, ~~$2 million and~~ $1 million ~~were~~was classified as accrued liabilities in our condensed consolidated balance sheets ~~as of~~for both September 30, ~~2021~~2022 and December 31, ~~2020~~2021, ~~respectively,~~ and $3 million ~~was~~and $4 million were classified as other noncurrent liabilities in our condensed consolidated balance sheets ~~as of both~~for September 30, ~~2021~~2022 and December 31, ~~2020~~2021., respectively. In certain cases, our remediation liabilities may be payable over periods of up to 30 years. We may incur losses for environmental remediation in excess of the amounts accrued; however, we are not able to estimate the amount or range of such potential excess.

Environmental Matters

Under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and similar state laws, a current or former owner or operator of real property in the U.S. may be liable for remediation costs regardless of whether the release or disposal of hazardous substances was in compliance with law at the time it occurred, and a current owner or operator may be liable regardless of whether it owned or operated the facility at the time of the release. Outside the U.S., analogous contaminated property laws, such as those in effect in France and Australia, can hold past owners and/or operators liable for remediation at former facilities. Currently, there are approximately nine former facilities or third-party sites in the U.S. for which we have been notified of potential claims against us for cleanup liabilities, including, but not limited to, sites listed under CERCLA. Based on current information and past experiences at other CERCLA sites, we do not expect these third-party claims to have a material impact on our condensed consolidated financial statements.

Under the Resource Conservation and Recovery Act (“RCRA”) in the U.S. and similar state laws, we may be required to remediate contamination originating from our properties as a condition to our hazardous waste permit. Some of our manufacturing sites have an extended history of industrial chemical manufacturing and use, including on-site waste disposal. We are aware of soil, groundwater or surface contamination from past operations at some of our sites, and we may find contamination at other sites in the future. For example, our Geismar, Louisiana facility is the subject of ongoing remediation requirements imposed under RCRA. Similar laws exist in a number of locations in which we currently operate, or previously operated, manufacturing facilities, such as Australia, India, France, Hungary and Italy.

North Maybe Canyon Mine Remediation

The North Maybe Canyon Mine site is a CERCLA site and involves a former phosphorous mine near Soda Springs, Idaho, which is believed to have been operated by several companies, including a predecessor company to us. In 2004, the U.S. Forest Service notified us that we are a CERCLA potentially responsible party (“PRP”) for contamination originating from the site. In February 2010, we and Wells Cargo (another PRP) agreed to conduct a Remedial Investigation/Feasibility Study of a portion of the site and are currently engaged in that process. At this time, we are unable to reasonably estimate our potential liabilities at this site.

3330

Table of Contents

17. STOCK-BASED COMPENSATION PLANS

As of September 30, ~~2021~~2022, we had approximately 76 million shares remaining under the stock-based compensation plans available for grant. Option awards have a maximum contractual term of 10 years and generally must have an exercise price at least equal to the market price of our common stock on the date the option award is granted. Outstanding stock-based awards generally vest annually over a three-year period or in total at the end of a three-year period. Certain performance share unit awards vest in total at the end of a two-year period.

The compensation cost from continuing operations under the stock-based compensation plans for our Company and Huntsman International were as follows (dollars in millions):

	*Three months*				*Nine months*				*Three months*				*Nine months*
	*ended*				*ended*				*ended*				*ended*
	*September 30,*				*September 30,*				*September 30,*				*September 30,*
	*2021*		*2020*		*2021*		*2020*		*2022*		*2021*		*2022*		*2021*
Huntsman Corporation compensation cost	$	8	$	6	$	24	$	20	$	6	$	8	$	26	$	23
Huntsman International compensation cost		8		6		23		19		6		8		24		22

The total income tax benefit recognized in the condensed consolidated statements of operations for us and Huntsman International for stock-based compensation arrangements was $2$7 million and $3$2 million for the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, respectively.

Stock Options

The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatility of our common stock through the grant date. The expected term of options granted was estimated based on the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of grant. The assumptions noted below represent the weighted average of the assumptions utilized for stock options granted during the periods.

Three months

Nine months

ended

ended

September 30,

September 30,

2021(1)

2020

2021

2020

Dividend yield
NA 3.1 % 2.3 % 3.0 %
Expected volatility
NA 53.7 % 53.3 % 53.1 %
Risk-free interest rate
NA 0.4 % 0.7 % 1.4 %
Expected life of stock options granted during the period (in years)
NA 5.9 5.9 5.9

	*Nine months*
	*ended*
	*September 30,*
	*2022(1)*	*2021(2)*
Dividend yield	NA		2.3	%
Expected volatility	NA		53.3	%
Risk-free interest rate	NA		0.7	%
Expected life of stock options granted during the period (in years)	NA		5.9

(1)	During the ~~three~~nine months ended September 30, 2022, no stock options were granted.
(2)	During the nine months ended September 30, 2021,~~, 0~~ stock options were ~~granted.~~only granted during the first quarter.

A summary of stock option activity under the stock-based compensation plans as of September 30, ~~2021~~2022 and changes during the nine months then ended is presented below:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Option Awards

Shares

Price

Term

Value

(in thousands)

(years)

(in millions)

Outstanding at January 1, 2021
4,815 $ 20.37
Granted
304 28.58
Exercised
(697 ) 17.44
Forfeited
(71 ) 24.29
Outstanding at September 30, 2021
4,351 21.35 5.8 $ 37
Exercisable at September 30, 2021
3,309 20.59 5.0 31

						*Weighted*
				*Weighted*		*average*
				*average*		*remaining*		*Aggregate*
				*exercise*		*contractual*		*intrinsic*
Option awards	*Shares*			*price*		*term*		*value*
	(in thousands)					(years)		(in millions)
Outstanding at January 1, 2022		4,054		$	21.62
Granted		—			—
Exercised		(597	)		19.63
Forfeited		(31	)		25.61
Outstanding at September 30, 2022		3,426			21.93		5.0	$	13
Exercisable at September 30, 2022		3,016			21.58		4.6		12

3431

Table of Contents

~~The weighted-average grant-date fair value of stock options granted during the~~ ~~nine~~ ~~months ended~~ ~~September 30, 2021~~ ~~was $11.48 per option.~~ As of September 30, ~~2021~~2022, there was $6approximately $2 million of total unrecognized compensation cost related to nonvested stock option arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately ~~1.7~~1.1 years.

The total intrinsic value of stock options exercised during the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 was approximately $8$12 million and $4$8 million, respectively. Cash received from stock options exercised during ~~each~~both of the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 was approximately $6 ~~million and $2 million, respectively.~~million. The cash tax benefit from stock options exercised during ~~each~~both of the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 was approximately $2 ~~million and $1 million, respectively.~~million.

Nonvested Shares

Nonvested shares granted under the stock-based compensation plans consist of restricted stock and performance share unit awards, which are accounted for as equity awards, and phantom stock, which is accounted for as a liability award because it can be settled in either stock or cash. The fair value of each restricted stock and phantom stock award is estimated to be the closing stock price of Huntsman’s stock on the date of grant.

We grant two types of performance share unit awards. For one type of performance share unit award, the performance criteria are total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the three-year performance periods. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, the weighted-average expected volatility rate was ~~44.9%~~43.5% and ~~34.0%~~44.9%, respectively, and the weighted average risk-free interest rate was ~~0.2%~~1.67% and ~~1.4%~~0.2%, respectively. For the performance share unit awards granted induring the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, the number of shares earned varies based upon the Company achieving certain performance criteria over a three-year performance period.

During the first quarter of 2022, we began issuing a second type of performance award, which also includes a market condition. The performance criteria are our corporate free cash flow achieved relative to targets set by management, modified for the total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the ~~three~~two-year performance ~~periods.~~period. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the nine months ended September 30, 2022, the weighted-average expected volatility rate was 37.9% and the weighted average risk-free interest rate was 1.43%. For the performance share unit awards granted during the nine months ended September 30, 2022, the number of shares earned varies based upon the Company achieving certain performance criteria over a two-year performance period.

A summary of the status of our nonvested shares as of September 30, ~~2021~~2022 and changes during the nine months then ended is presented below:

	*Equity Awards*						*Liability Awards*					*Equity awards*						*Liability awards*
					*Weighted*					*Weighted*						*Weighted*					*Weighted*
					*Average*					*Average*						*average*					*average*
					*Grant-Date*					*Grant-Date*						*grant-date*					*grant-date*
	*Shares*				*Fair Value*		*Shares*			*Fair Value*		*Shares*				*fair value*		*Shares*			*fair value*
	(in thousands)						(in thousands)					(in thousands)						(in thousands)
Nonvested at January 1, 2021		1,867			$	23.18		411		$	23.08
Nonvested at January 1, 2022													2,178			$	25.07		367		$	24.91
Granted		856				31.06		184			28.58		716				48.00		102			41.04
Vested		(521	)	⁽¹⁾⁽²⁾		28.19		(189	)		24.55		(1,056	)	⁽¹⁾⁽²⁾		23.12		(188	)		24.00
Forfeited		(17	)			23.96		(20	)		24.18		(30	)			31.61		(17	)		28.35
Nonvested at September 30, 2021		2,185				25.07		386			24.92
Nonvested at September 30, 2022													1,808				35.18		264			31.57

(1)

As of September 30, ~~2021~~2022, a total of ~~457,294~~106,285 restricted stock units were vested but not yet issued, of which ~~30,438~~7,066 vested during the nine months ended September 30, ~~2021~~2022. These shares have not been reflected as vested shares in this table because, in accordance with the restricted stock unit agreements, shares of common stock are not issued for vested restricted stock units until termination of employment.

(2)

A total of ~~110,542~~193,623 performance share unit awards are reflected in the vested shares in this table, which represents the target number of performance share unit awards for this grant and were included in the balance at December 31, ~~2020~~2021. During the nine months ended September 30, ~~2021~~2022, ~~only 76,055~~an additional 96,814 performance share unit awards with a grant date fair value of ~~$41.93~~$29.68 were issued ~~related to this vest~~ due to the target performance criteria ~~not~~being ~~met.~~exceeded.

As of September 30, ~~2021~~2022, there was ~~$36~~approximately $39 million of total unrecognized compensation cost related to nonvested share compensation arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately ~~2.0~~1.8 years. The value of share awards that vested during the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021 was ~~$18~~approximately $32 million and ~~$24~~$18 million, respectively.

3532

Table of Contents

18. INCOME TAXES

We use the asset and liability method of accounting for income taxes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial and tax reporting purposes. We evaluate deferred tax assets to determine whether it is more likely than not that they will be realized. Valuation allowances are reviewed on an individual tax jurisdiction basis to analyze whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. These conclusions require significant judgment. In evaluating the objective evidence that historical results provide, we consider the cyclicality of our businesses and cumulative income or losses during the applicable period. Cumulative losses incurred over the applicable period limits our ability to consider other subjective evidence such as our projections for the future. Changes in expected future income in applicable jurisdictions could affect the realization of deferred tax assets in those jurisdictions.

During the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, there was 0no tax benefit or expense recognized in connection with the net losses of ~~$28~~$9 million and ~~$100~~$28 million, respectively, on fair value adjustments to our Venator investment and related option to sell our remaining Venator shares recorded as part of non-operating income from continuing operations. ~~As of~~Through December 31, ~~2019,~~2021, we have recognized the portion of our Venator investment tax basis in excess of book that we ultimately expect to be able to utilize; ~~therefore,~~ no incremental tax benefit has been recognized on the year-to-date fair value losses incurred in ~~2020~~2021 or ~~2021.~~2022. As a significant, unusual and non-operating item, these amounts were treated discretely and excluded from the annual effective tax rate calculation for interim reporting.

Huntsman Corporation

We recorded income tax expense from continuing operations of ~~$114~~$155 million and $9$101 million for the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

Huntsman International

Huntsman International recorded income tax expense from continuing operations of ~~$115~~$156 million and $9$102 million for the nine months ended September 30, ~~2021~~2022 and ~~2020~~2021, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

19. EARNINGS PER SHARE

Basic ~~earnings~~income per share excludes dilution and is computed by dividing net income attributable to Huntsman Corporation ~~common stockholders~~ by the weighted average number of shares outstanding during the period. Diluted ~~earnings~~income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing net income attributable to Huntsman Corporation ~~common stockholders~~ by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities.

Basic and diluted ~~earnings~~income per share is determined using the following information (in millions):

	*Three months*				*Nine months*					*Three months*					*Nine months*
	*ended*				*ended*					*ended*					*ended*
	*September 30,*				*September 30,*					*September 30,*					*September 30,*
	*2021*		*2020*		*2021*		*2020*			*2022*		*2021*			*2022*		*2021*
Numerator:
Basic and diluted income (loss) from continuing operations:
Income (loss) from continuing operations attributable to Huntsman Corporation	$	214	$	48	$	451	$	(91	)
Basic and diluted net income:
Income from continuing operations attributable to Huntsman Corporation										$	101	$	203	��	$	521	$	412
Net income attributable to Huntsman Corporation	$	209	$	48	$	448	$	691		$	100	$	209		$	551	$	448

Denominator:
Weighted average shares outstanding		219.4		219.8		220.2		220.8			197.7		219.4			205.2		220.2
Dilutive shares:
Stock-based awards		1.9		1.5		2.0		0			1.5		1.9			2.0		2.0
Total weighted average shares outstanding, including dilutive shares		221.3		221.3		222.2		220.8			199.2		221.3			207.2		222.2

Additional stock-based awards of approximately ~~1.0~~1.3 million and ~~3.8~~1.0 million weighted average equivalent shares of stock were outstanding during the three months ended September 30, ~~2021~~2022 and ~~2020~~2021, respectively, and approximately ~~1.5~~0.9 million and ~~6.1~~1.5 million weighted average equivalent shares of stock were outstanding during the nine months ended September 30, ~~2021~~2022 and ~~2020,~~2021, respectively. However, these stock-based awards were not included in the computation of diluted ~~earnings~~income per share for the ~~three~~ ~~and~~ ~~nine~~ ~~months ended~~ ~~September~~ ~~30,~~~~2021~~ ~~and~~ ~~2020~~respective periods mentioned above because the effect would be anti-dilutive.

3633

Table of Contents

20. OPERATING SEGMENT INFORMATION

We derive our revenues, earnings and cash flows from the manufacture and sale of a wide variety of differentiated and commodity chemical products. We have 4three operating segments, which are also our reportable segments: Polyurethanes, Performance Products and Advanced ~~Materials and Textile Effects.~~Materials. We have organized our business and derived our operating segments around differences in product lines. Beginning in the third quarter of 2022, the results of our Textile Effects Business are reported as discontinued operations in our condensed consolidated financial statements for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business.”

The major products of each reportable operating segment are as follows:

Segment		Products
Polyurethanes		MDI, polyols, TPU and other polyurethane-related products
Performance Products		Specialty amines, ethyleneamines, maleic anhydride and technology licenses
Advanced Materials		~~Basic liquid and solid epoxy resins; specialty~~Specialty resin compounds; cross-linking, matting, and curing and toughening agents; epoxy, acrylic and polyurethane-based formulations; specialty nitrile latex, alkyd resins and carbon nano materials
~~Textile Effects~~		~~Textile chemicals and dyes~~

Sales between segments are generally recognized at external market prices and are eliminated in consolidation. ~~Adjusted~~We use adjusted EBITDA ~~is presented as a~~to measure of the financial performance of our global business units and for reporting the results of our operating segments. This measure includes all operating items relating to the businesses. The adjusted EBITDA of ~~our reportable~~ operating segments excludes items that principally apply to our Company as a whole. The following schedule includes revenues and adjusted EBITDA ~~from continuing operations~~ for each of our reportable operating segments ~~are as follows~~ (dollars in millions):. We have revised our prior year presentation below to reconcile total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes, in addition to net income, and removed “corporate and other costs, net” from the total reportable segments’ adjusted EBITDA and included such amounts in the reconciliation to income from continuing operations before income taxes. Additionally, we have revised our prior year presentation of total reportable segments’ revenues, in which we removed intersegment eliminations from the total reportable segments’ revenues.

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Revenues:
Polyurethanes	$	1,257		$	1,403		$	3,996		$	3,626
Performance Products		434			399			1,406			1,075
Advanced Materials		328			304			999			881
Total reportable segments’ revenue		2,019			2,106			6,401			5,582
Intersegment eliminations		(8	)		(9	)		(28	)		(24	)
Total	$	2,011		$	2,097		$	6,373		$	5,558

Huntsman Corporation:
Segment adjusted EBITDA(1):
Polyurethanes	$	138		$	246		$	591		$	661
Performance Products		110			103			408			254
Advanced Materials		58			48			192			150
Total reportable segments’ adjusted EBITDA		306			397			1,191			1,065

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:
Interest expense, net—continuing operations		(16	)		(15	)		(46	)		(52	)
Depreciation and amortization—continuing operations		(72	)		(68	)		(207	)		(205	)
Corporate and other costs, net(2)		(35	)		(48	)		(123	)		(146	)
Net income attributable to noncontrolling interests		15			16			46			49
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		(1	)		(5	)		(11	)		(19	)
Fair value adjustments to Venator investment, net		(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt		—			—			—			(27	)
Certain legal and other settlements and related expenses		(1	)		—			(15	)		(10	)
Costs associated with the Albemarle Settlement, net		(1	)		—			(3	)		—
(Loss) gain on sale of business/assets		(16	)		—			(27	)		30
Income from transition services arrangements		—			2			2			6
Certain nonrecurring information technology project implementation costs		(1	)		(2	)		(4	)		(6	)
Amortization of pension and postretirement actuarial losses		(10	)		(19	)		(32	)		(56	)
Plant incident remediation (costs) credits		(1	)		(2	)		4			(3	)
Restructuring, impairment and plant closing and transition costs(3)		(14	)		—			(44	)		(36	)
Income from continuing operations before income taxes		146			253			722			562

Income tax expense—continuing operations		(30	)		(34	)		(155	)		(101	)
(Loss) income from discontinued operations		(1	)		6			30			36
Net income	$	115		$	225		$	597		$	497

Three months

Nine months

ended

ended

September 30,

September 30,

2021

2020

2021

2020

Revenues:

Polyurethanes
$ 1,403 $ 936 $ 3,626 $ 2,554
Performance Products
399 238 1,075 758
Advanced Materials
304 199 881 632
Textile Effects
188 142 588 424
Corporate and eliminations
(9 ) (5 ) (24 ) (18 )
Total
$ 2,285 $ 1,510 $ 6,146 $ 4,350

Huntsman Corporation:

Segment adjusted EBITDA(1):

Polyurethanes
$ 246 $ 156 $ 661 $ 271
Performance Products
103 36 254 123
Advanced Materials
48 25 150 103
Textile Effects
22 8 75 24
Corporate and other(2)
(48 ) (37 ) (146 ) (114 )
Total
371 188 994 407
Reconciliation of adjusted EBITDA to net income (loss):

Interest expense, net—continuing operations
(15 ) (24 ) (52 ) (63 )
Income tax expense—continuing operations
(38 ) (15 ) (114 ) (9 )
Income tax expense—discontinued operations
(5 ) 0 (5 ) (239 )
Depreciation and amortization—continuing operations
(72 ) (70 ) (219 ) (206 )
Net income attributable to noncontrolling interests
16 9 49 15
Other adjustments:

Business acquisition and integration expenses and purchase accounting inventory adjustments
(5 ) (9 ) (19 ) (30 )
EBITDA from discontinued operations(3)
0 0 2 1,021
Fair value adjustments to Venator investment
(3 ) 6 (28 ) (100 )
Loss on early extinguishment of debt
0 0 (27 ) 0
Certain legal and other settlements and related income (expenses)
0 4 (10 ) (2 )
Gain on sale of businesses/assets
0 0 30 1
Income from transition services arrangements
2 1 6 6
Certain nonrecurring information technology project implementation costs
(2 ) (1 ) (6 ) (3 )
Amortization of pension and postretirement actuarial losses
(22 ) (20 ) (65 ) (57 )
Plant incident remediation costs
(2 ) 0 (3 ) (1 )
Restructuring, impairment and plant closing and transition costs
0 (12 ) (36 ) (34 )
Net income
$ 225 $ 57 $ 497 $ 706

3734

Table of Contents

Three months

Nine months

ended

ended

September 30,

September 30,

2021

2020

2021

2020

Huntsman International:

Segment adjusted EBITDA(1):

Polyurethanes
$ 246 $ 156 $ 661 $ 271
Performance Products
103 36 254 123
Advanced Materials
48 25 150 103
Textile Effects
22 8 75 24
Corporate and other(2)
(47 ) (36 ) (140 ) (110 )
Total
372 189 1,000 411
Reconciliation of adjusted EBITDA to net income (loss):

Interest expense, net—continuing operations
(15 ) (24 ) (52 ) (65 )
Income tax expense—continuing operations
(39 ) (15 ) (115 ) (9 )
Income tax expense—discontinued operations
(5 ) 0 (5 ) (239 )
Depreciation and amortization—continuing operations
(72 ) (70 ) (219 ) (206 )
Net income attributable to noncontrolling interests
16 9 49 15
Other adjustments:

Business acquisition and integration expenses and purchase accounting inventory adjustments
(5 ) (9 ) (19 ) (30 )
EBITDA from discontinued operations(3)
0 0 2 1,021
Fair value adjustments to Venator investment
(3 ) 6 (28 ) (100 )
Loss on early extinguishment of debt
0 0 (27 ) 0
Certain legal and other settlements and related income (expenses)
0 4 (10 ) (2 )
Gain on sale of businesses/assets
0 0 30 1
Income from transition services arrangements
2 1 6 6
Certain nonrecurring information technology project implementation costs
(2 ) (1 ) (6 ) (3 )
Amortization of pension and postretirement actuarial losses
(22 ) (20 ) (67 ) (59 )
Plant incident remediation costs
(2 ) 0 (3 ) (1 )
Restructuring, impairment and plant closing and transition costs
0 (12 ) (36 ) (34 )
Net income
$ 225 $ 58 $ 500 $ 706

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Huntsman International:
Segment adjusted EBITDA(1):
Polyurethanes	$	138		$	246		$	591		$	661
Performance Products		110			103			408			254
Advanced Materials		58			48			192			150
Total reportable segments’ adjusted EBITDA		306			397			1,191			1,065

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:
Interest expense, net—continuing operations		(16	)		(15	)		(46	)		(52	)
Depreciation and amortization—continuing operations		(72	)		(68	)		(207	)		(205	)
Corporate and other costs, net(2)		(36	)		(47	)		(119	)		(140	)
Net income attributable to noncontrolling interests		15			16			46			49
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		(1	)		(5	)		(11	)		(19	)
Fair value adjustments to Venator investment, net		(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt		—			—			—			(27	)
Certain legal and other settlements and related expenses		(1	)		—			(15	)		(10	)
Costs associated with the Albemarle Settlement, net		(1	)		—			(3	)		—
(Loss) gain on sale of business/assets		(16	)		—			(27	)		30
Income from transition services arrangements		—			2			2			6
Certain nonrecurring information technology project implementation costs		(1	)		(2	)		(4	)		(6	)
Amortization of pension and postretirement actuarial losses		(10	)		(19	)		(32	)		(58	)
Plant incident remediation (costs) credits		(1	)		(2	)		4			(3	)
Restructuring, impairment and plant closing and transition costs(3)		(14	)		—			(44	)		(36	)
Income from continuing operations before income taxes		145			254			726			566

Income tax expense—continuing operations		(30	)		(35	)		(156	)		(102	)
(Loss) income from discontinued operations		(1	)		6			30			36
Net income	$	114		$	225		$	600		$	500

(1)

We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what the chief operating decision maker uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests, ~~and~~ certain Corporate and other items and income from discontinued operations, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) ~~EBITDA from discontinued operations; (c)~~ fair value adjustments to Venator ~~investment; (d)~~investment, net; (c) loss on early extinguishment of debt; ~~(e)~~(d) certain legal and other settlements and related ~~income (expenses);~~expenses; (e) costs associated with the Albemarle Settlement, net; (f) (loss) gain on sale of ~~businesses/~~business/assets; (g) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; (h) certain nonrecurring information technology project implementation costs; (i) amortization of pension and postretirement actuarial losses; (j) plant incident remediation ~~costs;~~credits (costs); and (k) restructuring, impairment, plant closing and transition costs.

(2)

Corporate and other costs, net includes unallocated corporate overhead, unallocated foreign exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets.

(3)	Includes ~~the gain on the sale of~~costs associated with transition activities related primarily to our ~~Chemical Intermediates Businesses in~~ ~~2020.~~Corporate program to optimize our global approach to leverage shared services capabilities.

3835

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We operate in ~~four~~three segments: Polyurethanes, Performance Products and Advanced ~~Materials and Textile Effects.~~Materials. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining and synthetic fiber ~~textile chemicals and dyes~~ industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride and epoxy-based polymer ~~formulations, textile chemicals and dyes.~~formulations. Our revenues from continuing operations for the three months ended September 30, 2022 and 2021 were $2,011 million and $2,097 million, respectively, and for the nine months ended September 30, 2022 and 2021 ~~and 2020~~ were ~~$6,146~~$6,373 million and ~~$4,350~~$5,558 million, respectively.

RecentDevelopments

~~Amendments~~European Restructuring Program

In early November 2022, we announced our commitment and specific plans to ~~Accounts Receivable Securitization Programs~~further realign our cost structure beyond the current in-progress cost optimization programs with additional restructuring in Europe. The new program will include exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we expect to record restructuring expenses of approximately $50 million through 2023.

Sale of Textile Effects Business

On ~~July 1, 2021,~~August 9, 2022, we entered into ~~amendments~~a definitive agreement to sell our ~~A/R Programs that, among other things, extended~~Textile Effects Business to Archroma for a total enterprise value of $718 million, which includes the ~~scheduled termination dates~~assumption of approximately $125 million in net underfunded pension liabilities as of December 31, 2021. We anticipate the transaction will close no later than the first half of 2023. Beginning in the third quarter of 2022, the results of our ~~A/R Programs from April 2022 to July 2024.~~Textile Effects Business are reported as discontinued operations for all periods presented. For ~~additional~~more information, see “Note ~~8. Debt—Direct~~4. Discontinued Operations and ~~Subsidiary Debt—A/R Programs”~~Business Dispositions—Sale of Textile Effects Business” to our condensed consolidated financial statements.

3936

Table of Contents

Outlook

We expect the following factors to impact our operating segments:

Polyurethanes:

●

Fourth quarter ~~2021~~2022 adjusted EBITDA estimated to be between ~~$200~~$55 million and ~~$220~~$85 million

●

~~Positive trends in construction, though impacted~~European profitability negatively driven by ~~raw material constraints~~high energy prices and declining demand

●

Americas end markets weaker, particularly in construction

	~~Automotive~~●	Modest increase in automotive market ~~continues~~sales volumes year-over-year
	●	Lower production rates to ~~be weak~~ reduce inventory and match lower demand

Performance Products:

●

Fourth quarter ~~2021~~2022 adjusted EBITDA estimated to be between ~~$95~~$60 million and ~~$100~~$80 million

●

~~Commercial initiatives~~Lower sales volumes year-over-year, primarily in Europe and in construction markets

●

Adjusted EBITDA margin expected to ~~positively impact results~~be within 20% to 25%

Advanced Materials:

●

Fourth quarter ~~2021~~2022 adjusted EBITDA estimated to be between ~~$47~~$40 million and ~~$52~~$45 million

●

~~Aerospace continues to recover~~Automotive and aerospace markets remain stable

●

~~Pricing increases to offset raw material cost increases~~Demand headwinds in industrial markets

~~Textile Effects~~

●

~~Fourth quarter 2021 adjusted EBITDA estimated to be between $20 million and $22 million~~

	●	~~Favorable trends in sustainable solutions~~
	●	~~Pricing increases to offset raw material cost increases~~

In the third quarter of ~~2021,~~2022, both our effective tax rate and our adjusted effective tax rate ~~was 15%~~were 21%. For ~~2021,~~2022, our adjusted effective tax rate is expected to be approximately 19% to 20%, which is below our previously expected rate of approximately 22% to 24% due largely to tax benefits for increased export sales and services taxed at a U.S. income tax rate lower than 21%. We continue to expect our forward adjusted effective tax rate will be approximately 22% to 24%. For further information, see “—Non-GAAP Financial Measures” and “Note 18. Income Taxes” to our condensed consolidated financial statements.

Refer to “Forward-Looking Statements” for a discussion of our use of forward-looking statements in this Quarterly Report on Form 10-Q.

4037

Table of Contents

Results of Operations

For each of our Company and Huntsman International, the following tables set forth the condensed consolidated results of operations from continuing operations (dollars in millions, except per share amounts):

Huntsman Corporation

	Three months									Nine months									Three months									Nine months
	ended									ended									ended									ended
	September 30,						Percent			September 30,						Percent			September 30,						Percent			September 30,						Percent
	2021			2020			Change			2021			2020			Change			2022			2021			change			2022			2021			change
Revenues	$	2,285		$	1,510			51	%	$	6,146		$	4,350			41	%	$	2,011		$	2,097			(4	)%	$	6,373		$	5,558			15	%
Cost of goods sold		1,802			1,231			46	%		4,840			3,612			34	%		1,662			1,660			—			5,017			4,397			14	%
Gross profit		483			279			73	%		1,306			738			77	%		349			437			(20	)%		1,356			1,161			17	%
Operating expenses, net		239			208			15	%		692			660			5	%		199			208			(4	)%		621			597			4	%
Restructuring, impairment and plant closing (credits) costs		(1	)		12			NM			34			34			—
Restructuring, impairment and plant closing costs (credits)																				12			(1	)		NM			36			34			6	%
Operating income		245			59			315	%		580			44			NM			138			230			(40	)%		699			530			32	%
Interest expense, net		(15	)		(24	)		(38	)%		(52	)		(63	)		(17	)%		(16	)		(15	)		7	%		(46	)		(52	)		(12	)%
Equity in income of investment in unconsolidated affiliates		34			21			62	%		118			25			372	%		21			34			(38	)%		55			118			(53	)%
Fair value adjustments to Venator investment		(3	)		6			NM			(28	)		(100	)		(72	)%
Fair value adjustments to Venator investment, net																				(7	)		(3	)		133	%		(9	)		(28	)		(68	)%
Loss on early extinguishment of debt		—			—			—			(27	)		—			NM			—			—			—			—			(27	)		(100	)%
Other income, net		7			10			(30	)%		23			27			(15	)%		10			7			43	%		23			21			10	%
Income (loss) from continuing operations before income taxes		268			72			272	%		614			(67	)		NM
Income from continuing operations before income taxes																				146			253			(42	)%		722			562			28	%
Income tax expense		(38	)		(15	)		153	%		(114	)		(9	)		NM			(30	)		(34	)		(12	)%		(155	)		(101	)		53	%
Income (loss) from continuing operations		230			57			304	%		500			(76	)		NM
Income from continuing operations																				116			219			(47	)%		567			461			23	%
(Loss) income from discontinued operations, net of tax~~(1)~~		(5	)		—			NM			(3	)		782			NM			(1	)		6			NM			30			36			(17	)%
Net income		225			57			295	%		497			706			(30	)%		115			225			(49	)%		597			497			20	%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(16	)		(9	)		78	%		(49	)		(15	)		227	%		(15	)		(16	)		(6	)%		(46	)		(49	)		(6	)%
Interest expense, net from continuing operations		15			24			(38	)%		52			63			(17	)%		16			15			7	%		46			52			(12	)%
Income tax expense from continuing operations		38			15			153	%		114			9			NM			30			34			(12	)%		155			101			53	%
Income tax expense from discontinued operations		5			—			NM			5			239			(98	)%		7			9			(22	)%		14			18			(22	)%
Depreciation and amortization of continuing operations		72			70			3	%		219			206			6	%
Depreciation and amortization from continuing operations																				72			68			6	%		207			205			1	%
Depreciation and amortization from discontinued operations																				3			4			(25	)%		11			14			(21	)%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		5			9						19			30						1			5						11			19
EBITDA from discontinued operations(1)		—			—						(2	)		(1,021	)
Fair value adjustments to Venator investment		3			(6	)					28			100
EBITDA from discontinued operations																				(9	)		(19	)					(55	)		(68	)
Fair value adjustments to Venator investment, net																				7			3						9			28
Loss on early extinguishment of debt		—			—						27			—						—			—						—			27
Certain legal and other settlements and related (income) expenses		—			(4	)					10			2
Gain on sale of businesses/assets		—			—						(30	)		(1	)
Certain legal and other settlements and related expenses																				1			—						15			10
Costs associated with the Albemarle Settlement, net																				1			—						3			—
Loss (gain) on sale of business/assets																				16			—						27			(30	)
Income from transition services arrangements		(2	)		(1	)					(6	)		(6	)					—			(2	)					(2	)		(6	)
Certain nonrecurring information technology project implementation costs		2			1						6			3						1			2						4			6
Amortization of pension and postretirement actuarial losses		22			20						65			57						10			19						32			56
Plant incident remediation costs		2			—						3			1
Restructuring, impairment and plant closing and transition costs		—			12						36			34
Adjusted EBITDA(2)	$	371		$	188			97	%	$	994		$	407			144	%
Plant incident remediation costs (credits)																				1			2						(4	)		3
Restructuring, impairment and plant closing and transition costs(2)																				14			—						44			36
Adjusted EBITDA(1)																			$	271		$	349			(22	)%	$	1,068		$	919			16	%

Net cash provided by operating activities from continuing operations										$	163		$	110			48	%										$	595		$	182			227	%
Net cash (used in) provided by investing activities											(439	)		1,105			NM
Net cash used in investing activities from continuing operations																													(176	)		(430	)		(59	)%
Net cash used in financing activities											(809	)		(546	)		48	%											(905	)		(809	)		12	%
Capital expenditures											(250	)		(170	)		47	%
Capital expenditures from continuing operations																													(186	)		(241	)		(23	)%

4138

Table of Contents

Huntsman International

	Three months									Nine months									Three months									Nine months
	ended									ended									ended									ended
	September 30,						Percent			September 30,						Percent			September 30,						Percent			September 30,						Percent
	2021			2020			Change			2021			2020			Change			2022			2021			change			2022			2021			change
Revenues	$	2,285		$	1,510			51	%	$	6,146		$	4,350			41	%	$	2,011		$	2,097			(4	)%	$	6,373		$	5,558			15	%
Cost of goods sold		1,802			1,231			46	%		4,840			3,612			34	%		1,662			1,660			—			5,017			4,397			14	%
Gross profit		483			279			73	%		1,306			738			77	%		349			437			(20	)%		1,356			1,161			17	%
Operating expenses, net		238			207			15	%		686			656			5	%		200			207			(3	)%		617			591			4	%
Restructuring, impairment and plant closing (credits) costs		(1	)		12			NM			34			34			—
Restructuring, impairment and plant closing costs (credits)																				12			(1	)		NM			36			34			6	%
Operating income		246			60			310	%		586			48			NM			137			231			(41	)%		703			536			31	%
Interest expense, net		(15	)		(24	)		(38	)%		(52	)		(65	)		(20	)%		(16	)		(15	)		7	%		(46	)		(52	)		(12	)%
Equity in income of investment in unconsolidated affiliates		34			21			62	%		118			25			372	%		21			34			(38	)%		55			118			(53	)%
Fair value adjustments to Venator investment		(3	)		6			NM			(28	)		(100	)		(72	)%
Fair value adjustments to Venator investment, net																				(7	)		(3	)		133	%		(9	)		(28	)		(68	)%
Loss on early extinguishment of debt		—			—			—			(27	)		—			NM			—			—			—			—			(27	)		(100	)%
Other income, net		7			10			(30	)%		21			25			(16	)%		10			7			43	%		23			19			21	%
Income (loss) from continuing operations before income taxes		269			73			268	%		618			(67	)		NM
Income from continuing operations before income taxes																				145			254			(43	)%		726			566			28	%
Income tax expense		(39	)		(15	)		160	%		(115	)		(9	)		NM			(30	)		(35	)		(14	)%		(156	)		(102	)		53	%
Income (loss) from continuing operations		230			58			297	%		503			(76	)		NM
Income from continuing operations																				115			219			(47	)%		570			464			23	%
(Loss) income from discontinued operations, net of tax~~(1)~~		(5	)		—			NM			(3	)		782			NM			(1	)		6			NM			30			36			(17	)%
Net income		225			58			288	%		500			706			(29	)%		114			225			(49	)%		600			500			20	%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(16	)		(9	)		78	%		(49	)		(15	)		227	%		(15	)		(16	)		(6	)%		(46	)		(49	)		(6	)%
Interest expense, net from continuing operations		15			24			(38	)%		52			65			(20	)%		16			15			7	%		46			52			(12	)%
Income tax expense from continuing operations		39			15			160	%		115			9			NM			30			35			(14	)%		156			102			53	%
Income tax expense from discontinued operations		5			—			NM			5			239			(98	)%		7			9			(22	)%		14			18			(22	)%
Depreciation and amortization of continuing operations		72			70			3	%		219			206			6	%
Depreciation and amortization from continuing operations																				72			68			6	%		207			205			1	%
Depreciation and amortization from discontinued operations																				3			4			(25	)%		11			14			(21	)%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		5			9						19			30						1			5						11			19
EBITDA from discontinued operations(1)		—			—						(2	)		(1,021	)
Fair value adjustments to Venator investment		3			(6	)					28			100
EBITDA from discontinued operations																				(9	)		(19	)					(55	)		(68	)
Fair value adjustments to Venator investment, net																				7			3						9			28
Loss on early extinguishment of debt		—			—						27			—						—			—						—			27
Certain legal and other settlements and related (income) expenses		—			(4	)					10			2
Gain on sale of businesses/assets		—			—						(30	)		(1	)
Certain legal and other settlements and related expenses																				1			—						15			10
Costs associated with the Albemarle Settlement, net																				1			—						3			—
Loss (gain) on sale of business/assets																				16			—						27			(30	)
Income from transition services arrangements		(2	)		(1	)					(6	)		(6	)					—			(2	)					(2	)		(6	)
Certain nonrecurring information technology project implementation costs		2			1						6			3						1			2						4			6
Amortization of pension and postretirement actuarial losses		22			20						67			59						10			19						32			58
Plant incident remediation costs		2			—						3			1
Restructuring, impairment and plant closing and transition costs		—			12						36			34
Adjusted EBITDA(2)	$	372		$	189			97	%	$	1,000		$	411			143	%
Plant incident remediation costs (credits)																				1			2						(4	)		3
Restructuring, impairment and plant closing and transition costs(2)																				14			—						44			36
Adjusted EBITDA(1)																			$	270		$	350			(23	)%	$	1,072		$	925			16	%

Net cash provided by operating activities from continuing operations										$	167		$	113			48	%										$	597		$	186			221	%
Net cash (used in) provided by investing activities											(544	)		1,379			NM
Net cash used in investing activities from continuing operations																													(942	)		(535	)		76	%
Net cash used in financing activities											(706	)		(824	)		(14	)%											(139	)		(706	)		(80	)%
Capital expenditures from continuing operations											(250	)		(170	)		47	%											(186	)		(241	)		(23	)%

4239

Table of Contents

Huntsman Corporation

	Three months									Three months									Three months									Three months
	ended									ended									ended									ended
	September 30, 2021									September 30, 2020									September 30, 2022									September 30, 2021
				Tax and									Tax and									Tax and									Tax and
	Gross			other(3)			Net			Gross			other(3)			Net			Gross			other(3)			Net			Gross			other(3)			Net
Reconciliation of net income to adjusted net income
Net income							$	225								$	57								$	115								$	225
Net income attributable to noncontrolling interests								(16	)								(9	)								(15	)								(16	)
Business acquisition and integration expenses and purchase accounting inventory adjustments	$	5		$	(2	)		3		$	9		$	(3	)		6		$	1		$	(1	)		—		$	5		$	(2	)		3
Loss from discontinued operations(1)(4)		—			5			5			—			—			—
Fair value adjustments to Venator investment		3			—			3			(6	)		—			(6	)
Certain legal and other settlements and related income		—			—			—			(4	)		1			(3	)
(Income) loss from discontinued operations(4)																				(9	)		10			1			(19	)		13			(6	)
Fair value adjustments to Venator investment, net																				7			—			7			3			—			3
Certain legal and other settlements and related expenses																				1			(1	)		—			—			—			—
Costs associated with the Albemarle Settlement, net																				1			(1	)		—			—			—			—
Loss on sale of businesses/assets																				16			(4	)		12			—			—			—
Income from transition services arrangements		(2	)		—			(2	)		(1	)		—			(1	)		—			—			—			(2	)		—			(2	)
Certain nonrecurring information technology project implementation costs		2			—			2			1			—			1			1			—			1			2			—			2
Amortization of pension and postretirement actuarial losses		22			(5	)		17			20			(4	)		16			10			(2	)		8			19			(4	)		15
Plant incident remediation costs		2			—			2			—			—			—			1			—			1			2			—			2
Restructuring, impairment and plant closing and transition costs		—			—			—			12			(3	)		9
Adjusted net income(2)							$	239								$	70
Restructuring, impairment and plant closing and transition costs(2)																				14			(3	)		11			—			—			—
Adjusted net income(1)																									$	141								$	226

Weighted average shares-basic								219.4									219.8									197.7									219.4
Weighted average shares-diluted								221.3									221.3									199.2									221.3

Basic net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	0.97								$	0.22								$	0.52								$	0.93
Income from discontinued operations								(0.02	)								—									(0.01	)								0.02
Net income							$	0.95								$	0.22								$	0.51								$	0.95

Diluted net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	0.96								$	0.22								$	0.51								$	0.92
Income from discontinued operations								(0.02	)								—									(0.01	)								0.02
Net income							$	0.94								$	0.22								$	0.50								$	0.94

Other non-GAAP measures:
Diluted adjusted net income per share(2)							$	1.08								$	0.32
Diluted adjusted net income per share(1)																									$	0.71								$	1.02

4340

Table of Contents

	Nine months									Nine months									Nine months									Nine months
	ended									ended									ended									ended
	September 30, 2021									September 30, 2020									September 30, 2022									September 30, 2021
				Tax and									Tax and									Tax and									Tax and
	Gross			other(3)			Net			Gross			other(3)			Net			Gross			other(3)			Net			Gross			other(3)			Net
Reconciliation of net income to adjusted net income
Net income							$	497								$	706								$	597								$	497
Net income attributable to noncontrolling interests								(49	)								(15	)								(46	)								(49	)
Business acquisition and integration expenses and purchase accounting inventory adjustments	$	19		$	(4	)		15		$	30		$	(6	)		24		$	11		$	(3	)		8		$	19		$	(4	)		15
Income from discontinued operations(1)(4)		(2	)		5			3			(1,021	)		239			(782	)
Fair value adjustments to Venator investment		28			—			28			100			—			100
Income from discontinued operations(4)																				(55	)		25			(30	)		(68	)		32			(36	)
Fair value adjustments to Venator investment, net																				9			—			9			28			—			28
Loss on early extinguishment of debt		27			(6	)		21			—			—			—			—			—			—			27			(6	)		21
Certain legal and other settlements and related expenses		10			(3	)		7			2			—			2			15			(4	)		11			10			(3	)		7
Gain on sale of businesses/assets		(30	)		4			(26	)		(1	)		—			(1	)
Costs associated with the Albemarle Settlement, net																				3			(1	)		2			—			—			—
Loss (gain) on sale of businesses/assets																				27			(6	)		21			(30	)		4			(26	)
Income from transition services arrangements		(6	)		1			(5	)		(6	)		1			(5	)		(2	)		—			(2	)		(6	)		1			(5	)
Certain nonrecurring information technology project implementation costs		6			(1	)		5			3			—			3			4			(1	)		3			6			(1	)		5
Amortization of pension and postretirement actuarial losses		65			(15	)		50			57			(12	)		45			32			(7	)		25			56			(13	)		43
Plant incident remediation costs		3			—			3			1			—			1
Restructuring, impairment and plant closing and transition costs		36			(8	)		28			34			(7	)		27
Adjusted net income(2)							$	577								$	105
Plant incident remediation (credits) costs																				(4	)		1			(3	)		3			—			3
Restructuring, impairment and plant closing and transition costs(2)																				44			(11	)		33			36			(8	)		28
Adjusted net income(1)																									$	628								$	531

Weighted average shares-basic								220.2									220.8									205.2									220.2
Weighted average shares-diluted								222.2									220.8									207.2									222.2

Basic net income attributable to Huntsman Corporation per share:
Income (loss) from continuing operations							$	2.04								$	(0.41	)
(Loss) income from discontinued operations								(0.01	)								3.54
Income from continuing operations																									$	2.54								$	1.87
Income from discontinued operations																										0.15									0.16
Net income							$	2.03								$	3.13								$	2.69								$	2.03

Diluted net income attributable to Huntsman Corporation per share:
Income (loss) from continuing operations							$	2.03								$	(0.41	)
(Loss) income from discontinued operations								(0.01	)								3.54
Income from continuing operations																									$	2.52								$	1.86
Income from discontinued operations																										0.14									0.16
Net income							$	2.02								$	3.13								$	2.66								$	2.02

Other non-GAAP measures:
Diluted adjusted net income per share(2)							$	2.60								$	0.47
Diluted adjusted net income per share(1)																									$	3.03								$	2.39

Net cash provided by operating activities from continuing operations							$	163								$	110								$	595								$	182
Capital expenditures from continuing operations								(250	)								(170	)								(186	)								(241	)
Free cash flow from continuing operations(2)							$	(87	)							$	(60	)
Free cash flow from continuing operations(1)																									$	409								$	(59	)

Other cash flow measure:
Taxes paid on sale of businesses(5)							$	3								$	188
Effective tax rate																										21	%								18	%
Impact of non-GAAP adjustments(5)																										1	%								—
Adjusted effective tax rate(1)																										22	%								18	%

Other cash flow measures:
Taxes paid on sale of business(6)																									$	—								$	(3	)
Cash received from the Albemarle Settlement, net(7)																										78									—

NM—Not meaningful

(1)	~~Includes the gain on the sale of our Chemical Intermediates Businesses recognized predominantly in the first quarter of 2020.~~ See “—Non-GAAP Financial Measures.”

(2)	~~See “—Non-GAAP Financial Measures.”~~Includes costs associated with transition activities related primarily to our Corporate program to optimize our global approach to leverage shared services capabilities.

(3)

The income tax impacts, if any, ~~of each adjusting item represent a ratable allocation of~~are computed on the ~~total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items~~pre-tax adjustments using a with and without approach.

(4)	In addition to income tax impacts, this adjusting item is also impacted by depreciation and amortization expense and interest expense.

(5)	For details regarding the tax impacts of our non-GAAP adjustments, please see the reconciliation of our net income to adjusted net income noted above.

(6)

Represents the taxes paid in the second quarter of 2021 in connection with the earnout provision achieved under the terms of the sales agreement of the India-based DIY ~~business and taxes paid in the first half of 2020 in connection with the sale of the Chemical Intermediates Businesses.~~business. For more information, see “Note 4. Discontinued Operations and Business ~~Dispositions”~~Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business” to our condensed consolidated financial statements.

(7)	Represents cash received of $332.5 million, net of legal fees and cash taxes paid of approximately $255 million.

4441

Table of Contents

Non-GAAP Financial Measures

Our condensed consolidated financial statements are prepared in accordance with GAAP, which we supplement with certain non-GAAP financial information. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in their entirety and not to rely on any single financial measure. These non-GAAP measures exclude the impact of certain income and expenses that we do not believe are indicative of our core operating results.

Adjusted EBITDA

Our management uses adjusted EBITDA to assess financial performance. Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) EBITDA from discontinued operations; (c) fair value adjustments to Venator ~~investment;~~investment, net; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related ~~(income)~~ expenses; (f) ~~gain~~costs associated with the Albemarle Settlement, net; (g) loss (gain) on sale of ~~businesses/~~business/assets; ~~(g)~~(h) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(h)~~(i) certain nonrecurring information technology project implementation costs; ~~(i)~~(j) amortization of pension and postretirement actuarial losses; ~~(j)~~(k) plant incident remediation (credits) costs; and ~~(k)~~(l) restructuring, impairment and plant closing and transition costs. We believe that net income of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted EBITDA.

We believe adjusted EBITDA is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. However, this measure should not be considered in isolation or viewed as a substitute for net income of Huntsman Corporation or Huntsman International, as appropriate, or other measures of performance determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA as used herein is not necessarily comparable to other similarly titled measures of other companies due to potential inconsistencies in the methods of calculation. Our management believes this measure is useful to compare general operating performance from period to period and to make certain related management decisions. Adjusted EBITDA is also used by securities analysts, lenders and others in their evaluation of different companies because it excludes certain items that can vary widely across different industries or among companies within the same industry. For example, interest expense can be highly dependent on a company’s capital structure, debt levels and credit ratings. Therefore, the impact of interest expense on earnings can vary significantly among companies. In addition, the tax positions of companies can vary because of their differing abilities to take advantage of tax benefits and because of the tax policies of the various jurisdictions in which they operate. As a result, effective tax rates and tax expense can vary considerably among companies. Finally, companies employ productive assets of different ages and utilize different methods of acquiring and depreciating such assets. This can result in considerable variability in the relative costs of productive assets and the depreciation and amortization expense among companies.

Nevertheless, our management recognizes that there are material limitations associated with the use of adjusted EBITDA in the evaluation of our Company as compared to net income of Huntsman Corporation or Huntsman International, as appropriate, which reflects overall financial performance. For example, we have borrowed money in order to finance our operations and interest expense is a necessary element of our costs and ability to generate revenue. Our management compensates for the limitations of using adjusted EBITDA by using this measure to supplement U.S. GAAP results to provide a more complete understanding of the factors and trends affecting the business rather than U.S. GAAP results alone.

4542

Table of Contents

Adjusted Net Income

Adjusted net income is computed by eliminating the after-tax amounts related to the following from net income attributable to Huntsman Corporation: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) ~~loss (income)~~income from discontinued operations; (c) fair value adjustments to Venator ~~investment;~~investment, net; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related ~~(income)~~ expenses; (f) costs associated with the Albemarle Settlement, net; (g) gain on sale of ~~businesses/~~business/assets; ~~(g)~~(h) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(h)~~(i) certain nonrecurring information technology project implementation costs; ~~(i)~~(j) amortization of pension and postretirement actuarial losses; ~~(j)~~(k) plant incident remediation (credits) costs; and ~~(k)~~(l) restructuring, impairment and plant closing and transition costs. Basic adjusted net income per share excludes dilution and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period. Adjusted diluted net income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities. Adjusted net income and adjusted net income per share amounts are presented solely as supplemental information.

We believe adjusted net income is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

Free Cash Flow

We believe free cash flow is an important indicator of our liquidity as it measures the amount of cash we generate. Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt. Starting with the quarter ended March 31, 2020, we updated our definition of free cash flow to a presentation more consistent with today’s market standard of net cash provided by operating activities less capital expenditures. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures.

Adjusted Effective Tax Rate

We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items, such as, business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted, that ~~management believes~~we believe are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. ~~We do not provide reconciliations for~~

Our forward-looking adjusted effective tax rate is calculated based on aour forecast effective tax rate, and the range of our forward-looking ~~basis~~adjusted effective tax rate equals the range of our forecast effective tax rate. We disclose forward-looking adjusted effective tax rate because we ~~are unable to provide a meaningful or accurate calculation or estimation of reconciling~~cannot adequately forecast certain items and events that may or may not impact us in the ~~information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items,~~near future, such as business acquisition and integration expenses ~~merger costs,~~and purchase accounting inventory adjustments, certain legal and other settlements and related ~~costs,~~expenses, gains on sale of businesses/assets and ~~amortization of pension and postretirement actuarial losses.~~certain tax only items, including tax law changes not yet enacted. Each of such ~~adjustments~~adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. ~~For~~In our view, our forward-looking adjusted effective tax rate represents the ~~same reasons, we are unable~~forecast effective tax rate on our underlying business operations but does not reflect any adjustments related to ~~address~~ the ~~probable significance of the unavailable information.~~items noted above that may occur and can cause our effective tax rate to differ.

4643

Table of Contents

Three Months Ended September 30, ~~2021~~2022 Compared with Three Months Ended September 30, ~~2020~~2021

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of ~~Chemical Intermediates Businesses”~~Textile Effects Business” to our condensed consolidated financial statements, the results from continuing operations primarily exclude the results of our ~~Chemical Intermediates Businesses and the results of our former polymers, base chemicals and Australian styrenics businesses~~Textile Effects Business for all periods presented. ~~The increase of $166 million in net~~For the three months ended September 30, 2022, income from continuing operations attributable to Huntsman Corporation ~~and the increase~~was $101 million, a decrease of ~~$165~~$102 million from $203 million in ~~net~~the 2021 period. For the three months ended September 30, 2022, income from continuing operations attributable to Huntsman International was $100 million, a decrease of $103 million from $203 million in the 2021 period. The decreases noted above were the result of the following items:

●

Revenues for the three months ended September 30, ~~2021 increased~~2022 decreased by ~~$775~~$86 million, or ~~51%~~4%, as compared with the ~~2020~~2021 period. The ~~increase~~decrease was primarily due to lower sales volumes in all our segments, partially offset by higher average selling prices ~~as well as higher sales volumes~~ in all our segments. See “—Segment Analysis” below.

●

Gross profit for the three months ended September 30, ~~2021 increased~~2022 decreased by ~~$204~~$88 million, or ~~73%~~20%, as compared with the ~~2020~~2021 period. The ~~increase~~decrease resulted primarily from ~~higher~~lower gross profits in ~~all~~ our ~~segments.~~Polyurethanes segment. See “—Segment Analysis” below.

●

~~Operating~~Our operating expenses, net and the operating expenses, net of Huntsman International for the three months ended September 30, ~~2021 increased~~2022 decreased by ~~$31~~$9 million and $7 million, respectively, or ~~15%~~4% and 3%, respectively, as compared with the ~~2020~~2021 period, primarily related to ~~an increase~~a decrease in selling, general and administrative expenses.

●

~~For~~Restructuring, impairment and plant closing costs were $12 million for the three months ended September 30, ~~2021, we recorded~~2022 as compared with a credit of $1 million in ~~restructuring, impairment and plant closing (credits) costs compared with costs of $12 million in~~ the ~~2020~~2021 period. For ~~more~~further information, ~~concerning restructuring activities,~~ see “Note 7. Restructuring, Impairment and Plant Closing Costs” to our condensed consolidated financial statements.

●

Interest expense, net for the three months ended September 30, 2021 decreased by $9 million, or 38%, as compared with the 2020 period, primarily related to the redemption in full of our 2021 Senior Notes in the first half of 2021.

●

Equity in income of investment in unconsolidated affiliates for the three months ended September 30, ~~2021 increased~~2022 decreased to ~~$34~~$21 million from ~~$21~~$34 million in the ~~2020~~2021 period, primarily related to ~~an increase~~a decrease in income at our PO/MTBE joint venture in China, in which we hold a 49% interest.

●

~~For the three months ended September 30, 2021, we recorded a net loss of $3 million in fair~~Fair value adjustments to our investment in Venator and the related option to sell our remaining Venator shares, net was a net loss of $7 million for the three months ended September 30, 2022 as compared with a ~~gain~~net loss of $6$3 million in the ~~2020~~2021 period. ~~See~~For further information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest” to our condensed consolidated financial statements.

●

Our income tax expense for the three months ended September 30, ~~2021 increased~~2022 decreased to ~~$38~~$30 million from ~~$15~~$34 million in the ~~2020~~2021 period. The income tax expense of Huntsman International for the three months ended September 30, ~~2021 increased~~2022 decreased to ~~$39~~$30 million from ~~$15~~$35 million in the ~~2020~~2021 period. The ~~increase~~decrease in income tax expense was primarily due to the ~~increase~~decrease in pretax income, exclusive of the fair value adjustments to our investment in ~~Venator, partially offset by approximately $11 million of tax benefits for increased export sales and services taxed at a U.S. income tax rate lower than 21% in the third quarter of 2021.~~Venator. Our income tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. For further information, ~~concerning~~see “Note 18. Income Taxes” to our condensed consolidated financial statements.

Table of Contents

	Three months						Percent
	ended						change
	September 30,						favorable
(Dollars in millions)	2022			2021			(unfavorable)
Revenues
Polyurethanes	$	1,257		$	1,403			(10	)%
Performance Products		434			399			9	%
Advanced Materials		328			304			8	%
Total reportable segments’ revenue		2,019			2,106			(4	)%
Intersegment eliminations		(8	)		(9	)		NM
Total	$	2,011		$	2,097			(4	)%

Huntsman Corporation
Segment adjusted EBITDA(1)
Polyurethanes	$	138		$	246			(44	)%
Performance Products		110			103			7	%
Advanced Materials		58			48			21	%
Total reportable segments’ adjusted EBITDA		306			397			(23	)%
Corporate and other		(35	)		(48	)		27	%
Total	$	271		$	349			(22	)%

Huntsman International
Segment adjusted EBITDA(1)
Polyurethanes	$	138		$	246			(44	)%
Performance Products		110			103			7	%
Advanced Materials		58			48			21	%
Total reportable segments’ adjusted EBITDA		306			397			(23	)%
Corporate and other		(36	)		(47	)		23	%
Total	$	270		$	350			(23	)%

NM—Not meaningful

(1)

For further information, including reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 20. Operating Segment Information” to our condensed consolidated financial statements.

	Three months ended September 30, 2022 vs 2021
	Average selling price(1)
	Local			Foreign currency			Mix &			Sales
	currency			translation impact			other			volumes(2)
Period-over-period increase (decrease)
Polyurethanes		12	%		(5	)%		(1	)%		(16	)%
Performance Products		23	%		(4	)%		3	%		(13	)%
Advanced Materials		16	%		(7	)%		15	%		(16	)%

	Three months ended September 30, 2022 vs June 30, 2022
	Average selling price(1)
	Local			Foreign currency			Mix &			Sales
	currency			translation impact			other			volumes(2)
Period-over-period increase (decrease)
Polyurethanes		(1	)%		(2	)%		—			(4	)%
Performance Products		(1	)%		(1	)%		1	%		(11	)%
Advanced Materials		2	%		(3	)%		2	%		(3	)%

(1)	Excludes revenues from tolling arrangements, byproducts and raw materials.

(2)	Excludes sales volumes of byproducts and raw materials.

Table of Contents

Polyurethanes

The decrease in revenues in our Polyurethanes segment for the three months ended September 30, 2022 compared to the same period of 2021 was primarily due to lower sales volumes and the negative impact of weaker major international currencies against the U.S. dollar, partially offset by higher MDI average selling prices. Sales volumes decreased primarily due to lower demand, particularly in our European and construction markets. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, lower MDI margins in Europe and Asia, the negative impact of weaker major international currencies against the U.S. dollar and lower equity earnings from our minority-owned joint venture in China, partially offset by higher MDI margins in the Americas and lower fixed costs.

Performance Products

The increase in revenues in our Performance Products segment for the three months ended September 30, 2022 compared to the same period of 2021 was primarily due to higher average selling prices, partially offset by lower sales volumes. Average selling prices increased primarily due to commercial excellence programs and in response to an increase in raw material costs. Sales volumes decreased primarily due to a shift in business strategy as well as lower demand, particularly in Europe. The increase in segment adjusted EBITDA was primarily due to increased revenues and margins, partially offset by higher costs.

Advanced Materials

The increase in revenues in our Advanced Materials segment for the three months ended September 30, 2022 compared to the same period of 2021 was primarily due to higher average selling prices, partially offset by lower sales volumes. Average selling prices increased largely in response to higher raw material, energy and logistics costs as well as improved sales mix. Sales volumes decreased primarily due to deselection of lower margin business. The increase in segment adjusted EBITDA was primarily due to higher sales prices and improved sales mix.

Corporate and other

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the three months ended September 30, 2022, adjusted EBITDA from Corporate and other for Huntsman Corporation was a loss of $35 million as compared to a loss of $48 million for the same period of 2021. For the three months ended September 30, 2022, adjusted EBITDA from Corporate and other for Huntsman International was a loss of $36 million as compared to a loss of $47 million for the same period of 2021. The increase in adjusted EBITDA from Corporate and other resulted primarily from an increase in unallocated foreign currency exchange gains and a decrease in corporate overhead costs and LIFO valuation losses.

Table of Contents

Nine Months Ended September 30, 2022 Compared with Nine Months Ended September 30, 2021

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business” to our condensed consolidated financial statements, the results from continuing operations primarily exclude the results of our Textile Effects Business for all periods presented. For the nine months ended September 30, 2022, income from continuing operations attributable to Huntsman Corporation was $521 million, an increase of $109 million from $412 million in the 2021 period. For the nine months ended September 30, 2022, income from continuing operations attributable to Huntsman International was $524 million, an increase of $109 million from $415 million in the 2021 period. The increases noted above were the result of the following items:

●

Revenues for the nine months ended September 30, 2022 increased by $815 million, or 15%, as compared with the 2021 period. The increase was primarily due to higher average selling prices in all our segments, partially offset by lower sales volumes in all our segments. See “—Segment Analysis” below.

●

Gross profit for the nine months ended September 30, 2022 increased by $195 million, or 17%, as compared with the 2021 period. The increase resulted primarily from higher gross profits in our Performance Products and Advanced Materials segments. See “—Segment Analysis” below.

●

Our operating expenses, net and the operating expenses, net of Huntsman International for the nine months ended September 30, 2022 increased by $24 million and $26 million, respectively, or 4% for both, as compared with the 2021 period, primarily related to the gain on sale of the India-based DIY business pursuant to an earnout provision in the second quarter of 2021 and an increase in legal expenses and selling, general and administrative expenses.

●

Interest expense, net for the nine months ended September 30, 2022 decreased by $6 million, or 12%, as compared with the 2021 period, primarily related to the redemption in full of our 2022 Senior Notes in the first half of 2021. For further information, see “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

●

Equity in income of investment in unconsolidated affiliates for the nine months ended September 30, 2022 decreased to $55 million from $118 million in the 2021 period, primarily related to a decrease in income at our PO/MTBE joint venture in China, in which we hold a 49% interest.

●

Fair value adjustments to our investment in Venator and the related option to sell our remaining Venator shares, net was a net loss of $9 million for the nine months ended September 30, 2022 as compared with a net loss of $28 million in the 2021 period. For further information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest” to our condensed consolidated financial statements.

●

Loss on early extinguishment of debt was nil for the nine months ended September 30, 2022 as compared with $27 million in the 2021 period, primarily due to the full redemption of our 2022 Senior Notes in the second quarter of 2021. For further information, see “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

●

Our income tax expense for the nine months ended September 30, 2022 increased to $155 million from $101 million in the 2021 period. The income tax expense of Huntsman International for the nine months ended September 30, 2022 increased to $156 million from $102 million in the 2021 period. The increase in income tax expense was primarily due to the increase in pretax income, exclusive of the fair value adjustments to our investment in Venator. Our income tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. For further information, see “Note 18. Income Taxes” to our condensed consolidated financial statements.

Table of Contents

	Three months						Percent			Nine months						Percent
	ended						Change			ended						Change
	September 30,						Favorable			September 30,						Favorable
(Dollars in millions)	2021			2020			(Unfavorable)
										2022			2021			(Unfavorable)
Revenues
Polyurethanes	$	1,403		$	936			50	%	$	3,996		$	3,626			10	%
Performance Products		399			238			68	%		1,406			1,075			31	%
Advanced Materials		304			199			53	%		999			881			13	%
Textile Effects		188			142			32	%
Corporate and eliminations		(9	)		(5	)		NM
Total reportable segments’ revenue											6,401			5,582			15	%
Intersegment eliminations											(28	)		(24	)		NM
Total	$	2,285		$	1,510			51	%	$	6,373		$	5,558			15	%

Huntsman Corporation
Segment adjusted EBITDA(1)
Polyurethanes	$	246		$	156			58	%	$	591		$	661			(11	)%
Performance Products		103			36			186	%		408			254			61	%
Advanced Materials		48			25			92	%		192			150			28	%
Textile Effects		22			8			175	%
Total reportable segments’ adjusted EBITDA											1,191			1,065			12	%
Corporate and other		(48	)		(37	)		(30	)%		(123	)		(146	)		16	%
Total	$	371		$	188			97	%	$	1,068		$	919			16	%

Huntsman International
Segment adjusted EBITDA(1)
Polyurethanes	$	246		$	156			58	%	$	591		$	661			(11	)%
Performance Products		103			36			186	%		408			254			61	%
Advanced Materials		48			25			92	%		192			150			28	%
Textile Effects		22			8			175	%
Total reportable segments’ adjusted EBITDA											1,191			1,065			12	%
Corporate and other		(47	)		(36	)		(31	)%		(119	)		(140	)		15	%
Total	$	372		$	189			97	%	$	1,072		$	925			16	%

NM—Not meaningful

(1)

For ~~more~~further information, including reconciliation of ~~segment~~total reportable segments’ adjusted EBITDA to ~~net~~ income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 20. Operating Segment Information” to our condensed consolidated financial statements.

Three months ended September 30, 2021 vs 2020

Average Selling Price(1)

Local

Foreign Currency

Mix &

Sales

Currency

Translation Impact

Other

Volumes(2)

Period-Over-Period Increase (Decrease)

Polyurethanes
40 % 2 % 6 % 2 %
Performance Products
49 % 2 % (8 )% 25 %
Advanced Materials
23 % 3 % 24 % 3 %
Textile Effects
15 % 3 % (2 )% 16 %

	Three months ended September 30, 2021 vs June 30, 2021												Nine months ended September 30, 2022 vs September 30, 2021
	Average Selling Price(1)												Average Selling Price(1)
	Local			Foreign Currency			Mix &			Sales			Local			Foreign Currency			Mix &			Sales
	Currency			Translation Impact			Other			Volumes(2)			Currency			Translation Impact			Other			Volumes(2)
Period-Over-Period (Decrease) Increase
Polyurethanes		8	%		(1	)%		4	%		10	%		21	%		(4	)%		(1	)%		(6	)%
Performance Products		8	%		(1	)%		2	%		(1	)%		34	%		(3	)%		4	%		(4	)%
Advanced Materials		5	%		—			1	%		(4	)%		19	%		(5	)%		16	%		(17	)%
Textile Effects		—			—			(2	)%		(7	)%

(1)	Excludes revenues from tolling arrangements, byproducts and raw materials.

(2)	Excludes sales volumes of byproducts and raw materials.

Table of Contents

Polyurethanes

The increase in revenues in our Polyurethanes segment for the ~~three~~nine months ended September 30, ~~2021~~2022 compared to the same period of ~~2020~~2021 was ~~largely~~primarily due to higher MDI average selling prices, partially offset by lower sales volumes and ~~slightly higher sales volumes. MDI average selling prices increased in all our regions.~~the negative impact of weaker major international currencies against the U.S. dollar. Sales volumes ~~increased~~decreased primarily due to ~~stronger~~lower demand, particularly in ~~relation to the ongoing recovery from the global economic slowdown, partially offset by the impact of Hurricane Ida at~~ our ~~Geismar, Louisiana facility that occurred in the third quarter of 2021.~~European and construction markets. The ~~increase~~decrease in segment adjusted EBITDA was primarily due to ~~higher MDI margins resulting from higher MDI pricing and slightly higher sales volumes as well as stronger~~lower equity earnings from our ~~PO/MTBE~~minority-owned joint venture in China, lower sales volumes and the negative impact of weaker major international currencies against the U.S. dollar, partially offset by higher ~~raw material costs.~~

~~Performance Products~~

~~The increase in revenues in our Performance Products segment for the three months ended September 30, 2021 compared to the same period of 2020 was primarily due to higher average selling prices~~margins and higher sales volumes. Average selling prices increased primarily due to stronger demand in relation to the ongoing recovery from the global economic slowdown as well as in response to an increase in raw material costs. Sales volumes also increased primarily due to stronger demand. The increase in segment adjusted EBITDA was primarily due to increased revenue and margins, partially offset by increasedlower fixed costs.

~~Advanced Materials~~

The increase in revenues in our Advanced Materials segment for the three months ended September 30, 2021 compared to the same period in 2020 was primarily due to higher sales volumes, higher average selling prices and the favorable net impact of the Gabriel Acquisition and the sale of the India-based DIY business. See “Note 3. Business Combinations and Acquisitions” and “Note 4. Discontinued Operations and Business Dispositions” to our condensed consolidated financial statements. Excluding our recent acquisition and divestiture, sales volumes increased across all of our specialty markets, primarily in relation to the ongoing recovery from the global economic slowdown. Average selling prices increased largely in response to higher raw material costs. The increase in segment adjusted EBITDA was primarily due to higher sales volumes and the benefit from our recent acquisition.

~~Textile Effects~~

The increase in revenues in our Textile Effects segment for the three months ended September 30, 2021 compared to the same period of 2020 was due to higher sales volumes and higher average selling prices. Sales volumes increased primarily due to increased demand resulting from the ongoing recovery from the global economic slowdown, particularly in the North Asia and Americas regions. Average selling prices increased primarily in response to higher freight and logistics costs. The increase in segment adjusted EBITDA was primarily due to higher sales revenues, partially offset by higher fixed costs.

~~Corporate and other~~

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the three months ended September 30, 2021, adjusted EBITDA from Corporate and other for Huntsman Corporation decreased by $11 million to a loss of $48 million from a loss of $37 million for the same period of 2020. For the three months ended September 30, 2021, adjusted EBITDA from Corporate and other for Huntsman International decreased by $11 million to a loss of $47 million from a loss of $36 million for the same period of 2020. The decrease in adjusted EBITDA from Corporate and other was primarily due to a charge from a LIFO inventory valuation reserve adjustment and an increase in corporate overhead costs, partially offset by an increase in unallocated foreign currency exchange gains.

~~Table of Contents~~

~~Nine Months Ended September 30, 2021 Compared with Nine Months Ended September 30, 2020~~

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of Chemical Intermediates Businesses” to our condensed consolidated financial statements, the results from continuing operations exclude the results of our Chemical Intermediates and Businesses and the results of our former polymers, base chemicals and Australian styrenics business for all periods presented. The increase of $542 million in net income from continuing operations attributable to Huntsman Corporation and the increase of $545 million in net income from continuing operations attributable to Huntsman International was the result of the following items:

●

Revenues for the nine months ended September 30, 2021 increased by $1,796 million, or 41%, as compared with the 2020 period. The increase was primarily due to higher average selling prices as well as higher sales volumes in all our segments. See “—Segment Analysis” below.

●

Gross profit for the nine months ended September 30, 2021 increased by $568 million, or 77%, as compared with the 2020 period. The increase resulted from higher gross profits in all our segments. See “—Segment Analysis” below.

●

Our operating expenses, net and the operating expenses, net of Huntsman International for the nine months ended September 30, 2021 increased by $32 million and $30 million, respectively, or 5% for both, as compared with the 2020 period, primarily related to an increase in selling, general and administrative expenses, partially offset by the pretax gain of $28 million recognized in the second quarter of 2021 in connection with the earnout provision achieved under the terms of the sale agreement of the India-based DIY business.

●

Our interest expense, net and interest expense, net of Huntsman International for the nine months ended September 30, 2021 decreased by $11 million and $13 million, respectively, or 17% and 20%, respectively, as compared with the 2020 period, primarily related to the redemption in full of our 2021 Senior Notes in the first half of 2021.

●

Equity in income of investment in unconsolidated affiliates for the nine months ended September 30, 2021 increased to $118 million from $25 million in the 2020 period, primarily related to an increase in income at our PO/MTBE joint venture in China, in which we hold a 49% interest.

●

For the nine months ended September 30, 2021, we recorded a net loss of $28 million in fair value adjustments to our investment in Venator and related option to sell our remaining Venator shares compared with a loss of $100 million in the 2020 period. See “Note 4. Business Dispositions—Sale of Venator Interest” to our condensed consolidated financial statements.

●

Loss on early extinguishment of debt for the nine months ended September 30, 2021 was $27 million compared with nil in the 2020 period, primarily due to the full redemption of our 2022 Senior Notes in the second quarter of 2021. See “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

●

Our income tax expense for the nine months ended September 30, 2021 increased to $114 million from $9 million in the 2020 period. The income tax expense of Huntsman International for the nine months ended September 30, 2021 increased to $115 from $9 million in the 2020 period. The increase in income tax expense was primarily due to pretax income, exclusive of the fair value adjustments to our investment in Venator, partially offset by approximately $11 million of tax benefits for increased export sales and services taxed at a U.S. income tax rate lower than 21% in the 2021 period. Our income tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. For further information concerning income taxes, see “Note 18. Income Taxes” to our condensed consolidated financial statements.

~~Table of Contents~~

Nine months

Percent

ended

Change

September 30,

Favorable

2021

2020

(Unfavorable)

Revenues

Polyurethanes
$ 3,626 $ 2,554 42 %
Performance Products
1,075 758 42 %
Advanced Materials
881 632 39 %
Textile Effects
588 424 39 %
Corporate and eliminations
(24 ) (18 ) NM
Total
$ 6,146 $ 4,350 41 %

Huntsman Corporation

Segment adjusted EBITDA(1)

Polyurethanes
$ 661 $ 271 144 %
Performance Products
254 123 107 %
Advanced Materials
150 103 46 %
Textile Effects
75 24 213 %
Corporate and other
(146 ) (114 ) (28 )%
Total
$ 994 $ 407 144 %

Huntsman International

Segment adjusted EBITDA(1)

Polyurethanes
$ 661 $ 271 144 %
Performance Products
254 123 107 %
Advanced Materials
150 103 46 %
Textile Effects
75 24 213 %
Corporate and other
(140 ) (110 ) (27 )%
Total
$ 1,000 $ 411 143 %

~~NM—Not meaningful~~

~~(1)~~

For more information, including reconciliation of segment adjusted EBITDA to net income of Huntsman Corporation or Huntsman International, as appropriate, see “Note 20. Operating Segment Information” to our condensed consolidated financial statements.

Nine months ended September 30, 2021 vs September 30, 2020

Average Selling Price(1)

Local

Foreign Currency

Mix &

Sales

Currency

Translation Impact

Other

Volumes(2)

Period-Over-Period (Decrease) Increase

Polyurethanes
31 % 3 % 4 % 4 %
Performance Products
29 % 4 % (5 )% 14 %
Advanced Materials
10 % 5 % 11 % 13 %
Textile Effects
(1 )% 3 % 5 % 32 %

~~(1)~~

~~Excludes revenues from tolling arrangements, byproducts and raw materials.~~

~~(2)~~

~~Excludes sales volumes of byproducts and raw materials.~~

~~Table of Contents~~

~~Polyurethanes~~

The increase in revenues in our Polyurethanes segment for the nine months ended September 30, 2021 compared to the same period of 2020 was largely due to higher MDI average selling prices and higher sales volumes. MDI average selling prices increased mostly in China and Europe with increases in our Americas region during the third quarter of 2021. Sales volumes increased primarily due to stronger demand in relation to the ongoing recovery from the global economic slowdown, partially offset by some unplanned downtime resulting from the U.S. Gulf Coast Winter Storm Uri that occurred in the first quarter of 2021, the scheduled turnaround at our Rotterdam, Netherlands facility during the second quarter of 2021 and the impact of Hurricane Ida at our Geismar, Louisiana facility that occurred in the third quarter of 2021. The increase in segment adjusted EBITDA was primarily due to higher MDI margins resulting from higher MDI pricing and higher sales volumes as well as stronger earnings from our PO/MTBE joint venture in China, partially offset by higher raw material costs

Performance Products

The increase in revenues in our Performance Products segment for the nine months ended September 30, ~~2021~~2022 compared to the same period of ~~2020~~2021 was primarily due to higher average selling prices, ~~and higher~~partially offset by lower sales volumes. Average selling prices increased primarily due to ~~stronger demand in relation to the ongoing recovery from the global economic slowdown as well as~~commercial excellence programs and in response to an increase in raw material costs. Sales volumes ~~also increased~~decreased primarily due to ~~stronger demand.~~a shift in business strategy as well as lower demand, particularly in Europe. The increase in segment adjusted EBITDA was primarily due to increased ~~revenue~~revenues and margins, partially offset by ~~increased fixed~~higher costs.

Advanced Materials

The increase in revenues in our Advanced Materials segment for the nine months ended September 30, ~~2021~~2022 compared to the same period ~~in 2020~~of 2021 was primarily due to higher ~~sales volumes, higher~~ average selling prices, and the favorable net impact of the CVC Thermoset Specialties Acquisition, the Gabriel Acquisition and the sale of the India-based DIY business. See “Note 3. Business Combinations and Acquisitions” and “Note 4. Discontinued Operations and Business Dispositions” to our condensed consolidated financial statements. Excluding our recent acquisitions and divestiture and with the exception of our global aerospace business,partially offset by lower sales ~~volumes increased across all markets, primarily in relation to the ongoing recovery from the global economic slowdown.~~volumes. Average selling prices increased largely in response to higher raw material, energy and logistics costs ~~and~~as well as improved sales mix. Sales volumes decreased primarily due to ~~the impact~~deselection of ~~a weaker U.S. dollar against major international currencies.~~lower margin business. The increase in segment adjusted EBITDA was primarily due to higher sales ~~volumes~~prices and ~~the benefit from our recent acquisitions.~~

~~Textile Effects~~

~~The increase in revenues in our Textile Effects segment for the nine months ended September 30, 2021 compared to the same period of 2020 was primarily due to higher~~improved sales volumes and slightly higher average selling prices. Sales volumes increased primarily due to increased demand resulting from the ongoing recovery from the global economic slowdown. Average selling prices slightly increased primarily due to the impact of a weaker U.S. dollar against major international currencies. The increase in segment adjusted EBITDA was primarily due to higher sales revenues, partially offset by higher fixed costs.mix.

Corporate and other

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the nine months ended September 30, ~~2021,~~2022, adjusted EBITDA from Corporate and other for Huntsman Corporation ~~decreased by $32~~was a loss of $123 million as compared to a loss of $146 million ~~from a loss of $114 million~~ for the same period of ~~2020.~~2021. For the nine months ended September 30, ~~2021,~~2022, adjusted EBITDA from Corporate and other for Huntsman International ~~decreased by $30~~was a loss of $119 million as compared to a loss of $140 million ~~from a loss of $110 million~~ for the same period of ~~2020.~~2021. The ~~decrease~~increase in adjusted EBITDA from Corporate and other ~~was~~resulted primarily ~~due to a charge~~ from ~~a LIFO inventory valuation reserve adjustment and an increase in corporate overhead costs, partially offset by~~ an increase in unallocated foreign currency exchange ~~gains.~~gains and a decrease in corporate overhead costs and LIFO valuation losses.

5249

Table of Contents

Liquidity and Capital Resources

The following is a discussion of our liquidity and capital resources and does not include separate information with respect to Huntsman International in accordance with General Instructions H(1)(a) and (b) of Form 10-Q.

Cash Flows for the Nine Months Ended September 30, ~~2021~~2022 Compared with the Nine Months Ended September 30, ~~2020~~ 2021

Net cash provided by operating activities from continuing operations for the nine months ended September 30, 2022 and 2021 ~~and 2020~~ was ~~$163~~$595 million and ~~$110~~$182 million, respectively. The increase in net cash provided by operating activities from continuing operations during the nine months ended September 30, ~~2021~~2022 compared with the same period in ~~2020~~2021 was primarily attributable to increased operating income as described in “—Results of Operations” above for the nine months ended September 30, ~~2021~~2022 as compared with the same period of ~~2020, partially offset by~~2021 as well as a ~~$382~~net cash inflow of $143 million ~~unfavorable variance~~related to changes in operating assets and liabilities.

Net cash ~~(used in) provided by~~used in investing activities from continuing operations for the nine months ended September 30, 2022 and 2021 ~~and 2020~~ was ~~$(439)~~$176 million and ~~$1,105~~$430 million, respectively. During the nine months ended September 30, ~~2021~~2022 and ~~2020,~~2021, we paid ~~$250~~$186 million and ~~$170~~$241 million for capital expenditures, respectively. During the nine months ended September 30, 2021, we received $43 million for the sale of businesses, primarily due to the receipt of $28 million pursuant to an earnout provision in connection with the sale of ~~our~~the India-based DIY business, and we paid $245 million for the acquisition of businesses, primarily related to approximately $242 million paid for the Gabriel Acquisition, net of cash acquired. During the nine months ended September 30, 2020, we received approximately $1.92 billion for the sale of our Chemical Intermediates Businesses, and we paid $653 million in connection with the Icynene-Lapolla Acquisition and the CVC Thermoset Specialties Acquisition, net of cash acquired.

Net cash used in financing activities for the nine months ended September 30, 2022 and 2021 was $905 million and ~~2020 was~~ $809 million, respectively. During the nine months ended September 30, 2022 and ~~$546~~2021, we paid $755 million and $102 million for repurchases of our common stock, respectively. During the nine months ended September 30, 2021, we redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 2021 Senior Notes, and we redeemed in full $400 million in aggregate principal amount of our 2022 Senior Notes. Additionally, during the nine months ended September 30, 2021, we issued $400 million in aggregate principal amount of our 2031 Senior Notes and received borrowings of approximately 104 million SAR (approximately $27 million) related to funding on a new term loan facility of our consolidated 50%-owned joint venture, AAC. See “Note 8. Debt—Direct and Subsidiary Debt—Variable Interest Entity Debt” to our condensed consolidated financial statements. During the nine months ended September 30, 2020, we repaid a total of $153 million on our Revolving Credit Facility and repaid in full $109 million on our 2019 Term Loan in the third quarter of 2020.

Free cash flow from continuing operations for the nine months ended September 30, 2022 and 2021 was a source of cash of $409 million and ~~2020 was~~ a use of cash of ~~$87~~$59 million, ~~and $60 million,~~ respectively. The increase in free cash flow was primarily attributable to the increase in cash provided by operating activities from continuing operations as well as a decrease in cash used for capital expenditures during the nine months ended September 30, 2022 as compared with the same period in 2021.

Table of Contents

Changes in Financial Condition

The following information summarizes our working capital position (dollars in millions):

September 30,

Less

December 31,

(Decrease)

Percent

2021

Acquisition(1)

Subtotal

2020

Increase

Change

Cash and cash equivalents
$ 505 $ (9 ) $ 496 $ 1,593 $ (1,097 ) (69 )%
Accounts and notes receivable, net
1,239 (13 ) 1,226 910 316 35 %
Inventories
1,174 (26 ) 1,148 848 300 35 %
Other current assets
196 — 196 217 (21 ) (10 )%
Total current assets
3,114 (48 ) 3,066 3,568 (502 ) (14 )%
Accounts payable
985 (7 ) 978 876 102 12 %
Accrued liabilities
569 (2 ) 567 458 109 24 %
Current portion of debt
16 — 16 593 (577 ) (97 )%
Current operating lease liabilities
54 — 54 52 2 4 %
Total current liabilities
1,624 (9 ) 1,615 1,979 (364 ) (18 )%
Working capital
$ 1,490 $ (39 ) $ 1,451 $ 1,589 $ (138 ) (9 )%

	September 30,		December 31,		(Decrease)			Percent
	2022		2021		Increase			Change
Cash and cash equivalents	$	515	$	1,041	$	(526	)		(51	)%
Accounts and notes receivable, net		1,004		1,015		(11	)		(1	)%
Inventories		1,079		1,038		41			4	%
Receivable associated with the Albemarle Settlement		—		333		(333	)		(100	)%
Other current assets		115		155		(40	)		(26	)%
Current assets held for sale(1)		483		346		137			40	%
Total current assets		3,196		3,928		(732	)		(19	)%

Accounts payable		898		1,114		(216	)		(19	)%
Accrued liabilities		393		713		(320	)		(45	)%
Current portion of debt		12		12		—			—
Current operating lease liabilities		50		49		1			2	%
Current liabilities held for sale(1)		242		163		79			48	%
Total current liabilities		1,595		2,051		(456	)		(22	)%
Working capital	$	1,601	$	1,877	$	(276	)		(15	)%

(1)

~~Represents amounts related to~~Total assets and liabilities held for sale as of September 30, 2022 are classified as current because it is probable that the ~~Gabriel Acquisition.~~sale of our Textile Effects Business will close within a year. For more information see “Note 3.4. Discontinued Operations and Business ~~Combinations and Acquisitions—Acquisition~~Dispositions—Sale of ~~Gabriel Performance Products”~~Textile Effects Business” to our condensed consolidated financial statements.

Our working capital decreased by ~~$138~~$276 million as a result of the net impact of the following significant changes:

●

The decrease in cash and cash equivalents of ~~$1,097~~$526 million resulted from the matters identified on our condensed consolidated statements of cash flows. See also “—Cash Flows for the Nine Months Ended September 30, 2022 Compared with the Nine Months Ended September 30, 2021.”

●

~~Accounts receivable~~Inventories increased by ~~$316~~$41 million primarily due to higher ~~revenues~~inventory costs.

●

Receivable associated with the arbitration award we won on October 28, 2021 in excess of $600 million against Albemarle Corporation (“Albemarle”) for fraud and breach of contract (the “Albemarle Settlement”) decreased to nil due to the ~~third~~receipt of the final arbitration award payment of $332.5 million during the second quarter of ~~2021 compared~~2022.

●

Other current assets decreased by $40 million primarily due to ~~the fourth quarter~~amortization of ~~2020.~~

deferred charges related to insurance premiums.

●

~~Inventories increased~~Accounts payable decreased by ~~$300~~$216 million primarily due to ~~higher inventory costs~~a decrease in non-trade payables related to insurance premiums and ~~volumes.~~

●

~~Accounts payable increased by $102 million primarily due to higher inventory purchases.~~a reduction of capital accruals.

●

Accrued liabilities ~~increased~~decreased by ~~$109~~$320 million primarily related to ~~higher~~the payment of legal fees and cash taxes associated with the Albemarle Settlement and a decrease in accrued compensation costs and current income taxes payable.

●

~~Current portion of debt decreased by $577 million primarily due to the redemption of our 2021 Senior Notes in the first half of 2021.~~

5351

Table of Contents

Direct and Subsidiary Debt

See “Note 8. Debt—Direct and Subsidiary Debt” to our condensed consolidated financial statements.

Debt Issuance Costs

See “Note 8. Debt—Direct and Subsidiary Debt—Debt Issuance Costs” to our condensed consolidated financial statements.

Revolving Credit Facility

See “Note 8. Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our condensed consolidated financial statements.

~~Term Loan Credit Facility~~

~~See “Note 8. Debt—Direct and Subsidiary Debt—Term Loan Credit Facility” to our condensed consolidated financial statements.~~

A/R Programs

See “Note 8. Debt—Direct and Subsidiary Debt—A/R Programs” to our condensed consolidated financial statements.

Senior Notes

See “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

Variable Interest Entity Debt

See “Note 8. Debt—Direct and Subsidiary Debt—Variable Interest Entity Debt” to our condensed consolidated financial statements.

~~Note Payable from Huntsman International to Huntsman Corporation~~

~~See “Note 8. Debt—Direct and Subsidiary Debt—Note Payable from Huntsman International to Huntsman Corporation” to our condensed consolidated financial statements.~~

Compliance with Covenants

See “Note 8. Debt—Compliance with Covenants” to our condensed consolidated financial statements.

5452

Table of Contents

We depend upon our cash, Revolving Credit Facility, A/R Programs and other debt instruments to provide liquidity for our operations and working capital needs. As of September 30, ~~2021,~~2022, we had ~~$1,955~~$1,946 million of combined cash and unused borrowing capacity, consisting of ~~$505~~$515 million in cash, ~~$1,190~~$1,189 million in availability under our Revolving Credit Facility and ~~$260~~$242 million in availability under our A/R Programs. Our liquidity can be significantly impacted by various factors. The following matters are expected to have a significant impact on our liquidity:

Short-Term Liquidity

●

Cash invested in our accounts receivable and inventory, net of accounts payable, was approximately ~~$546~~$301 million for the nine months ended September 30, ~~2021,~~2022, as reflected in our condensed consolidated statements of cash flows. We expect volatility in our working capital components to continue.

●

During ~~2021,~~2022, we expect to spend approximately ~~$350~~$280 million on capital expenditures. Our future expenditures ~~including spending~~include certain environmental, health and safety maintenance and upgrades; periodic maintenance and repairs applicable to major units of ~~approximately $100 million on a new MDI splitter in Geismar, Louisiana.~~manufacturing facilities; expansions of our existing facilities; certain cost reduction projects; and certain information technology expenditures. We expect to fund capital expenditures with cash provided by operations.

●

During the nine months ended September 30, ~~2021,~~2022, we made contributions to our pension and other postretirement benefit plans related to continuing operations of ~~$45~~$35 million. During ~~2021,~~2022, we expect to contribute an additional amount of approximately $9$10 million to these plans.

●

~~On February 7, 2018 and on May 3, 2018, our Board of Directors collectively authorized us to repurchase up to an aggregate of $1 billion in shares of our common stock.~~

During the ~~three months and~~ nine months ended September 30, ~~2021,~~2022, we repurchased ~~3,971,784~~22,853,686 shares of our common stock for approximately ~~$102~~$752 million, excluding commissions, under ~~the~~our share repurchase program. From October 1, 2022 through October 25, 2022, we repurchased an additional 1,539,537 shares of our common stock for approximately $40 million, excluding commissions.

●

On October 28, 2021, we won an arbitration award in excess of $600 million against Albemarle. On November 4, 2021, Albemarle agreed to waive any appeal and pay $665 million, of which we received $332.5 million on December 2, 2021 and received a final payment of $332.5 million on May 2, 2022. We paid legal fees and cash taxes of approximately $255 million in the second quarter of 2022.

●

Long-Term Liquidity

●

On April 28, 2021, our Board of Directors declared a $0.1875 per share cash dividend on our common stock. This represents a 15% increase from the previous dividend. We expect to distribute an additional $5.5 million in dividends each quarter related to this dividend increase.

●

On May 26, 2021, Huntsman International completed a $400 million offering of its 2031 Senior Notes. On June 23, 2021, Huntsman International applied the net proceeds from the offering, along with cash on hand, to redeem in full the $400 million in aggregate principal amount of its 2022 Senior Notes. For additional information, see “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

●

~~On July 1, 2021, we entered into amendments to our A/R Programs that, among other things, extended the scheduled termination dates of our A/R Programs from April 2022 to July 2024.~~

●

On a new MDI splitter being constructed in Geismar, Louisiana, we expect to spend approximately $50 million in the remainder of 2021 and 2022. We expect to fund capital expenditures with cash provided by operations.

●

During 2020, management implemented cost realignment and synergy plans. In connection with these plans, we ~~expect~~remain committed to ~~achieve~~achieving annualized cost savings and synergy benefits of ~~more than $120~~approximately $140 million ~~by the end of~~during 2023, as previously communicated. Associated with ~~associated~~these plans, we expect net cash restructuring and integration costs, including capital expenditures, of approximately $115 million, of which we have spent approximately $102 million to date.

●

During 2021, management announced additional cost realignment plans. In connection with these plans, we currently expect to achieve annualized cost savings of approximately $100 million by the end of 2023. Associated with these plans, we expect net cash restructuring and integration costs, including capital expenditures, of approximately $135 million through 2024, of which we have spent approximately $25 million to date.

●

In early November 2022, we announced our commitment and specific plans to further realign our cost structure beyond the current in-progress cost optimization programs with additional restructuring in Europe. The new program will include exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we expect to record restructuring expenses of approximately $50 million through 2023, and we have identified approximately $40 million of annualized cost savings to be achieved by the end of 2023.

●

On February 14, 2022, our Board of Directors declared a $0.2125 per share cash dividend on our common stock. This represents a 13% increase from the previous dividend.

●

On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site. The case was filed after Praxair refused to properly maintain its own Geismar facility and then repeatedly failed to supply our requirements for industrial gas needed to manufacture MDI under long-term supply contracts that expired in 2013. After the court applies the appropriate amount of interest, we expect that total damages awarded to us will exceed $125 million. The award is subject to appeal, and as such, we have not yet recognized the award in our condensed consolidated statements of operations.

●

On May 20, 2022, Huntsman International entered into the 2022 Revolving Credit Facility. Borrowings will bear interest at the rates specified in the credit agreement governing the 2022 Credit Facility, which will vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the credit agreement will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional $500 million, subject to the satisfaction of certain conditions. In connection with entering into the 2022 Revolving Credit Facility, Huntsman International terminated all commitments and repaid all obligations under its 2018 $1.2 billion senior unsecured credit facility. See “Note ~~7. Restructuring, Impairment~~8. Debt—Direct and ~~Plant Closing Cost”~~Subsidiary Debt—Revolving Credit Facility” to our condensed consolidated financial statements.

As of September 30, ~~2021,~~2022, we had ~~$16~~$12 million classified as current portion of debt, including debt at our variable interest entities of ~~$13~~$10 million and certain other short-term facilities and scheduled amortization payments totaling $3$2 million. We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months.

As of September 30, ~~2021,~~2022, we had approximately ~~$365~~$462 million of cash and cash equivalents ~~including restricted cash,~~ held by our foreign subsidiaries, including our variable interest entities. We intend to use cash held in our foreign subsidiaries to fund our local operations. Nevertheless, we could repatriate cash as dividends, which dividends would generally not be subject to U.S. taxation as a result of the U.S. Tax Reform Act. However, such repatriation may potentially be subject to certain foreign withholding taxes.

5553

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, ~~2021.~~2022. Based on this evaluation, our chief executive officer and chief financial officer have concluded that, as of September 30, ~~2021,~~2022, our disclosure controls and procedures were effective, in that they ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

No changes to our internal control over financial reporting occurred during the quarter ended September 30, ~~2021~~2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). However, we can only give reasonable assurance that our internal controls over financial reporting will prevent or detect material misstatements on a timely basis. ~~Ineffective internal controls over financial reporting could cause investors to lose confidence in our reported financial information and could result in a lower trading price for our securities.~~

5654

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

~~Except as set forth below, there~~There have been no material developments with respect to the legal proceedings referenced in Part I, Item 3 of our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021.

~~Rockwood Litigation~~

On February 6, 2017, we filed a lawsuit in New York state court against Rockwood Specialties Group, Inc., Rockwood Holdings, Inc. (collectively, “Rockwood”), Albemarle Corporation (as Rockwood’s successor) (“Albemarle”) and certain former Rockwood executives to recover damages for fraud and breach of contract in connection with our purchase of Rockwood’s pigments businesses, including its Color Pigments Division, for $1.1 billion in 2014. The case was ordered to arbitration under the rules of the American Arbitration Association and, after a two-week trial in May 2021, a panel consisting of three former federal judges awarded us in excess of $600 million for the fraud and breach, inclusive of punitive damages and statutory interest at 9%, of which we expect to net in excess of $400 million after attorney’s fees. The award is subject to confirmation and limited appeal in New York state court, and the arbitration panel directed us to file for reimbursement from Albemarle for attorney’s fees as prevailing party.

~~Texas Emissions Enforcement~~

On July 26, 2021, the Attorney General of the State of Texas filed a civil suit in the District Court of Travis County, Texas seeking civil penalties and attorney’s fees for alleged violations of the Texas Clean Air Act, Texas Commission on Environmental Quality regulations and facility permit terms. The complaint alleged multiple unauthorized emissions events and reporting discrepancies that occurred between December 2016 and June 2019 at our former manufacturing facility in Port Neches, Texas. The state is seeking monetary relief between $250,000 and $1 million. We completed the sale of our former Port Neches, Texas facility to Indorama Ventures Holdings L.P. on January 3, 2020. We believe that we are contractually indemnified for any defense costs and potential liability that may result from this action.

ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021. In addition to the risk factors noted in the Annual Report on Form 10-K, the following risk factor is applicable to us.

The proposed sale of our Textile Effects Business is contingent upon the satisfaction of a number of conditions, will require significant time and attention of our management and may have an adverse effect on us if not completed.

On August 9, 2022, we entered into a definitive agreement to sell our Textile Effects Business to Archroma for a total enterprise value of $718 million, which includes the assumption of approximately $125 million in net underfunded pension liabilities as of December 31, 2021. Completion of the proposed sale is subject to the satisfaction of various closing conditions, including but not limited to regulatory approvals. There can be no assurance that any of such conditions will be satisfied and that the proposed sale will be successfully completed. These or other unanticipated developments could delay or prevent the transaction from closing or cause it to occur on terms or conditions that are less favorable than anticipated, which could cause our common stock to experience negative reactions from the financial markets.

In pursuing the proposed sale, our ongoing businesses may be adversely affected, and we may be subject to certain risks and consequences, including, but not limited to, the following:

• execution of the proposed sale has required, and will continue to require, significant time and attention from management, which may postpone the execution of other initiatives that may have been beneficial to us;

• completion of the proposed sale will require strategic, structural and process realignment and restructuring actions within our operations, which could lead to a disruption of our operations, as well as the loss of, or inability to recruit, key personnel needed to operate and grow our businesses;

• completion of the proposed sale may require certain management and procedural redundancies as we prepare for closing, which may result in operating inefficiencies; and

• whether or not the proposed sale is completed, we may be responsible for certain costs and expenses, such as legal, accounting and other professional fees, which may be significant.

Any of these factors could have a material adverse effect on our financial condition, results of operations, cash flows and the price of our common stock.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information with respect to shares of our common stock that we repurchased as part of our share repurchase program and shares of restricted stock granted under our stock incentive plans that we withheld upon vesting to satisfy our tax withholding obligations during the three months ended September 30, ~~2021.~~2022.

Total number of

Approximate dollar

shares purchased

value of shares that

Total number

Average

as part of publicly

may yet be purchased

of shares

price paid

announced plans

under the plans or

purchased

per share(1)

or programs(2)

programs(2)

July
344 $ 26.70 — $ 420,000,000
August
2,973,750 25.40 2,972,351 345,000,000
September
999,559 26.37 999,433 318,000,000
Total
3,973,653 25.64 3,971,784

					Total number of		Approximate dollar
					shares purchased		value of shares that
	Total number		Average		as part of publicly		may yet be purchased
	of shares		price paid		announced plans		under the plans or
	purchased		per share(1)		or programs(2)		programs(2)
July 1 - July 31		1,944,359	$	28.86		1,943,177	$	1,342,000,000
August 1 - August 31		3,815,850		29.37		3,814,930		1,230,000,000
September 1 - September 30		3,175,239		26.16		3,174,808		1,147,000,000
Total		8,935,448		28.12		8,932,915

(1)

Represents net purchase price per share, exclusive of any fees or commissions.

(2)

On ~~February 7, 2018 and on May 3, 2018,~~October 26, 2021, our Board of Directors ~~authorized us to repurchase up to an aggregate of $1 billion in shares of our common stock. The~~approved a new share repurchase program isof $1 billion. In conjunction with the inception of this program, we retired our prior share repurchase program. On March 25, 2022, our Board of Directors increased the authorization of our existing share prepurchase program from $1 billion of repurchases to $2 billion. Similar to our prior share repurchase program, the share repurchase program will be supported by our free cash flow generation. Repurchases may be made in the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. ~~Subsequent to the end of the first quarter of 2020, we suspended share repurchases under our existing share repurchase program in order to enhance our liquidity position in response to COVID-19.~~ During the third quarter of ~~2021,~~2022, we ~~resumed the share repurchase program and~~ repurchased ~~3,971,784~~8,932,915 shares of our common stock for approximately ~~$102~~$251 million, excluding commissions.

5755

Table of Contents

ITEM 6. EXHIBITS

See the Exhibit Index at the end of this Quarterly Report on Form 10-Q for exhibits filed with this report.

5856

Table of Contents

EXHIBIT INDEX

Incorporated by Reference
Exhibit Number

Exhibit Description
Form
Exhibit
Filing Date
10.1 Master Amendment No. 10 to U.S. Receivables Loan Agreement, U.S. Servicing Agreement, U.S. Receivables Purchase Agreement and Transaction Documents, dated as of July 1, 2021 10-Q 10.1 July 30, 2021
10.2 Amended and Restated European Receivables Loan Agreement, dated as of July 1, 2021 10-Q 10.2 July 30, 2021
10.3 * Independent Services Agreement No. ISA-SD-2021 (Sean Douglas)
31.1
*
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2
*
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1
*
Certification of Chief Executive Office r pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2
*
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS
*
Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH
*
Inline XBRL Taxonomy Extension Schema

101.CAL
*
Inline XBRL Taxonomy Extension Calculation Linkbase

101.LAB
*
Inline XBRL Taxonomy Extension Label Linkbase

101.PRE
*
Inline XBRL Taxonomy Extension Presentation Linkbase

101.DEF
*
Inline XBRL Taxonomy Extension Definition Linkbase

104

The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

			Incorporated by Reference
Exhibit Number		Exhibit Description	Form	Exhibit	Filing Date
2.1	*	Equity and Asset Purchase Agreement, dated as of August 9, 2022, by and among Huntsman, Archroma, Archroma Germany and solely for purposes set forth in the Purchase Agreement, the Archroma Financing Party.	8-K	2.1	August 9, 2022
31.1	**	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	**	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	**	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	**	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	**	Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	**	Inline XBRL Taxonomy Extension Schema
101.CAL	**	Inline XBRL Taxonomy Extension Calculation Linkbase
101.LAB	**	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	**	Inline XBRL Taxonomy Extension Presentation Linkbase
101.DEF	**	Inline XBRL Taxonomy Extension Definition Linkbase
104		The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

^*	Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Huntsman agrees to furnish supplementally to the SEC a copy of any omitted schedule upon request by the SEC.
**	Filed herewith

5957

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

Dated: ~~October 29, 2021~~November 4, 2022	HUNTSMAN CORPORATION
	HUNTSMAN INTERNATIONAL LLC

	By:	/s/ PHILIP M. LISTER
		Philip M. Lister
		Executive Vice President and Chief Financial Officer
		and Manager (Principal Financial Officer)

	By:	/s/ STEVEN C. JORGENSEN
		Steven C. Jorgensen
		Vice President and Controller (Authorized Signatory and
		Principal Accounting Officer)

6058

Fair value of assets acquired and liabilities assumed:
Cash paid for the CVC Thermoset Specialties Acquisition	$	304

Accounts receivable	$	12
Inventories		37
Property, plant and equipment		67
Intangible assets		117
Goodwill		120
Accounts payable		(7	)
Accrued liabilities		(1	)
Deferred income taxes		(41	)
Total fair value of net assets acquired	$	304

Fair value of assets acquired and liabilities assumed:
Cash paid for the Icynene-Lapolla Acquisition	$	353

Cash	$	7
Accounts receivable		36
Inventories		32
Prepaid expenses and other current assets		2
Property, plant and equipment		9
Intangible assets		130
Goodwill		167
Other noncurrent assets		4
Accounts payable		(14	)
Accrued liabilities		(11	)
Deferred income taxes		(9	)
Total fair value of net assets acquired	$	353

	*Workforce reductions*			*Non-cancelable lease and contract termination costs*		*Other restructuring costs*			*Total*
Accrued liabilities as of January 1, 2021	$	29		$	2	$	—		$	31
2021 charges for 2020 and prior initiatives		13			—		5			18
2021 charges for 2021 initiatives		2			—		—			2
2021 payments for 2020 and prior initiatives		(12	)		—		(4	)		(16	)
2021 payments for 2021 initiatives		(1	)		—		—			(1	)
Accrued liabilities as of September 30, 2021	$	31		$	2	$	1		$	34

	September 30,		Less					December 31,		(Decrease)			Percent
	2021		Acquisition(1)			Subtotal		2020		Increase			Change
Cash and cash equivalents	$	505	$	(9	)	$	496	$	1,593	$	(1,097	)		(69	)%
Accounts and notes receivable, net		1,239		(13	)		1,226		910		316			35	%
Inventories		1,174		(26	)		1,148		848		300			35	%
Other current assets		196		—			196		217		(21	)		(10	)%
Total current assets		3,114		(48	)		3,066		3,568		(502	)		(14	)%
Accounts payable		985		(7	)		978		876		102			12	%
Accrued liabilities		569		(2	)		567		458		109			24	%
Current portion of debt		16		—			16		593		(577	)		(97	)%
Current operating lease liabilities		54		—			54		52		2			4	%
Total current liabilities		1,624		(9	)		1,615		1,979		(364	)		(18	)%
Working capital	$	1,490	$	(39	)	$	1,451	$	1,589	$	(138	)		(9	)%